NZ723135B2 - Integrative fungal solutions for protecting bees - Google Patents
Integrative fungal solutions for protecting bees Download PDFInfo
- Publication number
- NZ723135B2 NZ723135B2 NZ723135A NZ72313515A NZ723135B2 NZ 723135 B2 NZ723135 B2 NZ 723135B2 NZ 723135 A NZ723135 A NZ 723135A NZ 72313515 A NZ72313515 A NZ 72313515A NZ 723135 B2 NZ723135 B2 NZ 723135B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- bees
- bee
- mycelium
- extracts
- ganoderma
- Prior art date
Links
- 241000257303 Hymenoptera Species 0.000 title claims description 364
- 230000002538 fungal effect Effects 0.000 title description 49
- 239000000284 extract Substances 0.000 claims abstract description 186
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 109
- 239000000203 mixture Substances 0.000 claims abstract description 68
- 238000000034 method Methods 0.000 claims abstract description 58
- 230000003612 virological effect Effects 0.000 claims abstract description 49
- 241000123330 Fomes fomentarius Species 0.000 claims abstract description 38
- 241001480612 Ganoderma resinaceum Species 0.000 claims abstract description 35
- 230000001965 increasing effect Effects 0.000 claims abstract description 34
- 241000408172 Fomitopsis officinalis Species 0.000 claims abstract description 27
- 241000222481 Schizophyllum commune Species 0.000 claims abstract description 26
- 241000222355 Trametes versicolor Species 0.000 claims abstract description 24
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 20
- 241000123150 Fomitopsis pinicola Species 0.000 claims abstract description 19
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 19
- 241001149422 Ganoderma applanatum Species 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 102
- 241000233866 Fungi Species 0.000 claims description 91
- 235000000346 sugar Nutrition 0.000 claims description 80
- 241000238876 Acari Species 0.000 claims description 67
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 51
- 235000012907 honey Nutrition 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 241000222336 Ganoderma Species 0.000 claims description 27
- 230000000967 entomopathogenic effect Effects 0.000 claims description 26
- 241000958507 Stropharia Species 0.000 claims description 24
- 235000006408 oxalic acid Nutrition 0.000 claims description 22
- 230000001717 pathogenic effect Effects 0.000 claims description 20
- 241000241413 Propolis Species 0.000 claims description 19
- 229940069949 propolis Drugs 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 241000222354 Trametes Species 0.000 claims description 15
- 239000002244 precipitate Substances 0.000 claims description 15
- 235000020374 simple syrup Nutrition 0.000 claims description 14
- 239000000642 acaricide Substances 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- 241000123196 Piptoporus betulinus Species 0.000 claims description 12
- 241000958510 Stropharia rugosoannulata Species 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 235000009508 confectionery Nutrition 0.000 claims description 10
- 235000013500 Melia azadirachta Nutrition 0.000 claims description 9
- 235000001603 Pleurotus ostreatus Nutrition 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000013589 supplement Substances 0.000 claims description 8
- 235000007685 Pleurotus columbinus Nutrition 0.000 claims description 7
- 150000008163 sugars Chemical class 0.000 claims description 7
- 241000123370 Antrodia Species 0.000 claims description 6
- 241001237914 Psilocybe Species 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 240000004202 Ganoderma oregonense Species 0.000 claims description 5
- 241001480597 Ganoderma tsugae Species 0.000 claims description 5
- 241000222640 Polyporus Species 0.000 claims description 5
- 239000004519 grease Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 241000735439 Heterobasidion annosum Species 0.000 claims description 4
- 241001237941 Hypholoma Species 0.000 claims description 4
- 241001669562 Hypholoma capnoides Species 0.000 claims description 4
- 240000005995 Laetiporus sulphureus Species 0.000 claims description 4
- 235000007714 Laetiporus sulphureus Nutrition 0.000 claims description 4
- 244000237986 Melia azadirachta Species 0.000 claims description 4
- 241000131430 Mycena Species 0.000 claims description 4
- 241001062357 Psilocybe cubensis Species 0.000 claims description 4
- 241000332761 Psilocybe cyanescens Species 0.000 claims description 4
- 241001082316 Trametes elegans Species 0.000 claims description 4
- 235000013871 bee wax Nutrition 0.000 claims description 4
- 229940092738 beeswax Drugs 0.000 claims description 4
- 239000012166 beeswax Substances 0.000 claims description 4
- 239000000469 ethanolic extract Substances 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 241001327634 Agaricus blazei Species 0.000 claims description 3
- 235000002469 Clitocybe nuda Nutrition 0.000 claims description 3
- 241001059883 Clitocybe odora Species 0.000 claims description 3
- 241001236189 Conocybe Species 0.000 claims description 3
- 241000906988 Ganoderma atrum Species 0.000 claims description 3
- 244000309594 Ganoderma brownii Species 0.000 claims description 3
- 241000901378 Ganoderma curtisii Species 0.000 claims description 3
- 235000015718 Ganoderma oregonense Nutrition 0.000 claims description 3
- 241000222635 Lenzites betulinus Species 0.000 claims description 3
- 241001503562 Lepiota Species 0.000 claims description 3
- 244000290281 Lepista nuda Species 0.000 claims description 3
- 241000222464 Neolentinus ponderosus Species 0.000 claims description 3
- 241000123113 Phellinus igniarius Species 0.000 claims description 3
- 241001138370 Pleurotus pulmonarius Species 0.000 claims description 3
- 241001237975 Termitomyces Species 0.000 claims description 3
- 241000001727 Tropicoporus linteus Species 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 3
- 235000008504 concentrate Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 241000222518 Agaricus Species 0.000 claims description 2
- 240000000146 Agaricus augustus Species 0.000 claims description 2
- 235000002889 Agaricus augustus Nutrition 0.000 claims description 2
- 240000007440 Agaricus campestris Species 0.000 claims description 2
- 241000004862 Agaricus lilaceps Species 0.000 claims description 2
- 240000007068 Agaricus silvaticus Species 0.000 claims description 2
- 240000001538 Agaricus subrufescens Species 0.000 claims description 2
- 235000008121 Agrocybe aegerita Nutrition 0.000 claims description 2
- 244000045069 Agrocybe aegerita Species 0.000 claims description 2
- 241000305729 Conocybe smithii Species 0.000 claims description 2
- 241001292349 Coprinopsis nivea Species 0.000 claims description 2
- 244000234623 Coprinus comatus Species 0.000 claims description 2
- 235000004439 Coprinus comatus Nutrition 0.000 claims description 2
- 241001534815 Hypsizygus marmoreus Species 0.000 claims description 2
- 241000644152 Hypsizygus tessulatus Species 0.000 claims description 2
- 241000286803 Laetiporus cincinnatus Species 0.000 claims description 2
- 241000149440 Lentinus tuber-regium Species 0.000 claims description 2
- 241000030943 Phellinus robustus Species 0.000 claims description 2
- 241000233748 Pholiotina cyanopus Species 0.000 claims description 2
- 244000212450 Pleurotus cystidiosus Species 0.000 claims description 2
- 241000392433 Pleurotus sapidus Species 0.000 claims description 2
- 241001061526 Pluteus cervinus Species 0.000 claims description 2
- 241001236760 Psathyrella Species 0.000 claims description 2
- 241000377771 Psilocybe allenii Species 0.000 claims description 2
- 241000332760 Psilocybe azurescens Species 0.000 claims description 2
- 241000123160 Sarcomyxa serotina Species 0.000 claims description 2
- 241001476308 Stereum ostrea Species 0.000 claims description 2
- 241001275950 Stropharia caerulea Species 0.000 claims description 2
- 241001062394 Stropharia semiglobata Species 0.000 claims description 2
- 241001230654 Trametes cingulata Species 0.000 claims description 2
- 241000321980 Trametes gibbosa Species 0.000 claims description 2
- 240000006794 Volvariella volvacea Species 0.000 claims description 2
- 235000004501 Volvariella volvacea Nutrition 0.000 claims description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 2
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 2
- 235000005974 protein supplement Nutrition 0.000 claims description 2
- 229940116540 protein supplement Drugs 0.000 claims description 2
- 241000333570 Gymnopus Species 0.000 claims 2
- 241000565604 Macrolepiota procera Species 0.000 claims 2
- 240000006765 Pleurotus columbinus Species 0.000 claims 2
- 241000965186 Agaricus brasiliensis Species 0.000 claims 1
- 235000004570 Agaricus campestris Nutrition 0.000 claims 1
- 235000008610 Agaricus subrufescens Nutrition 0.000 claims 1
- 241001236191 Agrocybe praecox Species 0.000 claims 1
- 241001083841 Aquatica Species 0.000 claims 1
- 241001480589 Chlorophyllum rhacodes Species 0.000 claims 1
- 241001236167 Conocybe rickenii Species 0.000 claims 1
- 241000958930 Conocybe tenera Species 0.000 claims 1
- 241001236802 Coprinopsis lagopus Species 0.000 claims 1
- 244000153785 Coprinus micaceus Species 0.000 claims 1
- 235000016438 Coprinus micaceus Nutrition 0.000 claims 1
- 241000390476 Ganoderma lingzhi Species 0.000 claims 1
- 241000964788 Hydrophilus <angiosperm> Species 0.000 claims 1
- 241000286804 Laetiporus conifericola Species 0.000 claims 1
- 241000287745 Leratiomyces ceres Species 0.000 claims 1
- 241000919676 Leratiomyces squamosus Species 0.000 claims 1
- 241000890123 Leratiomyces squamosus var. thraustus Species 0.000 claims 1
- 244000103635 Lyophyllum ulmarium Species 0.000 claims 1
- 235000015934 Lyophyllum ulmarium Nutrition 0.000 claims 1
- 241001657046 Mycena pura Species 0.000 claims 1
- 241001480584 Panaeolus foenisecii Species 0.000 claims 1
- 241001261684 Panaeolus subbalteatus Species 0.000 claims 1
- 241000222639 Panellus stipticus Species 0.000 claims 1
- 235000002475 Pleurotus cystidiosus Nutrition 0.000 claims 1
- 241000414073 Pseudoinonotus dryadeus Species 0.000 claims 1
- 241001237928 Psilocybe stuntzii Species 0.000 claims 1
- 241000222647 Stereum complicatum Species 0.000 claims 1
- 241000123055 Stereum hirsutum Species 0.000 claims 1
- 241001578971 Trametes ectypa Species 0.000 claims 1
- 241000222357 Trametes hirsuta Species 0.000 claims 1
- 241000217816 Trametes villosa Species 0.000 claims 1
- 241001619444 Wolfiporia cocos Species 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 241000414067 Inonotus obliquus Species 0.000 abstract description 28
- 241000256844 Apis mellifera Species 0.000 description 174
- 241000700605 Viruses Species 0.000 description 117
- 241000894007 species Species 0.000 description 97
- 230000008901 benefit Effects 0.000 description 75
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 47
- 230000000840 anti-viral effect Effects 0.000 description 42
- 239000002023 wood Substances 0.000 description 41
- 230000000694 effects Effects 0.000 description 38
- 230000036541 health Effects 0.000 description 37
- 231100000765 toxin Toxicity 0.000 description 35
- 241000256837 Apidae Species 0.000 description 34
- 108090000623 proteins and genes Proteins 0.000 description 34
- 239000003053 toxin Substances 0.000 description 34
- 108700012359 toxins Proteins 0.000 description 34
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 32
- 241000238631 Hexapoda Species 0.000 description 32
- 241000895647 Varroa Species 0.000 description 32
- 241000255925 Diptera Species 0.000 description 30
- 239000000575 pesticide Substances 0.000 description 30
- 244000052769 pathogen Species 0.000 description 29
- 230000009286 beneficial effect Effects 0.000 description 28
- 201000010099 disease Diseases 0.000 description 28
- 241000196324 Embryophyta Species 0.000 description 25
- 230000004083 survival effect Effects 0.000 description 25
- 150000001875 compounds Chemical class 0.000 description 24
- 230000000844 anti-bacterial effect Effects 0.000 description 23
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 22
- 241001126829 Nosema Species 0.000 description 22
- 239000000054 fungal extract Substances 0.000 description 22
- 230000006872 improvement Effects 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- 235000013305 food Nutrition 0.000 description 21
- 241001480537 Fomitopsis Species 0.000 description 19
- 241000223250 Metarhizium anisopliae Species 0.000 description 19
- 208000035475 disorder Diseases 0.000 description 19
- 230000009467 reduction Effects 0.000 description 19
- 238000006722 reduction reaction Methods 0.000 description 19
- 241000318498 Black queen cell virus Species 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 18
- 108090000790 Enzymes Proteins 0.000 description 18
- 208000024780 Urticaria Diseases 0.000 description 18
- 239000002253 acid Substances 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 18
- 239000003205 fragrance Substances 0.000 description 18
- 150000002500 ions Chemical class 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 18
- 230000037361 pathway Effects 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 17
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 17
- 235000001671 coumarin Nutrition 0.000 description 17
- 150000004775 coumarins Chemical class 0.000 description 17
- 208000015181 infectious disease Diseases 0.000 description 17
- 210000000416 exudates and transudate Anatomy 0.000 description 16
- 230000001976 improved effect Effects 0.000 description 16
- 244000045947 parasite Species 0.000 description 16
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 15
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 15
- 241001506928 Deformed wing virus Species 0.000 description 15
- 241000282412 Homo Species 0.000 description 15
- 241000282458 Ursus sp. Species 0.000 description 15
- 244000144987 brood Species 0.000 description 15
- 230000007123 defense Effects 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 238000001784 detoxification Methods 0.000 description 14
- 150000004676 glycans Chemical class 0.000 description 14
- 230000036039 immunity Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 235000015097 nutrients Nutrition 0.000 description 14
- 229920001282 polysaccharide Polymers 0.000 description 14
- 239000005017 polysaccharide Substances 0.000 description 14
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical class OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 14
- 230000000843 anti-fungal effect Effects 0.000 description 13
- 230000006378 damage Effects 0.000 description 13
- 210000000987 immune system Anatomy 0.000 description 13
- 150000008442 polyphenolic compounds Chemical class 0.000 description 13
- 235000013824 polyphenols Nutrition 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 241000223201 Metarhizium Species 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 230000007423 decrease Effects 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 235000013339 cereals Nutrition 0.000 description 11
- 239000002917 insecticide Substances 0.000 description 11
- 235000016709 nutrition Nutrition 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 10
- 241000221198 Basidiomycota Species 0.000 description 10
- 235000018185 Betula X alpestris Nutrition 0.000 description 10
- 235000018212 Betula X uliginosa Nutrition 0.000 description 10
- 240000007594 Oryza sativa Species 0.000 description 10
- 235000007164 Oryza sativa Nutrition 0.000 description 10
- 241000723677 Tobacco ringspot virus Species 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 244000053095 fungal pathogen Species 0.000 description 10
- 235000009566 rice Nutrition 0.000 description 10
- 241001163131 Israeli acute paralysis virus Species 0.000 description 9
- 240000001462 Pleurotus ostreatus Species 0.000 description 9
- 241000607479 Yersinia pestis Species 0.000 description 9
- 230000003466 anti-cipated effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 230000010152 pollination Effects 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 230000035882 stress Effects 0.000 description 9
- 231100000331 toxic Toxicity 0.000 description 9
- 230000002588 toxic effect Effects 0.000 description 9
- 230000003827 upregulation Effects 0.000 description 9
- 241000756673 Anisops Species 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 230000000842 anti-protozoal effect Effects 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000001419 dependent effect Effects 0.000 description 8
- 230000002431 foraging effect Effects 0.000 description 8
- 230000009368 gene silencing by RNA Effects 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 7
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 7
- 241000238421 Arthropoda Species 0.000 description 7
- 108010029541 Laccase Proteins 0.000 description 7
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 7
- 241001558516 Varroa destructor Species 0.000 description 7
- 229940121375 antifungal agent Drugs 0.000 description 7
- 239000003443 antiviral agent Substances 0.000 description 7
- 239000000470 constituent Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- 235000021436 nutraceutical agent Nutrition 0.000 description 7
- 230000003071 parasitic effect Effects 0.000 description 7
- 244000052613 viral pathogen Species 0.000 description 7
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 241000009794 Agaricomycetes Species 0.000 description 6
- 241000123326 Fomes Species 0.000 description 6
- 241000123222 Hericium Species 0.000 description 6
- 241000123247 Inonotus Species 0.000 description 6
- 241000222350 Pleurotus Species 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 238000009341 apiculture Methods 0.000 description 6
- 239000005667 attractant Substances 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 235000021310 complex sugar Nutrition 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000000417 fungicide Substances 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000028993 immune response Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000002417 nutraceutical Substances 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 150000002989 phenols Chemical class 0.000 description 6
- 230000003389 potentiating effect Effects 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- 241000228197 Aspergillus flavus Species 0.000 description 5
- 240000005343 Azadirachta indica Species 0.000 description 5
- 241000751139 Beauveria bassiana Species 0.000 description 5
- 241000218631 Coniferophyta Species 0.000 description 5
- 241000122990 Nosema ceranae Species 0.000 description 5
- 241000123107 Phellinus Species 0.000 description 5
- QVDSEJDULKLHCG-UHFFFAOYSA-N Psilocybine Natural products C1=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CNC2=C1 QVDSEJDULKLHCG-UHFFFAOYSA-N 0.000 description 5
- 108020004459 Small interfering RNA Proteins 0.000 description 5
- 229930182558 Sterol Natural products 0.000 description 5
- 239000003904 antiprotozoal agent Substances 0.000 description 5
- 229940121357 antivirals Drugs 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002939 deleterious effect Effects 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 150000002913 oxalic acids Chemical class 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- QKTAAWLCLHMUTJ-UHFFFAOYSA-N psilocybin Chemical compound C1C=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CN=C21 QKTAAWLCLHMUTJ-UHFFFAOYSA-N 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 150000003432 sterols Chemical class 0.000 description 5
- 235000003702 sterols Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 4
- 241000256846 Apis cerana Species 0.000 description 4
- 241000235349 Ascomycota Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 4
- 241000960414 Kashmir bee virus Species 0.000 description 4
- 241000123335 Piptoporus Species 0.000 description 4
- 241000030942 Sacbrood virus Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 210000001520 comb Anatomy 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 4
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 108091070501 miRNA Proteins 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 3
- 241000317943 Acute bee paralysis virus Species 0.000 description 3
- 241000220276 Aethina tumida Species 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 3
- 235000011437 Amygdalus communis Nutrition 0.000 description 3
- 241001276404 Arius Species 0.000 description 3
- 241000219429 Betula Species 0.000 description 3
- RTIXKCRFFJGDFG-UHFFFAOYSA-N Chrysin Natural products C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 description 3
- 241000254173 Coleoptera Species 0.000 description 3
- 241000948221 Coniferiporia weirii Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000235577 Entomophthorales Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102000005720 Glutathione transferase Human genes 0.000 description 3
- 108010070675 Glutathione transferase Proteins 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 241001669525 Gymnopilus Species 0.000 description 3
- 241000222634 Lenzites Species 0.000 description 3
- 241000218922 Magnoliophyta Species 0.000 description 3
- 241001295810 Microsporidium Species 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 241001492486 Nosema apis Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 241000743698 Pinicola Species 0.000 description 3
- 241000222341 Polyporaceae Species 0.000 description 3
- 241001556152 Porodaedalea pini Species 0.000 description 3
- 241000377764 Psilocybe ovoideocystidiata Species 0.000 description 3
- 102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 3
- 108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 241000222646 Stereum Species 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 229940093797 bioflavonoids Drugs 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001713 cholinergic effect Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 150000002137 ergosterols Chemical class 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- -1 fatty acids Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000001785 ferulic acid Nutrition 0.000 description 3
- 229940114124 ferulic acid Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000015788 innate immune response Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 231100000518 lethal Toxicity 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000002420 orchard Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000007918 pathogenicity Effects 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229930195001 polyporoid Natural products 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000028070 sporulation Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- 239000002676 xenobiotic agent Substances 0.000 description 3
- 230000002034 xenobiotic effect Effects 0.000 description 3
- UGMQOYZVOPASJF-OXUZYLMNSA-N (2r)-2-[(3s,5r,10s,13r,14r,17r)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)CC[C@]21C UGMQOYZVOPASJF-OXUZYLMNSA-N 0.000 description 2
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical compound COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 2
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 2
- UYEMGAFJOZZIFP-UHFFFAOYSA-N 3,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC(O)=C1 UYEMGAFJOZZIFP-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- 240000004507 Abelmoschus esculentus Species 0.000 description 2
- 241001580838 Acarapis woodi Species 0.000 description 2
- 241001351288 Achroia grisella Species 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 229930195730 Aflatoxin Natural products 0.000 description 2
- 241000222485 Agaricales Species 0.000 description 2
- 241000959647 Albatrellus Species 0.000 description 2
- 241000256836 Apis Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 239000005878 Azadirachtin Substances 0.000 description 2
- 235000003932 Betula Nutrition 0.000 description 2
- 241000222478 Bjerkandera adusta Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000288673 Chiroptera Species 0.000 description 2
- 239000005888 Clothianidin Substances 0.000 description 2
- 241001246291 Cloudy wing virus Species 0.000 description 2
- 241001634499 Cola Species 0.000 description 2
- 241000222680 Collybia Species 0.000 description 2
- 241001600093 Coniophora Species 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 241001401034 Crithidia mellificae Species 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 235000014466 Douglas bleu Nutrition 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000255896 Galleria mellonella Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241001480619 Ganoderma australe Species 0.000 description 2
- 241001489091 Ganoderma sinense Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 241000222684 Grifola Species 0.000 description 2
- 241000234540 Gymnopus peronatus Species 0.000 description 2
- 240000000588 Hericium erinaceus Species 0.000 description 2
- 241000735452 Heterobasidion Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 241000123249 Inonotus hispidus Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000222342 Irpex Species 0.000 description 2
- 241000222435 Lentinula Species 0.000 description 2
- 241000222065 Lycoperdon Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 244000028178 Marasmius oreades Species 0.000 description 2
- 235000017233 Marasmius oreades Nutrition 0.000 description 2
- 241001468188 Melissococcus plutonius Species 0.000 description 2
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 241000243190 Microsporidia Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 235000014528 Pholiota nameko Nutrition 0.000 description 2
- 244000168667 Pholiota nameko Species 0.000 description 2
- 241000392443 Pleurotus citrinopileatus Species 0.000 description 2
- 244000252132 Pleurotus eryngii Species 0.000 description 2
- 241000908220 Pleurotus salmoneostramineus Species 0.000 description 2
- 241000222383 Polyporales Species 0.000 description 2
- 241000222642 Polyporus squamosus Species 0.000 description 2
- 244000171085 Polyporus umbellatus Species 0.000 description 2
- 235000004837 Polyporus umbellatus Nutrition 0.000 description 2
- 240000001416 Pseudotsuga menziesii Species 0.000 description 2
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 2
- 241001062322 Psilocybe subaeruginosa Species 0.000 description 2
- 238000003559 RNA-seq method Methods 0.000 description 2
- 241000222480 Schizophyllum Species 0.000 description 2
- 241000576755 Sclerotia Species 0.000 description 2
- 241001599571 Serpula <basidiomycete> Species 0.000 description 2
- 235000010841 Silybum marianum Nutrition 0.000 description 2
- 241000123241 Sparassis Species 0.000 description 2
- 241000123672 Strophariaceae Species 0.000 description 2
- 241000741781 Trametes sp. Species 0.000 description 2
- 241000121220 Tricholoma matsutake Species 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 241000895650 Varroa jacobsoni Species 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 235000001978 Withania somnifera Nutrition 0.000 description 2
- 240000004482 Withania somnifera Species 0.000 description 2
- 229920002522 Wood fibre Polymers 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000005409 aflatoxin Substances 0.000 description 2
- 229940040563 agaric acid Drugs 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 2
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 2
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000031902 chemoattractant activity Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000008260 defense mechanism Effects 0.000 description 2
- 238000005115 demineralization Methods 0.000 description 2
- 230000002328 demineralizing effect Effects 0.000 description 2
- 230000018514 detection of nutrient Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- 230000003370 grooming effect Effects 0.000 description 2
- 229960001867 guaiacol Drugs 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 230000003129 miticidal effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000004766 neurogenesis Effects 0.000 description 2
- 239000002581 neurotoxin Substances 0.000 description 2
- 231100000618 neurotoxin Toxicity 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 238000010943 off-gassing Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 235000021309 simple sugar Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 239000002025 wood fiber Substances 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- VCWMRQDBPZKXKG-UHFFFAOYSA-N (2S)-O1-alpha-D-Galactopyranosyl-myo-inosit Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(O)C1O VCWMRQDBPZKXKG-UHFFFAOYSA-N 0.000 description 1
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- NIMIDMFTGGTHOH-JKSUJKDBSA-N (2r,3r)-3,7-dihydroxy-5-methoxy-2-phenyl-2,3-dihydrochromen-4-one Chemical compound C1([C@H]2OC=3C=C(O)C=C(C=3C(=O)[C@@H]2O)OC)=CC=CC=C1 NIMIDMFTGGTHOH-JKSUJKDBSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- QDVIEIMMEUCFMW-QXYPORFMSA-N (3z,5e)-6-(3,4-dihydroxyphenyl)-4-hydroxyhexa-3,5-dien-2-one Chemical compound CC(=O)\C=C(/O)\C=C\C1=CC=C(O)C(O)=C1 QDVIEIMMEUCFMW-QXYPORFMSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- OKXFBEYCJRMINR-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one;hydrate Chemical compound O.C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 OKXFBEYCJRMINR-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- KKWJCGCIAHLFNE-UHFFFAOYSA-N 22R-hydroxylanosterol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(C(O)CC=C(C)C)C)CCC21C KKWJCGCIAHLFNE-UHFFFAOYSA-N 0.000 description 1
- IUTKPPDDLYYMBE-UHFFFAOYSA-N 3,4,5-trihydroxybenzoic acid;hydrate Chemical compound O.OC(=O)C1=CC(O)=C(O)C(O)=C1 IUTKPPDDLYYMBE-UHFFFAOYSA-N 0.000 description 1
- DOJRAGZSWYBHIE-UHFFFAOYSA-N 3-(2-chlorophenyl)chromen-2-one Chemical compound ClC1=CC=CC=C1C1=CC2=CC=CC=C2OC1=O DOJRAGZSWYBHIE-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- 235000006020 Acacia catechu Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000682855 Aegerita Species 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 241001072650 Agaricus placomyces Species 0.000 description 1
- 241000222532 Agrocybe Species 0.000 description 1
- 241000584103 Agrocybe arvalis Species 0.000 description 1
- 241001076849 Aides Species 0.000 description 1
- 241000959650 Albatrellus syringae Species 0.000 description 1
- 241001136782 Alca Species 0.000 description 1
- 241001599022 Alpova Species 0.000 description 1
- 241000134914 Amanita muscaria Species 0.000 description 1
- 241001419618 Amanita ponderosa Species 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000768824 Ampelocissus cinnamomea Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010053481 Antifreeze Proteins Proteins 0.000 description 1
- 241001545953 Apocephalus borealis Species 0.000 description 1
- 101100275556 Arabidopsis thaliana CYP19-3 gene Proteins 0.000 description 1
- 240000000940 Araucaria angustifolia Species 0.000 description 1
- 241000216654 Armillaria Species 0.000 description 1
- 241000216633 Armillaria gallica Species 0.000 description 1
- 244000221226 Armillaria mellea Species 0.000 description 1
- 241000221839 Ascosphaera apis Species 0.000 description 1
- 239000009405 Ashwagandha Substances 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241001628520 Astraeus hygrometricus Species 0.000 description 1
- 241000556475 Athelia neuhoffii Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 244000028550 Auricularia auricula Species 0.000 description 1
- 235000000023 Auricularia auricula Nutrition 0.000 description 1
- 240000005710 Auricularia polytricha Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000009581 Balanites aegyptiaca Nutrition 0.000 description 1
- 241000223679 Beauveria Species 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 238000006027 Birch reduction reaction Methods 0.000 description 1
- 241000346770 Bispora Species 0.000 description 1
- 241001600054 Boletinellus merulioides Species 0.000 description 1
- 241000222455 Boletus Species 0.000 description 1
- 244000009964 Boletus mirabilis Species 0.000 description 1
- 235000007138 Boletus mirabilis Nutrition 0.000 description 1
- 241000123405 Bondarzewia Species 0.000 description 1
- 241000123387 Bondarzewia berkeleyi Species 0.000 description 1
- 241001468687 Bridgeoporus Species 0.000 description 1
- 241001468680 Bridgeoporus nobilissimus Species 0.000 description 1
- BZQCVKMIWAETFB-UHFFFAOYSA-N CCOC(C(C(CC1=C2)=O)(C3=CC=CC=C3)OC1=CC=C2Cl)=O Chemical compound CCOC(C(C(CC1=C2)=O)(C3=CC=CC=C3)OC1=CC=C2Cl)=O BZQCVKMIWAETFB-UHFFFAOYSA-N 0.000 description 1
- 101150079826 CYP4 gene Proteins 0.000 description 1
- 241000254272 Callichilia subsessilis Species 0.000 description 1
- 241000959628 Calvatia gigantea Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 102000004308 Carboxylic Ester Hydrolases Human genes 0.000 description 1
- 108090000863 Carboxylic Ester Hydrolases Proteins 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 241000223655 Cenococcum geophilum Species 0.000 description 1
- 240000000024 Cercis siliquastrum Species 0.000 description 1
- 244000233006 Cereus variabilis Species 0.000 description 1
- 241000123410 Ceriporia Species 0.000 description 1
- 241000123413 Ceriporia purpurea Species 0.000 description 1
- 241000146399 Ceriporiopsis Species 0.000 description 1
- 241000250510 Cetraspora gilmorei Species 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- QQEPOVDLEDDLKC-UHFFFAOYSA-N ClC1=CC=C2C=C(C(OC2=C1)=O)C1=CC=CC=C1 Chemical compound ClC1=CC=C2C=C(C(OC2=C1)=O)C1=CC=CC=C1 QQEPOVDLEDDLKC-UHFFFAOYSA-N 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- 241000502280 Clitocybe Species 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 241000016778 Collybia tuberosa Species 0.000 description 1
- 241000123394 Coltricia Species 0.000 description 1
- 241000123409 Coltricia perennis Species 0.000 description 1
- 241001085790 Coprinopsis Species 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 241001264174 Cordyceps militaris Species 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- 241001577228 Cremnops washingtonensis Species 0.000 description 1
- 241000853009 Crithidia bombi Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 241000371644 Curvularia ravenelii Species 0.000 description 1
- 241001126325 Cyanea capillata Species 0.000 description 1
- 241001061533 Cyathus stercoreus Species 0.000 description 1
- 241000123284 Daedalea Species 0.000 description 1
- 241001055218 Dentiscutata heterogama Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000412745 Dryophilus Species 0.000 description 1
- UGMQOYZVOPASJF-UHFFFAOYSA-N Eburicoinsaeure Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)CCC21C UGMQOYZVOPASJF-UHFFFAOYSA-N 0.000 description 1
- 241000123301 Echinodontium Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000005066 Euchiton japonicus Species 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 241000369543 Fibroporia radiculosa Species 0.000 description 1
- 241000218218 Ficus <angiosperm> Species 0.000 description 1
- 240000003537 Ficus benghalensis Species 0.000 description 1
- 241000123208 Fistulina hepatica Species 0.000 description 1
- 241001537207 Flammulina Species 0.000 description 1
- 241001247880 Flammulina populicola Species 0.000 description 1
- 235000016640 Flammulina velutipes Nutrition 0.000 description 1
- 240000006499 Flammulina velutipes Species 0.000 description 1
- 241000562345 Flavodon Species 0.000 description 1
- 241000319212 Fomitopsis cana Species 0.000 description 1
- 241000319237 Fomitopsis subtropica Species 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical class O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241001123597 Funneliformis mosseae Species 0.000 description 1
- 241001065908 Gammarus clarus Species 0.000 description 1
- 241000901374 Ganoderma annulare Species 0.000 description 1
- 241001489089 Ganoderma neojaponicum Species 0.000 description 1
- 241001460418 Ganoderma tornatum Species 0.000 description 1
- 241000146398 Gelatoporia subvermispora Species 0.000 description 1
- 241000235500 Gigaspora Species 0.000 description 1
- 241000235502 Gigaspora margarita Species 0.000 description 1
- 244000103309 Glochidion macrocarpum Species 0.000 description 1
- 241000123332 Gloeophyllum Species 0.000 description 1
- 241000235503 Glomus Species 0.000 description 1
- 241000984804 Glomus aggregatum Species 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 241001595255 Gnomoniopsis clavulata Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 241000288140 Gruiformes Species 0.000 description 1
- 241001236294 Hebe Species 0.000 description 1
- 244000108095 Hemerocallis aurantiaca Species 0.000 description 1
- 240000000925 Hericium abietis Species 0.000 description 1
- 235000002157 Hericium abietis Nutrition 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000264877 Hippospongia communis Species 0.000 description 1
- 241000959207 Hydnellum Species 0.000 description 1
- 241000577951 Hydnum Species 0.000 description 1
- 241000991728 Hymenochaetales Species 0.000 description 1
- 241000221775 Hypocreales Species 0.000 description 1
- 241001534813 Hypsizygus Species 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 241001237927 Inocybe Species 0.000 description 1
- 241000746319 Inonotus andersonii Species 0.000 description 1
- CSYGXJQNODZRQO-UHFFFAOYSA-N Inotodiol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CC(O)C12C)C4(C)CCC(O)C(C)(C)C4CC3 CSYGXJQNODZRQO-UHFFFAOYSA-N 0.000 description 1
- 241000748655 Invertebrate iridescent virus 6 Species 0.000 description 1
- 241000222344 Irpex lacteus Species 0.000 description 1
- 241000207840 Jasminum Species 0.000 description 1
- 241000033814 Kakugo virus Species 0.000 description 1
- 241000543691 Lactarius deliciosus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000222689 Laetiporus Species 0.000 description 1
- 241001575153 Lake Sinai virus Species 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- 244000162269 Lentinus lepideus Species 0.000 description 1
- 235000017066 Lentinus lepideus Nutrition 0.000 description 1
- 241001536562 Lentinus squarrosulus Species 0.000 description 1
- 241000222451 Lentinus tigrinus Species 0.000 description 1
- 241000908176 Lepista Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241000357708 Leucozonia ponderosa Species 0.000 description 1
- 244000286380 Leymus racemosus Species 0.000 description 1
- 108010054320 Lignin peroxidase Proteins 0.000 description 1
- 241000721696 Lymantria Species 0.000 description 1
- 240000005856 Lyophyllum decastes Species 0.000 description 1
- 235000013194 Lyophyllum decastes Nutrition 0.000 description 1
- 241000567939 Macrocybe crassa Species 0.000 description 1
- 241001480581 Marasmius Species 0.000 description 1
- 241000123315 Meripilus Species 0.000 description 1
- 241000123318 Meripilus giganteus Species 0.000 description 1
- 241000790612 Meruliporia incrassata Species 0.000 description 1
- 240000000157 Morchella angusticeps Species 0.000 description 1
- 235000012860 Morchella angusticeps Nutrition 0.000 description 1
- 240000002769 Morchella esculenta Species 0.000 description 1
- 241000263600 Mycena chlorophos Species 0.000 description 1
- 241001296613 Mycena citricolor Species 0.000 description 1
- 241000596246 Mycena haematopus Species 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 244000232885 Naematoloma sublateritium Species 0.000 description 1
- 241000909578 Nectandra Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 101100084053 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ppi-2 gene Proteins 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- LIAAXDIHRFDDIV-UHFFFAOYSA-N OCC(C=CC=CC(C=C1)=CC(O)=C1O)=O Chemical compound OCC(C=CC=CC(C=C1)=CC(O)=C1O)=O LIAAXDIHRFDDIV-UHFFFAOYSA-N 0.000 description 1
- 241001619489 Oligoporus Species 0.000 description 1
- 241001237902 Omphalotus Species 0.000 description 1
- 241001247959 Omphalotus olearius Species 0.000 description 1
- 241001529432 Ophiocordyceps Species 0.000 description 1
- 241001656390 Ophiocordyceps sphecocephala Species 0.000 description 1
- 241000124210 Ophiocordyceps unilateralis Species 0.000 description 1
- 241000222637 Ossicaulis lignatilis Species 0.000 description 1
- 241001635641 Oxyporus <beetle> Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000193418 Paenibacillus larvae Species 0.000 description 1
- 241001236144 Panaeolus Species 0.000 description 1
- 241001059395 Panaeolus cyanescens Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 241000123526 Peziza Species 0.000 description 1
- 241000123127 Phaeolus Species 0.000 description 1
- 241000123129 Phaeolus schweinitzii Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241000222385 Phanerochaete Species 0.000 description 1
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
- 241000222395 Phlebia Species 0.000 description 1
- 241000410088 Phlebia tremellosa Species 0.000 description 1
- 241000722337 Pholiota Species 0.000 description 1
- 241000287319 Pholiota terrestris Species 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 241000296795 Piloderma bicolor Species 0.000 description 1
- FGUBFGWYEYFGRK-HNNXBMFYSA-N Pinocembrin Natural products Cc1cc(C)c2C(=O)C[C@H](Oc2c1)c3ccccc3 FGUBFGWYEYFGRK-HNNXBMFYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241001503962 Pisolithus tinctorius Species 0.000 description 1
- 231100000742 Plant toxin Toxicity 0.000 description 1
- 241000219238 Pleurotus abalonus Species 0.000 description 1
- 241001138368 Pleurotus dryinus Species 0.000 description 1
- 241000392438 Pleurotus euosmus Species 0.000 description 1
- 241000318836 Pleurotus nebrodensis Species 0.000 description 1
- 244000158441 Pleurotus sajor caju Species 0.000 description 1
- 241001138365 Pleurotus smithii Species 0.000 description 1
- 241000958500 Pluteus Species 0.000 description 1
- 241001536566 Polyporus tuberaster Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241001088162 Primula auricula Species 0.000 description 1
- 235000006894 Primula auricula Nutrition 0.000 description 1
- 240000005519 Prunus mexicana Species 0.000 description 1
- 241000140437 Psathyrella coprophila Species 0.000 description 1
- 241001006479 Psathyrella epimyces Species 0.000 description 1
- 241001015941 Psathyrella hydrophila Species 0.000 description 1
- 240000005350 Pseudoraphis spinescens Species 0.000 description 1
- SPCIYGNTAMCTRO-UHFFFAOYSA-N Psilocine Natural products C1=CC(O)=C2C(CCN(C)C)=CNC2=C1 SPCIYGNTAMCTRO-UHFFFAOYSA-N 0.000 description 1
- 241001061682 Psilocybe caerulescens Species 0.000 description 1
- 241001418126 Psilocybe serbica Species 0.000 description 1
- 241001072092 Psilocybe serbica var. bohemica Species 0.000 description 1
- 241001258934 Psilocybe tampanensis Species 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000214030 Rhizophagus fasciculatus Species 0.000 description 1
- 241001671588 Rhizopogon nigrescens Species 0.000 description 1
- 241000292488 Rhizopogon roseolus Species 0.000 description 1
- 241001638069 Rigidoporus microporus Species 0.000 description 1
- 241000050443 Ruthnielsenia tenuis Species 0.000 description 1
- 101100062195 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CPR4 gene Proteins 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 244000287330 Sambucus caerulea Species 0.000 description 1
- 241000577946 Sarcodon Species 0.000 description 1
- 241001121959 Sarcomyxa Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001311582 Schizopora Species 0.000 description 1
- 241001123565 Schizopora paradoxa Species 0.000 description 1
- 241000438996 Scleroderma albidum Species 0.000 description 1
- 241001329371 Scleroderma aurantium Species 0.000 description 1
- 241000885076 Scleroderma polyrhizum Species 0.000 description 1
- 241001123599 Scutellospora Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 241001599029 Serpula himantioides Species 0.000 description 1
- 241000673450 Sicyos herbstii Species 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000272503 Sparassis radicata Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001561977 Stropharia aeruginosa Species 0.000 description 1
- 241000796953 Stropharia ambigua Species 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 241000228343 Talaromyces flavus Species 0.000 description 1
- 244000204900 Talipariti tiliaceum Species 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 244000079568 Tragia hirsuta Species 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 241001505683 Tremella aurantia Species 0.000 description 1
- 241000908178 Tremella fuciformis Species 0.000 description 1
- 241000221427 Tremella mesenterica Species 0.000 description 1
- 241000221365 Tremellales Species 0.000 description 1
- 241001149558 Trichoderma virens Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000121219 Tricholoma Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241001245280 Tropilaelaps Species 0.000 description 1
- 241001038073 Tropilaelaps mercedesae Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241001559484 Varroidae Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 241001507667 Volvariella Species 0.000 description 1
- 240000008497 Wahlenbergia marginata Species 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- 241001619454 Wolfiporia Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000001560 acacia catechu Substances 0.000 description 1
- 210000004430 acanthocyte Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 238000001720 action spectrum Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000004479 aerosol dispenser Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 238000002832 anti-viral assay Methods 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000002592 antimutagenic agent Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 230000010138 bee pollination Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 230000002032 cellular defenses Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- YARKTHNUMGKMGS-LQGKIZFRSA-N chembl3193980 Chemical compound COC1=C(O)C(OC)=CC(\C=N\N=C\C=2C=C(OC)C(O)=C(OC)C=2)=C1 YARKTHNUMGKMGS-LQGKIZFRSA-N 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 229940043370 chrysin Drugs 0.000 description 1
- 235000015838 chrysin Nutrition 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000004456 color vision Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 101150078068 cyp6 gene Proteins 0.000 description 1
- 101150010272 cyp9 gene Proteins 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000005860 defense response to virus Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- LIVBXKAVLWBDCR-FRRGXQJJSA-N dehydrosulphurenic acid Natural products [H][C@@]1(C[C@H](O)[C@@]2(C)C3=CC[C@]4([H])[C@]([H])(CC[C@H](O)C4(C)C)C3=CC[C@]12C)[C@@H](CCC(=C)C(C)C)C(O)=O LIVBXKAVLWBDCR-FRRGXQJJSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VONWDASPFIQPDY-UHFFFAOYSA-N dimethyl methylphosphonate Chemical compound COP(C)(=O)OC VONWDASPFIQPDY-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000002355 dual-layer Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000000531 effect on virus Effects 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- ZEPCRIPMALGRJR-UHFFFAOYSA-N ellagic acid, dihydrate Chemical compound O.O.OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 ZEPCRIPMALGRJR-UHFFFAOYSA-N 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-APGDWVJJSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000002031 ethanolic fraction Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 230000019637 foraging behavior Effects 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003197 gene knockdown Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- KZSXJTYOPKQNLT-BCKMTSFNSA-N glucinol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](OC)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@@H]1O KZSXJTYOPKQNLT-BCKMTSFNSA-N 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000009808 hippocampal neurogenesis Effects 0.000 description 1
- QDVIEIMMEUCFMW-UHFFFAOYSA-N hispolone Natural products CC(=O)C=C(O)C=CC1=CC=C(O)C(O)=C1 QDVIEIMMEUCFMW-UHFFFAOYSA-N 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000007938 immune gene expression Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- KKWJCGCIAHLFNE-KFPHZHIMSA-N inotodiol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H]([C@H](O)CC=C(C)C)C)CC[C@]21C KKWJCGCIAHLFNE-KFPHZHIMSA-N 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 230000007787 long-term memory Effects 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000002705 metabolomic analysis Methods 0.000 description 1
- 230000001431 metabolomic effect Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000002686 mushroom body Anatomy 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 230000023105 myelination Effects 0.000 description 1
- VZUGBLTVBZJZOE-KRWDZBQOSA-N n-[3-[(4s)-2-amino-1,4-dimethyl-6-oxo-5h-pyrimidin-4-yl]phenyl]-5-chloropyrimidine-2-carboxamide Chemical compound N1=C(N)N(C)C(=O)C[C@@]1(C)C1=CC=CC(NC(=O)C=2N=CC(Cl)=CN=2)=C1 VZUGBLTVBZJZOE-KRWDZBQOSA-N 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 239000003958 nerve gas Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000003018 neuroregenerative effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000926 not very toxic Toxicity 0.000 description 1
- PMOWTIHVNWZYFI-UHFFFAOYSA-N o-Coumaric acid Natural products OC(=O)C=CC1=CC=CC=C1O PMOWTIHVNWZYFI-UHFFFAOYSA-N 0.000 description 1
- 230000017025 olfactory learning Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000036281 parasite infection Effects 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 238000006303 photolysis reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- SUYJZKRQHBQNCA-LSDHHAIUSA-N pinobanksin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=CC=C1 SUYJZKRQHBQNCA-LSDHHAIUSA-N 0.000 description 1
- SUYJZKRQHBQNCA-UHFFFAOYSA-N pinobanksin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=CC=C1 SUYJZKRQHBQNCA-UHFFFAOYSA-N 0.000 description 1
- NIMIDMFTGGTHOH-UHFFFAOYSA-N pinobanksin-5-methyl ether Natural products OC1C(=O)C=2C(OC)=CC(O)=CC=2OC1C1=CC=CC=C1 NIMIDMFTGGTHOH-UHFFFAOYSA-N 0.000 description 1
- URFCJEUYXNAHFI-ZDUSSCGKSA-N pinocembrin Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=CC=C1 URFCJEUYXNAHFI-ZDUSSCGKSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 239000003123 plant toxin Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000007859 posttranscriptional regulation of gene expression Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- ZBWSBXGHYDWMAK-UHFFFAOYSA-N psilocin Chemical compound C1=CC=C(O)[C]2C(CCN(C)C)=CN=C21 ZBWSBXGHYDWMAK-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000012865 response to insecticide Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000010563 solid-state fermentation Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000013548 tempeh Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100001234 toxic pollutant Toxicity 0.000 description 1
- PMOWTIHVNWZYFI-AATRIKPKSA-N trans-2-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1O PMOWTIHVNWZYFI-AATRIKPKSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 244000000006 viral plant pathogen Species 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- DBRXOUCRJQVYJQ-CKNDUULBSA-N withaferin A Chemical compound C([C@@H]1[C@H]([C@@H]2[C@]3(CC[C@@H]4[C@@]5(C)C(=O)C=C[C@H](O)[C@@]65O[C@@H]6C[C@H]4[C@@H]3CC2)C)C)C(C)=C(CO)C(=O)O1 DBRXOUCRJQVYJQ-CKNDUULBSA-N 0.000 description 1
- SASUFNRGCZMRFD-JCUIILOWSA-N withanolide D Chemical compound C1C(C)=C(C)C(=O)O[C@H]1[C@](C)(O)[C@@H]1[C@@]2(C)CC[C@@H]3[C@@]4(C)C(=O)C=C[C@H](O)[C@@]54O[C@@H]5C[C@H]3[C@@H]2CC1 SASUFNRGCZMRFD-JCUIILOWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K51/00—Appliances for treating beehives or parts thereof, e.g. for cleaning or disinfecting
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/90—Feeding-stuffs specially adapted for particular animals for insects, e.g. bees or silkworms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Abstract
The present invention provides a method for reducing bee viral load and increasing bee life longevity with a bee feeding composition which comprises an effective amount of less than 10% by volumeof an extract of a medicinal mushroom mycelium of Inonotus obliquus, Ganoderma resinaceum, Fomitopsis pinicola, Fomes fomentarius, Schizophyllum commune, Trametes versicolor, Fomitopsis officinalis, Ganoderma applanatum, Ganoderma lucidum or combinations thereof; or an effective amount of 10% or less by volume of the extract of a medicinal mushroom mycelium of Fomes fomentarius and/or Trametes versicolor. icola, Fomes fomentarius, Schizophyllum commune, Trametes versicolor, Fomitopsis officinalis, Ganoderma applanatum, Ganoderma lucidum or combinations thereof; or an effective amount of 10% or less by volume of the extract of a medicinal mushroom mycelium of Fomes fomentarius and/or Trametes versicolor.
Description
TITLE OF THE INVENTION
Integrative fungal solutions for protecting bees
This application claims the benefit of U.S. provisional patent application no.
62/074,023, filed 11/02/2014, currently co-pending, herein orated by reference in
its ty. This application is also a continuation-in-part of U.S. patent application no.
14/247,207, filed 04/07/2014, currently co-pending, which claims the benefit of U.S.
provisional patent application no. 61/967,117, filed 03/10/2014, currently co-pending,
both of which are hereby incorporated by reference in their entirety.
TECHNICAL FIELD
The present invention relates to compositions containing extracts of mycelia
of fungal s, and their mixtures, to provide an armamentarium of defenses from
multiple stressors in order to help bees survive a complex of symptoms collectively
called colony se disorder (CCD). More particularly the present invention utilizes
specific concentrations of consumable extracts from pure cultured mycelium from
om forming fungi to reduce harmful viruses in bees and to increase the
ity of bees.
BACKGROUND ART
Approximately 0 species of insects, birds and mammals are involved in
the pollination of flowering plants. This includes almost 20,000 known s of bees.
The Food and Agriculture Organization of the United Nations estimates that of the
slightly more than 100 crop species that provide 90 percent of food supplies for 146
countries, 71 are bee-pollinated (mainly by wild bees), and several others are
pollinated by thrips, wasps, flies, beetles, moths and other insects. The annual
monetary value of pollination services in global agriculture could be as high as $200
billion. Protecting the Pollinators, Food and Agriculture Organization of the United
s. The co-evolution of plants and bees (Apis species) is fundamental to their
mutual survival. The bees spread pollen and many plants e rich nectar in return.
imately 4,000 bee species are native to North America. With the
uction of European (or “western”) honey bees (Apis mellifera) to North America
by colonists, cial orchards and farms that would not normally be able to survive
have thrived, although many New World crops and native flowering plants are primarily
dependent upon native bee species for pollination. Asian agriculture is similarly
dependent upon the Asian (or “eastern”) honey bee (Apis cerana), although lly on
a smaller and more regionalized scale (A. era has also been introduced).
Throughout lture the number of fruit, nut and vegetable crops benefitting from
bee pollination is staggering, as are the number of flowering trees, shrubs and
wildflowers. Indeed it is difficult to overstate the role of bees in the commercial
production of food. The loss of bees we are experiencing now is unprecedented and a
huge threat to food security worldwide. In some regions of China, for instance, the loss
of bees has necessitated hand ation to save crops, a dauntingly difficult task.
A honey bee hive is a warm, moist, densely populated environment inhabited
by closely related individuals—the perfect setting for viruses, bacteria, fungi, protozoa
and mites. Bees have successfully protected themselves for millions of years from such
threats with unique colony-level and individual-level host defense systems and immune
responses, but these defenses may be breaking down as the result of intense
domestication of the European honey bee and multiple threats, including new
anthropogenic stressors, resulting in a precipitous decline in the number of feral honey
bees and native bees in areas including North America, Europe and China from 1972
to 2006, and the emergence of colony collapse disorder (“COD”) in honey bees in
2006.
The domestic ee industry is dependent upon queen breeding, the
process of selection that brings about the lines to be propagated, and queen rearing,
the process of producing and g queen honey bees. The large majority of bee
breeding in the United States is carried out by 10-15 large queen-producing
companies, who exchange genetic information from about 500 breeder queens. Such
d genetic diversity may contribute to susceptibility to s diseases, pests or
colony collapse disorder. Particularly damaging to the rearing of queens are viruses,
especially the Black Queen Cell Virus and other viruses including the Deformed Wing
Virus, the Israeli Acute Bee sis Virus, and nearly two dozen others. More viruses
are pated to be discovered that contribute to illness in bees, including queens,
their brood, in workers, nurse bees and drones.
Colony losses and bee disappearances have occurred throughout the history
of beekeeping (“apiculture”), including various honey bee syndromes in the 18803, the
1900s through the 1920s, the 1960s and the 19903, such as “disappearing disease,”
“spring dwindle,” “fall e,” “autumn collapse” and “mystery disease.” In 2006,
some beekeepers began reporting unusually high losses of 30—90 percent of their
hives. This disappearing bee affliction was renamed “colony collapse disorder” (CCD,
sometimes referred to as spontaneous hive collapse or Mary Celeste syndrome in the
UK). CCD may or may not be related to the prior colony loss mes; it may be a
ely new disorder or a known disorder that previously only had a minor impact.
CCD is now approaching 30-40% with many beekeepers; with the ‘factory
farms,’ where up to 84,000 beehives are kept in one location, CCD can claim more
than 60%. This has raised the costs for almond tree ation, for example, from $25-
per bee colony per 1/2 to 1 acre of almond orchard for 3 weeks to more than $250.
More than 1/3 of all the non-animal food Americans consume is dependent upon
pollination from bees. Should this upward trend in bee colony losses ue, the
economic and societal expenses could run into the hundreds of billions of dollars.
The loss of the es provided by bees has other far—reaching implications.
For example, Neem trees, the source of thousands of popular , beauty and
insecticide products, are dependent upon pollination from bees, which are not
adversely affected. Interestingly, Neem products that contain the active ingredient,
azadirachtin, are useful for limiting or killing mites, including Varroa mites that transmit
diseases to bees, and including mites that transmit diseases to other animals and
. Should bees be lost, so too will this vast resource of health products and a
natural insecticide.
The main symptoms of CCD are the disappearance of the worker class
(resulting in very few or no adult “worker” bees in the hive), a live queen and few to no
dead bees on the ground around the colony. Often there is still honey in the hive,
immature capped brood bees are t (bees will not normally abandon a hive until
the capped brood have all hatched) and the hive contains honey and bee pollen that
was not ately robbed by neighboring bees. The hive is also slow to be robbed
by colony pests such as wax moths or small hive beetles. Varroa mites, a virus-
transmitting parasite of honey bees, have frequently been found in hives hit by CCD.
Collapsing es typically do not have enough bees to maintain colony brood and
have workers that consist of younger adult bees; the progression of symptoms may be
rapid or slow (up to two years). The colony may have ample food stores and be
ant to eat food provided by the beekeeper. See, for example, Honey Bees and
Colony Collapse Disorder, United States Department of Agriculture Agricultural
Research Service (2013).
The reasons for increasing colony collapse are complex and appear to be the
result of multiple factors. Suggested causes include increasing urbanization and loss of
biodiversity, particularly loss of wildflower meadows and “weeds” that provided high
quality bee forage, poor nutrition and malnutrition, immunodeficiencies, microbial
pathogens including viruses, ia, fungi and protozoa, both lethal and sub-lethal
exposure to insecticides, fungicides and herbicides, beekeeper applied miticides and
antibiotics, tic mites (Varroa destructor and V. oni mites and Acarapis
woodi tracheal mites), the fungi Nosema ceranae and N. apis, heavy metals, toxic
pollutants, natural plant toxins, biting insects, ive breeding in apiculture and loss
of genetic diversity, climate change, concentrations of hives, and increased
environmental stresses from drought and cold snaps, and ations of these
factors. Another factor is the new nature of the bee business and changing beekeeping
practices. In the USA, there are few or, in many regions, no feral bees and
domesticated bee es are often trucked hundreds of miles from factory bee
‘livestock’ apiaries, conferring additional stress factors to colony health and facilitating
wider spread of ions and parasites amongst bee populations.
Although the exact cause(s) and mechanisms of COD remain to be
elucidated, it appears the combination of stressors is of importance, particularly 1)
microbial viral and fungal pathogens such as Israeli Acute sis Virus ”), the
Black Queen Cell Virus (“BQCV”) and Deformed Wing Virus (“DWV”) and Nosema (a
pathogenic fungi); 2) parasitic mites (particularly Varroa mites); 3) pesticides at lethal or
thal doses, including itinoid insecticides (such as clothianidin,
thiamethoxam, and imidacloprid) and beekeeper-applied miticides ) and other
environmental stressors; 4) the management ors of beekeeping including
increasing viral exchange from trucked bees (particularly in the midwinter almond
pollination migration to California), and 5) honey bee diets including use of honey
substitutes and exposure to pollen of low nutritional value as d to native diverse
pollen and nectar of high nutritional value. ch suggests that honey bee diets,
parasites, diseases and le pesticides interact to have stronger negative effects
on managed honey bee colonies, while nutritional limitation and exposure to sublethal
doses of pesticides, in particular, may alter susceptibility to or the severity of bee
parasites and pathogens. Pettis et al., Crop Pollination s Honey Bees to
Pesticides Which Alters Their Susceptibility to the Gut Pathogen Nosema ceranae,
PLOS ONE, Published: July 24, 2013, DOI: 10.1371/journal.pone.0070182.
HONEY BEE HOST DEFENSE AND IMMUNE :
Colonies of bees may be infected by several species of parasites or diseases
at any time, but the -level and individual-level immune systems lly deal
with the infections (with the possible exception of parasitic Varroa destructor mites)
provided that environmental conditions are favorable. In the case of colony collapse,
that normally ive immune function is y faltering. After the introduction of the
parasitic, non-native Varroa destructor mite in 1987 to the United States, and its prolific
spread throughout apiary populations, bees today face unprecedented threats from
these virus-vectoring arthropods — fighting the viruses they introduce with immune
systems weakened from exposure to complex cocktails of xenobiotic toxins. This
convergence of stressors is a a for disaster and is evolutionarily unprecedented.
Additional stressors are the loss of plant biodiversity as s are cut, wood is
removed, and monoculture factory farms flatten the native landscapes. Bees, both
domesticated and wild, our greatest pollinators, are under assault from multiple
vectors. Bee tions have already been reported from some regions of China and
are expected to occur with increasing frequency throughout the world.
Honey bees have numerous physical, chemical and behavioral defenses at
the local population, colony hive, cell and dual bee levels. The first line of colony
and individual defense is to avoid allowing parasites to gain a foothold—bees spend
large amounts of energy on cooperative “social immunity" behaviors including
grooming their body surfaces (both self auto-grooming and allo-grooming of a nest
mate), cooperative hygienic or to detect and remove diseased brood and
corpses of adult bees from the hive, cleaning the inner surfaces of the nest cavity and
sterilizing all surfaces with antimicrobial secretions in their saliva (such as glucose
oxidase), and utilizing (sometimes called “stealing”) components of the plant immune
system by gathering the highly antimicrobial resins found at leaf buds and wounds,
incorporating them into propolis and using the propolis to form an antimicrobial barrier
around the colony, including heavy use at the entrance, coating inner surfaces of the
cavity and face of the comb and sealing cracks and crevices.
INDIVIDUAL SYSTEMIC IMMUNE RESPONSE:
Insects possess innate immunity, which is characterized by ecific
immune ons against invading pathogens, while lacking the complex “adaptive” or
“acquired” immunity such as ion of antibodies specific to new pathogens. The
defense mechanism in insects consists of cellular and humoral immunity. In the cellular
defense mechanism, plasmocytes and granulocytes are the major haemocytes that
react to foreign invaders either by phagocytosis and/or encapsulation. A hallmark of the
l reactions is the synthesis and secretion of anti—microbial peptides (AMPs) that
accumulate in the hemolymph and ly lyse foreign microbial cells and inhibit
ties of enzymes ial for pathogen replication. See ama, Innate
immune system in the honey bee, Honey Bee Research Group, National Institute of
Livestock and Grassland Science. This “induced” response of antimicrobial peptides
can last for weeks, and it s these peptides can be passed to nestmates to
confer resistance prior to infection. Oliver, Sick Bees — Part 3: The Bee Immune
System, American Bee Journal, October 2010.
The bee antiviral response is based upon RNA interference (RNAi). RNAi
“silences” the expression of genes between the transcription of the genetic code and its
translation into functional proteins. MicroRNA (miRNA, small ding RNAs that
function in networks of protein-coding genes and cell physiological processes via
transcriptional and post-transcriptional regulation of gene expression) and small
interfering RNA (siRNA, short double-stranded fragments) bind to specific messenger
RNA (mRNA) molecules and increase or decrease their activity, for example protein
production or defending cells against viral tide sequences. The miRNAs are a
well-conserved, evolutionarily ancient component of genetic tion found in many
eukaryotic organisms.
RNAi is initiated by the enzyme Dicer, which cleaves long double-stranded
(dsRNA) molecules into short double stranded fragments of siRNAs. Each siRNA is
unwound into two single-stranded ssRNAs, the passenger strand and the guide strand.
The guide strand is orated into the RNA—induced silencing complex (RISC). After
integration into the RISC, siRNAs base-pair to their target mRNA and cleave it, thereby
ting it from being used as a translation te. When the dsRNA is exogenous
(for e, coming from infection by a virus), the RNA is ed directly into the
cytoplasm and cleaved to short fragments by Dicer.
Bees possess more RNAi pathway components relative to flies and appear to
more readily mount a systemic RNAi response than do flies. It follows that bees should
be quite capable of battling viruses and arguably other pathogens through knockdowns
based on double-stranded RNAs of pathogen-expressed genes /Spivak 2009).
Notably, this form of response to viral attack provides a long-term memory similar to
WO 38361
that resulting from the antibodies produced in mammals. Oliver, Sick Bees — Part 4:
Immune Response to Viruses, an Bee Journal, November 2010.
VIRUSES, NOSEMA AND MICROBIAL PATHOGENS:
Bees are host to at least 18 viruses, nearly all being single-stranded RNA
viruses. Some are “emerging” pathogens, such as Deformed Wing Virus and Acute
Bee Paralysis Virus, which were once considered to be “economically irrelevant”
(Genersch 2010) and then, with the arrival of Varroa as a vector, began to visibly
ate colonies. Oliver, Sick Bees — Part 4: Immune Response to Viruses,
American Bee Journal, November 2010.
Viral es include c Paralysis Virus (CPV), Acute Bee Paralysis
Virus (ABPV), Israeli acute paralysis virus (IAPV), Kashmir Bee Virus (KBV), Black
Queen Cell Virus (BQCV), Cloudy Wing Virus (CWV), Sacbrood Virus (SBV),
Deformed Wing Virus (DWV), Kakugo Virus, Invertebrate Iridescent Virus type 6 (MV-
6), Lake Sinai Viruses (LSV1 and LSV2) and Tobacco Ringspot Virus (TRSV). Within
these viruses are many subtypes whose virulence towards bees is currently being
investigated. More pathogenic viruses will likely be discovered. The co—occurrence of
more than one internalized virus further nges the immunological health of bees. “I
do not know of any effective antiviral treatment in the market to fight the spectrum of
viruses known to occur in honey bees.” --Dr. Walter “Steve Sheppard, Chair,
Department of Entomology, Washington State University, Pullman, Washington
nal communication). Hence, there is a need for advantageous remedies, which
are non-toxic, yet active against more than one virus.
Bees are also vulnerable to pathogen host shifts. The tobacco ringspot virus
can replicate and produce virions in Apis mellifera ees, resulting in infections
hout the entire body, including extensive infection of the nervous system and
likely impacts on colony al. TRSV was also found in the gastric cecum of Varroa
mites, suggesting that Varroa mites may facilitate the spread of TRSV in bees while
avoiding systemic invasion. Li et al., Systemic Spread and Propagation of a Plant—
Pathogenic Virus in European Honeybees, Apis mellifera, mBio 5(1):e00898—13.
doi:10.1128/mBio.00898-13. The virus, first observed in infected tobacco, is spread
h infected pollen of us plant species including soy and numerous crops,
weeds and ornamentals.
Nosema apis is a microsporidium, recently reclassified as a fungus, which
invades the intestinal tracts of adult bees and causes Nosema disease, also known as
nosemosis. Nosema infection is also associated with Black Queen Cell Virus and
Kashmir Bee Virus. Nosema ceranae is becoming an increasing problem on both the
Asian honey bee Apis cerana and the n honey bee.
Some honey bee viruses (DWV and KBV) and the fungi Nosema e are
able to infect other species of bees and wasps, and ly Varroa gut cells;
honeybees are likely the source of the bumblebee pathogens. Fiirst et al., Disease
associations between honeybees and bumblebees as a threat to wild ators,
Nature, Volume:506, 364—366, (2014). This new bee-to-bee vector could be a g
point, causing wide scale collapse of many native bee s, with consequences well
beyond our control, or imagination. From a historical and biological perspective, this is
an ‘all hands on deck’ moment. What evolution has provided us over millions of years
can be lost in decades due to the human interventions whose incentives are short term
in view — at the expense of the long term.
Bacterial diseases of bees include American foulbrood (AFB), caused by
Paenibacillus larvae, and European foulbrood (EFB), caused by the bacterium
Melissococcus plutonius. Fungal diseases include Chalkbrood, caused by
Ascosphaera apis, and Stonebrood, a fungal disease caused by Aspergillus fumigatus,
Aspergillus flavus, and Aspergillus niger. New, as yet unidentified, fungal pathogens
are expected to co—occur or become a y cause of bee es in the future as
humans further alter the natural environment and cause unintended consequences
from the use of transgenic crops, more broadly known as GMOs — genetically modified
organisms. Such potential fungal pathogens include Candida, Cryptococcus,
Coccidiodes and other yeast-like organisms. And yet, many of these so-called
pathogens, especially, for instance, the pre-sporulating forms of entomopathogenic
fungi, have properties that can confer benefits to insects, including bees, provided that
their endogenous toxins are ated, reduced or altered so to not harm bees,
thereby ng the threat to bees by disease-causing, disease-bearing or disease-
spreading organisms.
All honey bees are infected by more than one species of ia, ing
beneficial mbionts that offer protection against yeasts, chalkbrood and
foulbrood. Apparently healthy bees may also be infected by more than one species of
virus. The dynamics of bee—bacteria, bee—virus and virus—virus interactions are complex
and poorly tood. Certain bee viruses may enhance the nce of other viruses
while some bee viruses may competitively suppress the ation of others. So too
there are likely bacteria-to-bacteria, bacteriophage-to-bacteria, fungi-to-bacteria and
fungi—to—virus interrelationships scientists have yet to discover. Many nt bee
viruses can exist in an “unapparent” infection — one can detect the presence of the
virus in bees, but there are no noticeable negative effects due to the infection. An
infection by a second virus or other stressor may cause a dormant virus to start
replicating. A number of researchers have found that the mere action of a Varroa mite
feeding upon a bee (which includes injection of immune suppressants by the mite) may
induce or activate the replication of unapparent and ly non-pathological virus
infections. Studies of immune responses have also shown that mites and viruses could
alter transcript levels of immunity—related genes in their ponding hosts. It is
common for collapsing colonies to be simultaneously infected with three or four
viruses, Varroa mites, Nosema ae and especially apis), and trypanosomes. See
Oliver, Sick Bees — Part 3: The Bee Immune System, American Bee Journal, October
2010.
Crithidia bombi is a trypanosomatid protozoan bee parasite known to have
s effects on bumblebees, particularly under starvation conditions. The related
Crithidia mellificae may be contributing to mortality in the honey bee. Ravoet et al.,
Comprehensive Bee Pathogen Screening in Belgium Reveals Crithidia mellificae as a
New Contributory Factor to Winter Mortality (2013), PLoS ONE 8(8): e72443.
VARROA MITES AND OTHER PARASITES:
Varroa destructor and Varroa jacobsoni are parasitic mites that feed on the
bodily fluids of bee adults, pupae and larvae. Acarapis woodi is a tracheal mite that
infests the airways of the honey bee. The Asian parasitic brood mites Tropilaelaps
e and T. mercedesae are considered serious potential threats to honeybees,
although they have not been found in the United States or Canada to date.
The Asian honey bee Apis cerana is the l host to the Varroa jacobsoni
mite and the parasite Nosema ceranae. Having co—evolved with these parasites, A.
cerana ts more careful grooming than A. mellifera, and thus has a more effective
defense mechanism against Varroa and Nosema, which are ng increasingly
s pests of the western honey bee.
Varroa mites breaching bees’ hygienic, mechanical and physiological barriers to
invasion have increasingly acted as a vector for viruses as well as causing major stress
to bees. Widespread colony losses have only been reported from countries is which
Varroa is a problem (Neumann 2010). es without mites may be virus free
ield 2009), but up to 100% of colonies with Varroa may be infected by one or
more s, even if there are no apparent symptoms (Tentcheva 2004). Oliver, Sick
Bees — Part 1, American Bee Journal, Aug 2010.
Varroa mites have been found to be far more susceptible to acids than are
honey bees. Organic acids such as oxalic acid, formic acid and lactic acid can be used
as “natural miticides” or mite treatments in the hive, as they are all naturally found in
honey. Oxalic acid is typically mixed with distilled water to prevent the formation of
salts, resulting in an acidic solution with pH often times <1. That the bees can tolerate
such a low pH while mites cannot is significant. The oxalic acid will capture calcium and
other minerals from the leton of the mites to form oxalates. When direct contact
of oxalic or formic acid with the chitinous like exoskeleton of the mites pulls out
calcium, the exoskeleton is weakened, thus making the mites susceptible to other
stressors, including but not limited to infection or toxin exposure from
entomopathogenic fungi.
Besides known colony insect pests, such as the greater and lesser wax moths
and the small hive beetle, the phorid fly, previously known to parasitize bees,
may be emerging as a threat to honey bees. Core et al., A New Threat to Honey Bees,
the Parasitic Phorid Fly Apocephalus borealis (2012), PLoS ONE 7(1): e29639.
doi:10.1371/journal.pone.0029639; Ravoet, supra.
PESTICIDES:
Pesticides cause le forms of stress to bees. Agricultural spraying may
affect honey bees and scale spraying programs for mosquitoes, gypsy moths,
spruce worms and other insect pests may cause direct or indirect bee kills including
native bumblebees and solitary bees. There is also a shift in the types of pesticides
d — many, such as neonicitinoids, are less toxic to vertebrates and the necessity
of repeated application is reduced, but they act systemically and are absorbed and
distributed throughout the plant upon seed or soil ent, including distribution to the
pollen and nectar.
Sub-lethal pesticide exposure, including exposure to ergic neonicitinoid
insecticides (nicotinic receptor agonists) and/or ergic organophosphate miticides
(acetylcholinesterase inhibitors), has been found to alter bee activity, development,
oviposition, behavior, offspring sex ratios, flight and mobility, navigation and orientation
ability, feeding behavior, ng, memory and immune function, population dynamics
and increase tibility to and mortality from diseases, including Nosema. See, for
example, Pettis, Crop ation Exposes Honey Bees to Pesticides Which Alters
Their Susceptibility to the Gut Pathogen Nosema e, supra at 1. Fungicides and
miticides used by beekeepers can have a pronounced ability on bees’ ability to
withstand parasite infection. Pettis, supra at 4. Often bees are exposed to a variety of
pesticides, which may have interactive s. See, for example, Di Prisco et al.,
Neonicitinoid clothianidin ely affects insect immunity and promotes replication of
a viral pathogen in honey bees, PNAS vol. 110, no. 46, Nov. 12, 2013, 18466-18471;
Pettis et al., Crop Pollination Exposes Honey Bees to Pesticides Which Alters Their
Susceptibility to the Gut Pathogen Nosema ceranae, PLoS ONE (2013); Palmer et al.,
Cholinergic pesticides cause mushroom body neuronal inactivation in honeybees,
Nature Communications, 4:1634, ; mson et al., Exposure to multiple
cholinergic pesticides impairs olfactory learning and memory in honeybees, The
Journal of Experimental Biology 216, 1799-1807 (2013); Derecka et al., Transient
Exposure to Low Levels of Insecticide Affects Metabolic Networks of Honeybee
Larvae, PLoS ONE 8(7), e68191 (2013), doi:10.1371ljournal.pone.0068191.
Exposure to fungicides also kills or reduces the beneficial fungi found on
pollen — the result likely being a higher incidence ofdisease in honeybees, ing
Nosema infections and chalkbrood (ironically, fungal diseases).
The bee genome has vely few genes that are related to fication
compared to solitary insects such as flies and mosquitoes. Some of the most marked
differences between bees and other insects occur in three superfamilies encoding
xenobiotic fying enzymes. Whereas most other insect genomes contain 80 or
more cytochrome P450 (CYP) genes, A. mellifera has only 46 cytochrome P450
genes, whilst humans host about 60 CYP genes. Honey bees have only about half as
many glutathione-S-transferases (GSTs) and carboxyl/cholinesterases (CCEs),
compared to most insect genomes. This includes 10—fold or greater alls in the
Delta and Epsilon GSTs and CYP4 P4503, members of which clades have been linked
to insecticide resistance in other species. Claudianos et al., A deficit of detoxification
enzymes: pesticide sensitivity and environmental response in the honeybee, Insect
Molecular Biology, 15(5), 615—636 (2006).
Whereas bees evolved to deal with plant phytochemicals and l toxins,
they now must additionally metabolize and detoxify pogenic insecticides,
miticides, ides, ides and environmental pollutants, an unprecedented
evolutionary challenge.
MANAGEMENT STRESSORS OF BEEKEEPING:
Use of honey or pollen substitutes (such as sugar syrup; high fructose corn
syrup; bee candy; “grease patties” containing grease, sugar and optionally salt or
essential oils; or “pollen patties” containing soy, yeast and nonfat dry milk, which may
have added pollen, possibly from areas inated with pesticides) may be a
2015/019543
contributing factor to declining bee populations and CCD for several reasons.
Malnutrition is likely a majorfactor in declining bee tions. Synthesized bee diets
simply do not provide the nutritional value obtained by bees from a mixture of quality
s. Although quality proteins, carbohydrates and vitamins can be provided to
honey bees in the lab, we still cannot keep them alive more than two months in
confinement on our best diets; they typically live, on average, about 30 days in
captivity. Garvey, About Bee Nutrition..., Posts Tagged: from the UC Apiaries
newsletter—The California rd Orchard.
Honey contains several substances that activate nutrient sensing, metabolic,
fication and immune processes in the European honey bee Apis mellifera, plus
other chemicals useful to honey bee health. The enzymes are found on the pollen walls
of flowers and enter the honey by sticking to the bees’ legs. Ingestion of tree resins,
s and tree saps via incorporation into propolis or bee glue is also known to
reduce bee susceptibility to both insecticides and microbial pathogens and up-regulate
the transcription of the detoxification genes. Honey substitutes or pollen patties, which
don’t contain these chemicals, may therefore contribute to colony collapse disorder.
See Mao, Wenfru, r, Mary A. and Berenbaum, May R., Honey constituents up-
regulate fication and immunity genes in the western honey bee Apis mellifera,
Proceedings of the National Academy of Sciences of the United States, 110(22), 8842-
8846 (2013). Mao et al. found that tuents in honey derived from pollen and tree
exudates, including aric acid (=4-hydroxycinnamic acid), pinocembrin,
pinobanksin and pinobanksin 5-methyl ether, are strong inducers of cytochrome P450
genes detoxification genes via a number of CYP6 and CYP9 family members.
Massively parallel RNA sequencing and RNA-seq analysis revealed that p—coumaric
acid specifically up-regulates all classes of detoxification genes as well as select genes
for antimicrobial peptides required for defense against pesticides and pathogens.
Those species of honey bees that nest in tree cavities use propolis to seal
cracks in the hive, as do bees in domestic hives, although feral honey bees coat the
entire inner surface of their nesting cavity, whereas icated honey bees lay down
comparatively little resin in ping hives. The coating of propolis has been
demonstrated to t AFB (AntLJnez 2008), fungi, and wax moth; Spivak has
demonstrated that propolis from some regions is effective against Varroa, and is
investigating its effect on viruses. Of great st is the finding (Simone 2009) that the
abundance of propolis appears to se the necessary investment in immune
function of hus, the bee colony, by self-medicating with antimicrobial als
from plants, incurs less of a metabolic cost in fighting ens. Oliver, Sick Bees —
Part 3: The Bee Immune System, American Bee Journal, October 2010.
BEARS, MUSHROOMS AND BEES:
The inventor noticed, on one of his many forays in the old growth forests of
the Olympic Peninsula, Washington State, a conifer tree scratched by a bear (a
photograph appears in the book he authored, Mycelium Running: How Mushrooms
Can Help Save the World, 2005, pg. 70, figure 75. Ten Speed Press, Berkeley). The
research literature on the inter-relationships between bears and mushrooms stated that
Fomitopsis species, brown rotting polypore wood conks, including the frequently seen
Fomitopsis pinico/a and the rarely seen Fomitopsis officinalis, were the most common
fungal species to grow after bear scratchings in conifer forests of the Pacific est
and elsewhere. Forest scientists showed that when bears scratch a living tree, they
leave an open wood, and the Fomitopsis species opportunistically gain an entry site for
infection. After a scratching, sugar-rich resin often beads out as droplets, attractive to
bears and bees. Indeed, when the author returned a few years later to the same bear-
hed tree deep in the old growth forests along the south fork of the Hoh River,
Fomitopsis la mushrooms were fruiting from the now-fallen tree.
“On young conifers, particularly Douglas—fir trees, bears will rip strips of bark
off with their teeth to reach insects or the sweet-tasting sap found inside. The bear’s
teeth leave long vertical grooves in the sapwood and large strips of bark are found
around the bases of trees they peel. These marks are typically made from April to July,
but the results may be seen all year. This foraging activity is common in tree
plantations where large stands of trees are similarly aged and of a single s.”
Link, Living with Wildlife: Black Bears, Washington State Dept. of Fish and Wildlife.
For this reason, a bounty was placed upon bears by forest stakeholders since
the bears were thought to reduce the profitability of forests for . Tens of
thousands of bears were killed by hunters hired by the timber ies. In the 19903,
it was discovered that bears actually benefit the forests by bring sea minerals,
particularly phosphorus and nitrogen, due to their foraging for salmon and trout in the
rivers adjacent to the forests. One reason the lowland old growth forests are so much
larger than old growth forests several thousand feet up in elevation, above the limit of
the migrating fish, is that bears brought the carcasses of fish onto shore, benefitting the
adjacent trees with phosphorus and other minerals that influence tree . Humans
are particularly adept at making decisions contrary to their long-term best interests due
to a fundamental misunderstanding about the onnectedness of nature.
In Stamets, Growing Gourmet and Medicinal Mushrooms, 1993, p. 42-43, the
current inventor stated “For 6 weeks one summer our bees attacked a King Stropharia
bed, exposing the mycelium to the air, and suckled the sugar-rich cytoplasm from the
wounds. A uous convoy of bees could be traced, from g to evening, from
our beehives to the mushroom patch, until the bed of King Stropharia literally
collapsed. When a report of this phenomenon was published in smith Magazine
(Ingle, 1988), bee keepers across North America wrote me to explain that they had
been long mystified by bees’ tion to sawdust piles.” Although it may not have
been clear to one of ordinary skill in the art if the bees were ted to the mycelium,
the lignin within the sawdust or wood resins within the sawdust, the inventor concluded
“Now it is clear the bees were seeking the underlying sweet mushroom mycelium.”
An urgent solution is needed to the problems of declining bee health and
colony collapse disorder.
DISCLOSURE OF INVENTION
The present inventor sees the intersection and interplay of several
mycological methods and itions as a possible integrated solution to CCD. Each
one of these elements may be sufficient to cause an effect leading to preventing or
reducing CCD. As an integrated platform of partial solutions, the totality of these
methods will achieve a synergistic benefit. More particularly, this invention focuses on
the antiviral and longevity enhancing effects from extracts from pure cultured
mycelium, diluted to within specific ranges, which proffer benefits to bees.
[0046A] In a particular aspect, the t invention provides a method for
(followed by page 19a)
reducing bee viral load and increasing bee life longevity comprising adding an effective
amount of less than 10% by volume of an extract of a medicinal om mycelium to a
feeding supplement for bees to produce a composition for reducing bee viral load and
increasing bee life longevity and feeding the composition for reducing bee viral load and
increasing bee life longevity to bees, wherein the medicinal mushroom mycelium is
selected from the group consisting of us obliquus, Ganoderma resinaceum,
Fomitopsis pinicola, Fomes fomentarius, Schizophyllum commune, Trametes olor,
Fomitopsis officinalis, Ganoderma applanatum, Ganoderma lucidum, and combinations
thereof.
[0046B] In another particular aspect, the present invention provides a method for
reducing bee viral load and sing bee life longevity comprising adding an extract of
a medicinal mushroom mycelium to a feeding supplement for bees to produce a
composition for reducing bee viral load and increasing bee life longevity and feeding the
composition for ng bee viral load and increasing bee life longevity to bees, wherein
the composition comprises an effective amount of 10% or less by volume of the extract of
a nal mushroom mycelium and wherein the medicinal om mycelium is
selected from the group consisting of Fomes fomentarius, Trametes versicolor, and a
combination thereof.
The basis of these compositions and methods include the extracellular exudates
and extracts made rom, of the pure cultured mycelium, prior to fruitbody ion,
in the mushroom species of the Agaricales, rales and Hymenochaetales in
combination or ndently. Preconidial mycelium and extracts of the preconidial
mycelium of entomopathogenic fungi may optionally be used to control mites and other
bee and hive parasites. es of these ts and bee products such as bee food or
bee treatment sprays offer multiple solutions to help prevent CCD or help bees overcome
CCD. Sustainable solutions to problems plaguing bees will be derived from promoting their
natural defenses through habitat
19a (followed by page 20)
enhancement via beneficial fungi, such as introducing om forming fungi that
have antiviral properties to wood, causing rot, and ultimately moist nesting cavities that
can be helpful to bees.
The inventor has isolated various strains of mushroom fungi, including
Pleurotus ostreatus, Trametes versicolor, and Psi/ocybe azurescens that have
demonstrated superior abilities to “bioremediate” or “mycoremediate” various toxins
including oil, pesticides and nerve gases such as Sarin, Soman and VX
(dimethylmethylphosphonate), working with Battelle Laboratories, a public report of
which was published in Jane’s Defence Weekly. (Fungi could combat chemical
weapons, Jane’s Defence Weekly, 1999. 32(7):37.)
The inventor has also isolated s strains of fungi, ing Fomitopsis
officinalis, Fomitopsis pinicola, Ganoderma applanatum, Ganoderma annularis,
Ganoderma lucidum, Ganoderma resinaceum, us obliquus, Irpex lacteus,
Phellinus linteus, Piptoporus betulinus, tus tus, Polyporus umbellatus,
Schizophyllum commune, and Trametes versicolor that have demonstrated superior
antiviral, antibacterial, antifungal and antiprotozoal ties.
Without being bound to any theory, the inventor would hypothesize that these
mushroom s are rich in compounds that up-regulate genes for detoxification and
defense against ants, pesticides and pathogens in animals, including humans and
bees. By repeatedly culturing and expanding orulating sectors of
entomopathogenic fungi, the inventor also discovered that such “pre-sporulating” or
nidial” mycelium and extracts of preconidial um emit odors and fragrances
(ranging from Metarhizium anisop/iae and illus flavus “butterscotch” to
Beauveria bassiana “vanilla cola” and “hard Christmas candy”) and tastes are attractive
to animals including humans and both non-social and social insects, which offer
advantages in control of pests such as Varroa mites.
The inventor now hypothesizes that the Fomitopsis colonization of the wood
from bear ng and the entry wound site (see above) would lead to the production
of enzymes (laccases, lignin peroxidases, cellulases), ergosterols and other sterols,
mycoflavonoids and especially arrays of ious complex polysaccharides that would
not only soften the wood, provide water, nutrition, and emit fragrances, all of which
would attract bees, while the extracellular exudates being secreted by the mycelium
would be rich in p—coumaric acids and coumarins and the glycosides of unsubstituted
and substituted benzoic, cinnamic and coumaric acids, all stimulating the up-regulation
of innate cytochrome p450 genes and enzymes and also ing antiviral and
antibacterial agents, all expressed during the decomposition of the infected tree. A
complex fungal tree nectar is exuded, one that provides physiological benefits and
boosts the innate immunity of bees via numerous pathways as the trees decompose. In
some instances, bees nest within these logs or in the ground beneath them, benefitting
from long-term contact. The bees can then incorporate these beneficial agents into
their honey, propolis and combs so to as to protect the brood, the queen and ultimately
the .
The inventor also hypothesizes that combinations of the fungal species
including but not limited to their resident phenols above and below will have additive or
even synergistic consequences, ing regulation and up—regulation of nutrient—
sensing, metabolic, detoxification, immunity and antimicrobial peptide genes and
systems. This invention speaks directly to the link between the t bees have with
fungi that are beneficial, not only nutritionally, but ally in activating the
cytochrome P450 pathways for vating and metabolizing otic and
pogenic toxins.
The current invention provides a plurality of partial solutions to provide
scientists, farmers, biotechnologists, policy makers and thought leaders with biological
tools of practical and scalable remedies before ecological collapse forces us to ever—
limiting options as biodiversity plummets. The combinations of these partial solutions
cumulatively and synergistically provide that which is necessary for bees to overcome
CCD.
Extracts of psis pinicola, Fomes fomentarius, Inonotus obliquus
Ganoderma resinaceum (Ganoderma lucidum var. ceum) and Schizophyl/um
commune have now been found to be ive in reducing the viral burden of honey
bees and extending the life or worker bees. “As an entomologist with 39 years of
experience studying bees, I am unaware of any reports of materials that extend the life
of worker bees more than this.” ——Dr. Walter “Steve Sheppard, Chair, Department of
logy, Washington State University, Pullman, Washington (personal
communication). The inventor now anticipates, as a consequence of this invention, that
other nd polypore mushrooms, for instance the birch polypore, orus
betulinus, and numerous other nd s will have greater and lesser antiviral
and longevity enhancing effects on bee health when the extracts of the pure cultured
um are grown and diluted to within an optimal range, and presented as food, in
the feed water, into honey, pollen patties, propolis, or even incorporated into the wood
frames used to construct bee hives or incorporated into sticky strips applied to bee
hives. The predominant viral species of n are Deformed Wing Virus, Sacbrood
virus, Israeli Acute Paralysis Virus and the Black Queen Cell Virus, each one of which
may exacerbate the activity of other viruses, and pathogens, as immunity fails from the
deleterious cumulative effect from these and other multiple stressors.
As Albert Einstein noted, “We cannot solve our problems with the same
thinking we used when we created them.” This patent follows this philosophy by
offering a complex platform of synergistic solutions addressing a multiplicity of
problems, which ultimately help bees overcome colony collapse disorder.
BRIEF DESCRIPTION OF THE DRAWINGS
is a line graph showing percent survival of bees over time when given
extracts of the mycelium of us obliquus (0.1%, 1% and 10%) with sugar water as
compared to a control population fed sugar water only.
is a line graph showing the percent survival of bees over time when
given extracts of the mycelium of rma resinaceum (0.1%, 1% and 10%) with
sugar water as compared to a control tion fed sugar water only.
is a line graph showing the percent survival of bees over time when
given ts of the mycelium of Fomitopsis pinicola (0.1%, 1% and 10%) with sugar
water as compared to a control population fed sugar water only.
is a line graph g the percent survival of bees over time when
given extracts of the mycelium of Fomes fomentarius (1%) with sugar water as
compared to a control population fed sugar water only.
is a graph of Kaplan-Meier ct-limit) survival estimates showing
the fraction of bees surviving over time when given ts of the mycelium of Fomes
fomentarius (0.1%, 1% and 10%) with sugar water as compared to a control population
fed sugar water only.
is a bar graph showing total virus particles in a l population and
bees given extracts of the mycelium of Inonotus obliquus (0.1%, 1% and 10%) with
sugar water as compared to a control population fed sugar water only at time zero, one
week and two weeks.
is a bar graph showing total virus particles in a control population fed
sugar water only and bees given extracts of the mycelium of Ganoderma resinaceum
(0.1%, 1% and 10%) with sugar water as compared to a control population at time
zero, one week and two weeks.
is a bar graph showing total virus particles in bees given extracts of the
mycelium of Fomitopsis pinicola (0.1%, 1% and 10%) with sugar water as compared to
a control population fed sugar water only at time zero and one week.
is a bar graph showing total virus particles in and bees given extracts
of the mycelium of Schizophyllum commune (0.1%, 1% and 10%) with sugar water as
compared to a control tion fed sugar water only at time zero and two weeks.
is a line graph g cycle threshold for Black Queen Cell Virus
over time in a control population and bees given extracts of the um of Inonotus
us (1%) and Ganoderma resinaceum (1%) with sugar water as compared to a
control population fed sugar water only.
is a line graph showing cycle threshold for Deformed Wing Virus over
time in a control population and bees given extracts of the mycelium of Inonotus
obliquus (1%) and Ganoderma resinaceum (1%) with sugar water as compared to a
control population fed sugar water only.
BEST MODE(S) FOR CARRYING OUT THE INVENTION AND INDUSTRIAL
APPLICABILITY
Bees are increasingly dealing with new anthropogenic stressors. Over
hundreds of millions of years fungi have d to fight viruses, bacteria and other
fungi; have evolved to infect parasites, including insects; have evolved s to
break down toxins; and have evolved substances to up-regulate such processes. This
means they offer a ial nutraceutical treasure trove of compounds useful for
protecting bees and other pollinators from such threats, including a plurality of antiviral,
2015/019543
antibacterial, antifungal and antiprotozoal compounds and nds useful for up-
ting the digestive, detoxification and immune systems of bees.
Without being held to any one theory, the inventor hypothesizes that the
fungal mycelium extracts specifically modulate, induce and increase the sion of
detoxification and xenobiotic lizing genes, specifically to up-regulate all classes
of fication genes, increase midgut metabolism of pesticides, function as a
nutraceutical ting immune and detoxification processes, up-regulate immune,
metabolic and nutrient pathways (lipid and glucose-metabolizing pathways) and up-
regulate genes encoding antimicrobial peptides. Moreover, select fungal species
support the microbiome of beneficial microorganisms in the digestion systems of bees,
and their compatibility is an important species-to-species bridge, matching beneficial
wood rotting fungi to the beneficial microbes resident in the hindgut of bees. The
ts of the present invention are expected to be prebiotics for the natural
microbiome within the bee’s digestive organs as well as to confer antiviral benefits, all
of which contribute to extending longevity of bees and their colonies, and their
collective functionality. r ment of this invention is to ferment the
mycelium of medicinal mushrooms with Bifidobacterium bifidum, Lactobacil/us
plantarum, Lactobacillus acidophilus, Lactobacillus sakei, Leuconostoc Iactis,
Streptococcus thermophiles and bacteriophages to make consumable and
environmentally applicable compositions beneficial to the microbiome of bees, animals
(people).
Since bees are under assault from multiple ens — mites, viruses,
microsporidia, protozoa, phorid flies and exposure to airborne pollutants — g a
robust broad-based platform of protection to help bolster the host immune defense of
bees is of paramount importance. For example, developing methods for creating
compositions using the extracellular es of the mycelium of select species of
fungi, ing but not restricted to Stropharia rugoso-annulata and other members of
the Strophariaceae, Fomitopsis pinicola and other members of the psidaceae
and izium liae and other members of the Clavicipitaceae, can help
prevent colony collapse disorder. Many other species of basidiomycetes and
ascomycetes are also expected to confer similar ts in the course of ch into
the ts of bee-beneficial exudates secreted by the laboratory grown, pure cultured
mycelium.
With regard to fungal extracts, mycelial extracts are preferred to “mushroom
extracts” because the hyphae produce extracellular exudates that are rich in accessible
water, oils, polysaccharides, amino acids, B vitamins, coumarins, p-coumaric acids,
phenols and polyphenols, as well as ergosterols, enzymes, acids, including fatty acids,
antibacterials and antivirals. The individual hyphal threads of the mycelium emits
complex scents that volatilize into the air whereas the mushrooms tend to be
nutritionally dense but do not have the extensive, exposed cellular surface area as the
same mass of mycelium. The mushroom fruitbody is composed of cellularly compacted
hyphae, laminated together, so only a small fraction of the mycelial mass in the
fruitbody is exposed to the atmosphere. Hence the mushroom fruitbodies lack the
fragrance attributes of the mycelium from which they form. Since these extracellular
exudates can readily dissolve into solution, these exudates can be more usefully
incorporated into amendments, such as pollen patties, sugar solutions or water, bee
sprays or foliar plant sprays, and are better attractants to bees and other insects than
the om fruitbodies. This is not currently s to those skilled in the arts of
mycology or entomology, whose focus has been more on the fruitbodies and spores
from fruitbodies, rather than the mycelium.
Although bees may seek the sugar rich ts exuding from the mycelium
rotting wood, the extracts at 100% - what the bees would be sipping — are far too
potent and toxic in most species in their natural form to be of benefit. Even at 10%, a
majority the tested extracts were toxic. Hence, if bees were to sip these droplets in
nature, they would likely sicken, prematurely die and not reap benefits. The inventor
and his team ered, that when the laboratory pure culture extracts were highly
diluted, to 10%, some toxicity remained but when further diluted to 1% or .1% or less,
ity substantially increased, especially in midlife, when the workers are at the
peak of their vigor and most productive in their foraging and pollen acquisition.
Similarly, when the extracts were diluted, antiviral ts were seen at the same time
longevity increased in several fungal species tested. This is especially important as the
reduction of the pathogen payload has an overall net benefit to the quality of the hive’s
overall health and mance. By combining extracts optimized for antiviral activity
with extracts optimized for longevity, greater benefits than either are anticipated.
Combined with ity benefits, the bees can be more productive as foragers, as
nurses taking care of the brood, and as helpers for hygiene control, with less illness
and better able to cope with ous stressors. In essence, the services that bees
provide internally within the hive, and ally for the environment, are substantially
augmented utilizing the methods and compositions described within this invention.
Extraction of pure culture, laboratory mycelium on sterilized substrates is
substantially ent than naturally occurring mycelium form — structurally,
quantitatively and qualitatively. Moreover, growing the pure culture mycelium on rice,
for instance, a non-native substrate, away from the numerous other co-occurring
microbes resident on naturally decomposing wood, produces an arguably different
substance than exudates from osing wood ndent with myriads of other
organisms (a gram of rotting wood naturally hosts hundreds of other microorganisms,
including bacteria protozoa, other fungi, co-inhabiting with or upon the wood
decomposing mycelium.). Hence the exudates from the raw mycelium in nature,
containing a plurality of organisms, is fundamentally different and are unlikely to t
bees with the same antiviral and longevity benefits seen with the specifically diluted,
pure culture extracts made from mycelium as described in the current invention. In
other words, the bees benefit from several alterations and manipulations by the
inventor e of nature: the exudates from the pure culture mycelium must be highly
diluted within discrete concentrations to show benefits. After finding the initial extracts
to be toxic, most chers would have abandoned this line of inquiry. Indeed, when
the inventor ed this idea to entomologists and gists skilled in the art, they
deferred to engage with the inventor as they expected toxicity, and did not want to
harm bees. Initial results, ironically, confirmed their suspicions. Some even said my
idea was “preposterous” and wanted nothing to do with it.
As with botanicals, it is expected that fungal extracts may be more effective
than single constituents or drugs. See, for example, Elfawal et al., Dried whole—plant
sia annua slows evolution of malaria drug resistance and mes resistance
to artemisinin, Proc Nat/Acad Sci USA 112(3):82’| -6 (2015).
Only recently, research has discovered that the mycelium has more genes
turned on than the mushrooms that ultimately are formed from it. As was noted by Li et
al., 2013, “The n-coding genes were sed higher in a or primordial
stages compared with those in the fruiting bodies.” Li et al., “Complete mitochondrial
genome of the medicinal mushroom Ganoderma lucidum.” PLoS ONE 8(8):e72038
(2013). doi:’| 0.1371/journal.pone.0072038.
Moreover, the network-like structure of the mycelium allows for epigenetic
evolution of strains that can be evolved to emit substances targeted specifically for the
benefit of bees. Such improvements are pated by the inventor as a method for
making strains and compositions more attractive to bees and more appropriate for
helping bees overcome CCD.
In essence, the inventor has devised a novel nutraceutical which is rich is a
wide array of coumarins, phenols and polyphenols; and anti-viral, anti-fungal, anti-
bacterial and anti-protozoal agents, and a wide diversity of specialized metabolites
such as antioxidants and antimutagens, which are ted as a result of mycelium
ing grains or wood and are attractive to bees and supportive of their host defense
against stressors and diseases. The extracts of mushrooms used medicinally for
human health have an unexpected benefit for bee health, including lowering antiviral
counts and extending bee lifespans. , the fungal contribution to propolis and
honey, as well as to pollen, augments the immune s of bees, and by extension
to people, on specific, fundamental, complex levels. The inventor notes extracts of
mycelium grown on grain inoculated wood are expected to contain more enols,
coumarins and compounds that up—regulate detoxification and immunity genes in the
bees, as opposed to extracts of mycelium grown via liquid fermentation.
Since nature may e s, even millennia, before new beneficial
associations can be established, with bees unable to react quickly enough to the recent
advent of new herbicides, pesticides, fungicides and miticides, we can jump start —
jumping ahead of ion — this process by giving these beneficial fungal species a
primary role in the pathways of bee biology and biochemistry to bolster their host
defenses and t GOD. The chemical ition of fungal mycelium is x
and variable within and among the various mushroom phyla, families and genera, traits
that makes fungal extracts a good defense against rapidly evolving pests and
pathogens.
TANTS:
One component of the invention is the use of fungal extracts, whereby the
extracts are generated from the mycelium of polyporoid, basidiomycetous and
ascomycetous species, to attract bees. The bees are attracted to the polysaccharide-
rich extracellular and intracellular metabolites secreted by the mycelium. Within these
exudates are compounds that attract bees, feed them with sugar rich and other
nutrients, provide antiviral, antifungal and antibacterial protection, while bolstering their
resistance to pesticides and ing colony health and honey tion. In fact,
honeys holding these fungal components could proffer medicinal benefits to bees and
other animal species, including humans.
These extracellular exudates from, for instance, the King Stropharia or the
Garden Giant mushroom (Stropharia rugoso-annu/ata), have an attractive effect on
bees, especially during the time when flowering plants of their preference are limited.
Bees are attracted both to the ellular extracts as well as living mycelium. Other
non—toxic mushroom species, which may or may not possess ral and life
extending properties, ing gourmet and medicinal mushrooms, are expected to
attract bees to varying s in a similar fashion.
The pleasant fragrance of Stropharia rugoso-annu/ata out-gassing from the
mycelium may attract bees, although no other scientists, to the best of this inventor’s
knowledge, has ever discovered or stated this. The present inventor has discovered
Stropharia rugoso-annu/ata um emits a rich, ting flower-like essence.
Oyster mushrooms in the genus Pleurotus, especially Pleurotus ostreatus, P.
pulmonarius, P. lignatilis, P. sapidus, P. eryngii, P. popu/inus and other related s
emit a ng anise-like fragrance, as does Clitocybe odora. Another candidate is the
split-gill re, Schizophyllum commune, one of the most common of all nd
omycetes, which produces a potent, sweet fragrance in culture, at times
overwhelming the olfactory senses of lab personnel, and is a source of coumarins and
coumaric acids. Interestingly, only those growing Schizophyllum commune in mass, in
vitro, on cereal grains or wood would ever know about this potent outgassing
fragrance. The inventor knows of no one else in his 40 years of ence who has
mentioned or reported on this fragrance phenomenon with this species. Schizophyllum
commune is one of the most prominent white rot, woodland species across the
temperate and tropical s of the world, and creates softened, sweet wood from
which bees can benefit. Many other species probably emit attractive fragrances to
bees, which are undetectable to humans or not noticeably enticing.
The mycelium from Agaricomycetes and the extracts made from the pure
culture mycelium may be the source of new bee attractants. The Agaricomycetes are
the only fungi that ose Iignin, and includes the gilled oms, such as
Stropharia rugoso-annu/ata, and the polypores, such as those related to psis
species. The Agaricomycetes encompasses ~16,000 described species. Many of the
Agaricomycetes dually decompose cellulose and lignin. Native bees use rotten logs for
nesting, as discussed above in connection with bears, fungi and bees, which the
inventor hypothesizes provides bees with the sugar rich and cytochrome P450 coding
and up—regulating compounds via water droplets and nectar secreted by the mycelium
of Agaricomycetes.
tly, our regenerated forests have about 10-15% of the wood debris
compared to native woodlands! This relatively recent loss of decomposable wood
debris limits the availability of these beneficial fungi to native and imported bees,
introducing a heretofore unreported, additional stress factor. The continued constriction
of debris fields further erodes the food webs essential not only to bees, but also to
most organisms that are dependent upon healthy and sustainable ecosystems.
For ce, fungal extracts of the preconidial (pre—sporulation) mycelium of
non-Agaricomycetes fungi, including Metarhizium anisop/iae and Aspergillus flavus,
have been shown by the inventor to t Phorid flies (and other s) (See US.
patent nos. 6,660,290, 7,122,176, 7,951,388, 7,951,389 and 8,501,207), arresting their
ion, and thus prevent these flies from ing diseases. Moreover, pathogen
hosting mites are also attracted and stopped from moving into the bee colonies using
these mycelium-based extracts, thus reducing not only the pathogen payloads mites
carry, but also reducing the numbers of mites which might otherwise infect the bees.
Similar approaches may be used to control beehive pests, such as the greater and
lesser wax moths and the small hive beetle, if needed. Moreover, strains of these pre—
sporulation entomopathogenic fungi can be ed for their high thermal tolerance
and their abilities for attracting and killing mites and flies which harm bees or vector
pathogens. Research into post-sporulation and spore-based Metarhizium anisop/iae
technologies (which may have the disadvantage of repelling mites and/or insects as
compared to the attractancy of preconidial mycelium) have trated the relative
ease with which strains may be selected for thermal tolerance to high hive
temperatures and high pathogenicity and/or mortality to Varroa mites. Rodriguez et al.,
ion of entomopathogenic fungi to control Varroa destructor (Acari: Varroidae),
Chilean J. Agric. Res., 69(4): 534-540 (2009); Rodriguez et al., Evaluation of
Metarhizium anisopliae var. anisopliae Qu-M845 isolate to l Varroa destructor
(Acari: dae) in laboratory and field trials, Chilean J. Agric. Res, 69(4): 541-547
(2009); Boyle, New Brunswick Department of Agriculture, Aquaculture and ies,
ated Pest Management - Compatible Biological Control of Varroa Mite of Honey
Bee; Fungi help combat honeybee killer, BBC News Science/Nature, August 9, 2002.
Moreover, the inventor has clearly shown that the idial mycelium of
pathogenic fungi, such as but not limited to, Metarhizium anisopliae, Beauveria
bassiana and Cordyceps species, elicit a stimulatory feeding response
stimulation) in many insects and other arthropods from the smelling and
subsequent ingestion of the extracts made from presporulating (preconidial) um.
However, bees show a unique tolerance to the toxins from the spores and mycelium of
Metarhizium anisopliae that harms mites and phorid flies. Hence having a blend of
entomopathogenic fungi, prior to sporulating, or extracts thereof, mixed with the spores
(conidia) of these same fungi, could stimulate the bees to consume more mycelia and
the extracts f, including the beneficial re fungi, resulting in a unique suite
of synergistic advantages, which includes longevity factors, antiviral, antibacterial and
antifungal effects, up-regulations of cytochrome (p450) detoxification pathways,
providing complex sugars, vitamins and nutrients, while lessening the toxicity of
anthropogenic insecticides, herbicides, ides, anthropogenic toxins and also
reducing mite and phorid fly populations, all the while introducing fungal species
supporting a healthy bee gut bacterial microbiome. Each one of these factors helps
bees reduce the stressors of colony collapse ers. The combination of these
benefits within one delivery system - as a composition or a method - is an
unprecedented approach, to the best of the knowledge of this inventor. s for
selecting and optimizing s within each species will likely result in improvements
as each variable is tested and combined.
Humans are d to perceiving color wavelengths of light from
approximately 390 to 750 nanometers (nm). Bees, like many insects, see colors from
approximately 300 to 650 nm. Many mushroom species like Oyster mushrooms
WO 38361
(Pleurotus tus) are triggered into ng around 360 nanometers, beyond the far
end of our ability to detect. (See Action spectra for Hyphal Aggregation, the first stage
of fruiting, in the basidiomycete Pleurotus ostreatus, Richartz and Maclellan in
Photochemistry and Photobiology pages 0, May 1987. Mushroom mycelium will
absorb some of this light and reflect much of it, due to the tions of absorption
through the translucent, hyaline cell walls of the mycelium.
When mycelium g deep within wood or the ground reaches the surface
of ground or wood, and is exposed to light, a phase change occurs in the mushroom’s
life cycle, going from mycelium to the first stages of mushroom formation, hyphal
aggregation and primordia (‘baby mushroom’) formation. The mycelium in many
species will not form primordia unless there is light exposure near to the ultraviolet or
360 nanometer or lower wavelengths. This is well within the range bees can detect but
beyond the limits of what humans can.
Attractiveness to mycelium stimulated by blue light invisible to humans but
visible to bees is highly significant discovery as bees are most easily trained to
associate food in the ultraviolet wavelengths of color. As Menzel and us
determined in 1989, bees could learn faster when the food was associated with violet
light as compared to all other colors. Menzel, R. and Backhaus, W. 1989. “Color vision
in honey bees: Phenomena and physiological mechanisms”. In D. Stavenga and R.
Hardie (eds.): Facets of vision, Berlin—Heidelberg—New York: 281—297.
Hence, bees finding surfacing mycelium, at the time when nutrients are being
up-channeled into the pre-primordia or primordia forming mycelium in se to
violet light wavelengths, and when this light is critical for stimulating um to switch
into mushroom formation, such detection by bees would be an opportune time to find
surfacing mycelium and capture dense nutrition when mycelium is so metabolically
active. Although hypothetical and ative by this inventor, this interaction merits
further research since bees can be trained to discover food based on light spectra
associations. This added element to this invention can accelerate the ng process
of bees for finding new food sources using the attributes of mycelium. As a result, the
embodiments of this invention also provide the benefit of enhancing the usefulness and
attractiveness of other forms of foods for g the health of bees using these
aforementioned al properties, particularly helping bees discover mycelium at the
primordia ion stages.
Surfacing um outgasses carbon e and exudates fragrances, and
this inventor hypothesizes that bees can detect mycelium not only from its scent, but
are also attracted to the mycelium’s response to this blue spectrum light, whereupon
mushroom mycelium begins to pack protein, vitamins, and sugar—rich nts at the
interface n the high carbon dioxide nment within substrates and the highly
ated environments just above, and in doing so builds ionally dense but
accessible primordia — the first stage of mushroom formation or basidiospores
formation (as in the case of resupinate polypores like Inonotus species, forming
exposed hymenial surfaces, or crusts, that are brightly colored such as Inonotus
andersonii). Many of the brightly colored fungal pigments, especially but not limited to
yellowish ones, exhibited by mycelium can be composed of fungal bioflavonoids, many
of which are polyphenols. Exploring this rich interface environment — the surface of
yellowish fungal mycelial membranes exposed to the atmosphere — is anticipated by
the inventor to be a rich reservoir for bees to harvest extracellular and intracellular
metabolites endowed with nutrients and immune-supporting compounds, including
“mycoflavonoids” and terols” including phenols and polyphenols not limited to
coumarins and benzoic and cinnamic acid derivatives including coumaric acids and
2015/019543
their glycosides.
By way of example, but not of tion, mycelia of some species, especially in
the genus Phellinus and lnonotus, produce brightly colored, ish ts in their
mycelium including polyphenols, for example hispolons such as 6-(3,4-
Dihydroxyphenyl)hydroxyhexa-3,5-dienone, (C12H1204), a bright yellow
bioactive group of compounds with idant and immune enhancing properties
derived from polypore species such as Inonotus hisipidus and Phellinus Iinteus. The
inventor hypothesizes these bright yellowish-colored mycelia would additionally attract
bees foraging for sugars, polyphenols, moisture, natural nts and other secretions
that have immune-building antiviral, antibacterial, antifungal and antiprotozoal
properties. Since bees are especially attracted to yellow colors, those species of fungi,
such as Phellinus and lnonotus, which produce bright yellowish colors, could
preferentially attract bees and also are directly associated with the yellowish
polyphenols containing coumarins to help bees activate their cytochrome P450 enzyme
pathways. This inventor sees the growing of these wood-decomposing species that
produce brightly pigmented mycelia as preferred candidates for designing mycelial
platforms and ts for helping bees. Consequently, extracts of mycelium forming
primordia and extracts of colored um are preferred bee attractants.
The mycelium in many fungal s will not form sporulating structures,
including but not limited to mushroom formation; such fungi are also preferred for
studying their mycelial extracts for bee attractancy and health.
VIRUSES, FUNGI, BACTERIA AND OA:
Bees infected by viruses can lose immune on, as well as the ability to
perform other metabolic functions, as a result of the s “hijacking” the ribosomal
machinery to their benefit, ally interfering with the crucial phenoloxidase
cascade, ssing immune responses before they are initiated, manipulating the
host’s immune signaling network, disabling the host’s antimicrobial peptides, interfering
with the RNAi response and/or creating antigens” that can overwhelm the host
immune system and otherwise adversely affecting bee health.
The exclusive dependence of viruses on the host cellular ery for their
propagation and survival make them highly susceptible to the characteristics of the
cellular environment like short RNA mediated interference. It also gives the virus an
opportunity to fight and/or modulate the host to suit its needs. Thus the range of
interactions possible through miRNA-mRNA cross talk at the host-pathogen interface is
large. These interactions can be further fine-tuned in the host by changes in gene
expression, mutations and polymorphisms. In the pathogen, the high rate of mutations
adds to the complexity of the interaction network. Viruses either produce micro—RNAs
or target host micro-RNAs essential to the host immune system. Scaria etal. (2006)
Host-virus interaction: a new role for microRNAs, Retroviro/ogy, 2006, 3:68; Oliver,
Sick Bees — Part 4: Immune se to Viruses, American Bee Journal, November
2010.
Mushroom mycelium es a wide array of compounds that can be anti-
bacterial or anti-viral. US. patent no. 8,765,138 to the inventor discloses the antiviral
activity of Fomitopsis officinalis, which includes activity against avian flu viruses and
herpes simplex I & ll. Other viruses are anticipated to be sensitive to the antivirals
being coded and expressed by the mycelium of Fomitopsis officinalis, and indeed
many species in the polyporaceae and omycetes fungi. The mycelial extracts are
active t numerous viruses that harm bees, particularly but not d to BQCV
(Black Cell Queen Virus), IAPV (Israeli Acute Paralysis Virus), DWV med Wing
Virus), TRV (Tobacco ot Virus), and their relatives. The active ingredients
limiting viruses within extracts are varied, but two groups are polyphenols including
coumarins and sterols including dehydrosulpherinic acids, eburicoic acids and related
compounds. istic benefits between these polyphenols and s can further
boost the host defense of bees. These compounds are resident within the xes
that include fatty acids, lipids and sterols. As such, many other active ingredients
related to fatty acids, lipids and sterols having antiviral ties are expected to be of
bee benefit. Many of these aforementioned nds known as bioflavonoids, and
the species that produce them, are of interest because some of these s produce
mycelium with bright yellowish colors, which may also serve to attract bees. Very little
work, if any, has been done by mycologists to detect the “colors” of myceliated wood
visible to bees but invisible, or nearly so, to the human eye, ally light reflected in
the ultraviolet bands.
The inventor has also discovered the antibacterial properties of Fomitopsis
officinalis mycelial extracts against staph, tuberculosis and E. coli bacteria. This
antibacterial activity is likely to confer an additional layer of protection from diseases
carried by other organisms. These ts will similarly have a positive influence in
limiting the deleterious effects from known and yet undiscovered bacteria that are
harmful to bees, animals and plants. See US. patent application serial no. 13/998,914
and related applications above.
It is expected that medicinal om species substances useful in humans
will similarly prove useful in up-regulating of immune genes and benefitting the bee’s
immune system. Since many such genes are evolutionarily conserved or similar, it is
expected that the extracts of the mycelium of such mushrooms will similarly be useful
in up-regulating genes and systems in bees to degrade and deal with infections.
The preferred effective dose varies from species to species, in part e
the extracts can be, in common with most medicines, medicinal at low doses and toxic
at high doses. In addition, some species such as Fomitopsis officinalis may have both
strong antiviral s and a lower toxic threshold as compared to other medicinal
species. In general, for all medicinal mushroom species mentioned herein by this
inventor, preferred doses range from 0.0001 % to 50%, with a more preferred range of
0.001%-25% and a most preferred range of 0.01% to 15%. With many of the polypore
extracts in particular, the results in general indicate that the extracts need to be diluted
to less than 10%, or less than 1% or less than 0.1 % with many of these polypore
mushroom extracts, to confer antiviral and longevity benefits to bees. A preferred dose
added to liquid or solid bee nutrients for Fomitopsis officinalis would be from O. 0001%-
.1 %; a red dose for Trametes versicolor or Fomes fomentarius and F. pinico/a.
would be from 0.1% to 10% based on results that show both improved longevity and
improved reduction in viral load at 10% concentrations. Except for Trametes versicolor
and Fomes fomentarius, in general 10% concentrations did not help increase bee
longevity. Consistently, higher concentrations, above 10% had adverse effects on
overall lifespans.
nal mushrooms and the mycelium of medicinal mushrooms are defined
as mushroom and mycelium that t health and nutrition. In the context of bees,
this includes mushroom and um that has the effect of increasing longevity,
increasing foraging abilities, increasing resistance to disease, increasing ability to
fy pogenic toxins, increasing parasite resistance, possessing ral,
antibacterial and/or ngal activity, and increasing bees’ ability to better withstand
stressors associated with the complex tively called ‘colony collapse disorder.’
Useful and preferred fungal genera include, by way of example but not of
limitation: the gilled mushrooms (Agaricales) Agaricus, Agrocybe, Armillaria, Clitocybe,
Collybia, Conocybe, Coprinus, Coprinopsis, Flammulina, Giganopanus, ilus,
Hypholoma, Inocybe, Hypsizygus, Lentinula, Lentinus, Lenzites, Lepiota, Lepista,
llum, ybe, Marasmius, Mycena, Omphalotus, Panel/us, Panaeo/us,
Sarcomyxa, Pho/iota, Pleurotus, s, Psathyrella, Psi/ocybe, Schizophyllum,
Stropharia, Termitomyces, Tricholoma, Volvariella, etc. ; the polypore mushrooms
(Polyporaceae) Albatrellus, Antrodia, ndera, Bondarzewia, Bridgeoporus,
Ceriporia, Coltricia, Coriolus, Daedalea, Dentocon‘icium, Echinodontium, ina,
Flavodon, Fomes, Fomitopsis, Ganoderma, hyl/um, Grifola, Heterobasidion,
lnonotus, lrpex, Laetiporus, Meripilus, Oligoporus, Oxyporus, Phaeolus, Phellinus,
Piptoporus, rus, Poria, phyl/um, Schizopora, Trametes, Wolfiporia; the
d mushrooms Hericium, Sarcodon, Hydnum, Hydnellum etc. ; Basidiomycetes
such as Auricu/aria, Calvafia, Ceriporiopsis, Coniophora, Cyafhus, Lycoperdon,
us, Phlebia, Serpula, Sparassis and Stereum; Ascomycetes such as Cordyceps,
Ophiocordyceps, Morchel/a, Tuber, Peziza, etc. ; ‘jelly fungi’ such as Tremella; the
mycorrhizal mushrooms, fungi such as Phanerochaete ding those such as P.
chrysosporium with an imperfect state and P. a).
Suitable fungal species and genera include by way of example only, but not of
limitation: Agaricus augustus, A. blazei, A. brasiliensis, A. brunnescens, A. campestris,
A. lilaceps, A. placomyces, A. subrufescens and A. sylvicola, Acau/ospora delicate;
be aegerita, A. praecox and A. s; Albatrellus hirtus and A. syringae; Alpova
pachyploeus; Amanita muscaria; Antrodia carbon/ca, A. cinnamomea and A.
radiculosa; Armillaria bulbosa, A. gal/ice, A. matsutake, A. mellea and A. ponderosa;
Astraeus hygrometricus; Athelia neuhoffii; Auricularia auricula and A. polytricha;
Bjerkandera adusta and B. adusta; Boletinellus merulioides; Boletus punctipes;
Bondarzewia berkeleyi; Bridgeoporus nobilissimus; Calvatia gigantea; Cenococcum
geophilum; Ceriporia purpurea; Ceriporiopsis subvermispora; Clitocybe odora, Col/ybia
albuminosa and C. tuberosa; Coltricia perennis; Coniophora a; Coprinus
comatus, C. niveus and ‘lnky Caps’; Cordyceps bassiana, C. variabilis, C. facis, C.
subsessilis, C. ophila, C. sphecocephala, C. rrhiza, C. gracilis, C.
militaris, C. washingtonensis, C. melolanthae, C. ravenelii, C. unilateralis, C. clavulata
and C. sinensis; Cyathus stercoreus; ea na; Dentocon‘icium sulphure/lum;
dontium tinctorium; Fistulina hepatica; Flammulina velutipes and F. populicola;
F/avodon ; Fomes fomentarius, F. lignosus; Fomitopsis officina/is, Fomitopsis
cana, F. subtropica and F. la; G. resinaceum, annularis, G. australe, G. atrum, G.
brownii, G. collosum, G. sinensis, G. Iingzhi, G. curtisii, G. japonicum, G. Iucidum, G.
lucidum var. resinaceum, G. neo-japonicum, G. oregonense, G. sinense, G. tornatum
and G. tsugae; Gigaspora gigantia, G. gilmorei, G. heterogama, G. margarita;
Gliocladium virens; Gloeophyllum saeparium; Glomus aggregatum, G. ca/edonius, G.
clarus, G. fasciculatum, G. fasiculatus, G. lame/losum, G. macrocarpum and G.
mosseae; Grifola frondosa; us dryophilus, Gymnopus peronatus, Hebe/oma
anthracophilum and H. liniforme; Hericium abietis, H. coral/aides, H. erinaceus
and H. capnoides; Heterobasidion annosum; Hypholoma capnoides and H.
sublateritium; ygus ulmarius and H. tessulatus (= H. marmoreus); Inonotus
hispidus and I. obliquus; Irpex s; Lactarius deliciosus; Laetiporus sulphureus (=
Polyporus reus), L. coniferco/a, L. cinncinatus; Lentinula edodes; Lentinus
lepideus, L. giganteus, L. ponderosa, L. squarrosulus and L. tigrinus; Lentinula
species; Lenzites betulina; Lepiota raohodes and L. a; Lepista nuda (= Clitocybe
nuda); Lycoperdon lilac/num and L. per/atum; Lyophyllum decastes; Macrocybe crassa;
Marasmius oreades; Meripilus giganteus; us incarnatus, M. incrassata and M.
tremellosus; Morchella angusticeps, M. pes and M. esculenta; Mycena citricolor,
M. alcalina and M. chlorophos; Omphalotus olearius; Panel/us stypticus, P. serotinus;
Paxil/us involutus; us schweinitzii; Phellinus igniarius, P. pini, P. Iinteus and P.
weirii; Pholiota nameko, P. squarrosa, Piloderma bicolor; Piptoporus nus;
Pisolithus tinctorius; Pleurotus citrinopileatus (= P. cornucopiae var. citrinopileatus), P.
cystidiosus, (= P. abalonus, P. smithii), P. djamor (= P. flabe/latus, P. salmoneo-
stramineus), P. dryinus, P. eryngii, P. lignatils, P. euosmus, P. nebrodensis, P.
ostreatus, P. pulmonarius (= P. sajor-caju) and P. tuberregium; Pluteus cervinus;
Polyporus indigenus, P. saporema, P. squamosus, P. tuberaster and P. umbe/latus (=
Grifo/a umbellata); Psathyrella hydrophila, Psi/ocybe allenii, aztecorum, P. azurescens,
P. stis, P. bohemica, P. caerulescens, P. coprophila, P. cubensis, P.
cyanescens, P. agenii, P. mexicana, P. ovoideocystidiata, P. pellicu/osa, P.
semi/anceata, P. serbica, P. subaeruginosa, P. tampanensis and P. weilii; Rhizopogon
nigrescens, R. roseolus and R. tenuis (= Glomus tenuis); Schizophyllum commune;
Schizopora paradoxa; Sclerocytis sisuosa; Serpula Iacrymans and S. himantioides;
Scleroderma albidum, S. aurantium and S. polyrhizum; Scutellospora ora;
Sparassis crispa and S. herbstii; Stereum catum and S. ostrea; aria
ambigua, S. aeruginosa, S. cyanea, S. anea, S. caerulea, S. semiglobata, S.
semigloboides, and S. -annu/ata; Sui/[us cothurnatus; Talaromyces flavus;
Termitomyces us; Trametes elegans, Trametes T. gibbosa, T. a, T.
cingulata, T. hirsuta, T. /ens and T. olor, Trichoderma viride, T. harmatum;
Trfcholoma giganteum and T. magnive/are (Matsutake); Tremella aurantia, T. fuciformis
and T. mesenterica; Volvariella volvacea; and numerous other beneficial fungi.
Preferred strains which have shown exceptional characteristics useful for the
practice of this invention, include, by way of example but not of limitation, Fomes
fomentarius (NY state), Ganoderma app/anatum (Strain Duckabush), Fomitopsis
officinalis (Strains I, Vl, X), psis la (Strain I), Ganoderma oregonense
(Meadow Lake), Heterobasidion annosum (Dosewalips), Pleurotus ostreatus (Strains
PW-OST, Nisqually), Psi/ocybe azurescens ts strain), Stropharia rugoso-
annulata n F), Trametes o/or (Kamilche Point) and Inonotus obliquus
(Stamets NY).
Additional suitable mushroom genera and species can be found in standard
mycological field guides such as Mushrooms Demystified (1979, 1986) by David Arora,
The Audubon Society Field Guide to North American oms (1981, 1995) by Gary
Lincoff, and Psilocybin oms of the World (1996) by Paul Stamets. Continually
d lists of suitable species based on the most recent DNA analysis can be found
at the Tree of Life and Encyclopedia of Life (EOL) web projects.
The extracts from the mycelium of Fomitopsis officinalis particularly, Inonotus
obliquus, Fomes fomentarius, Ganoderma resinaceum and other species in the
Polyporaceae generally, reduce the pathogenicity of s to bees by directly
reducing the viral le populations while also ying the immune systems of bees,
thus limiting their virulence and transmissibility. Moreover, bees better benefit from a
combination of a mixture of the antiviral components generated by the mycelium with
the antimicrobial properties of coumarins and other compounds produced by the
psis officinalis mycelium. The extracellular exudates secreted by the mycelium
of the beneficial fungi described herein have a combination of these constituents, but
balanced to have the net benefit of attracting bees so they are fortified with immune
enhancing, and nutritionally beneficial constituents. This multifaceted effect results in
fortifying the immune systems of bees and their colonies, making them less susceptible
to viral, bacterial, protozoal and fungal mitigated diseases.
The present inventor has found that Ganoderma, Fomes, Fomitopsis,
Fomitoporia, Ganoderma, ia, lnonotus, Irpex, Lenzites, Phellinus, Sparassis,
Hypholoma, Pleurotus, Schizophyl/um, and aria species demonstrate strong
anti-fungal properties and s these will also be useful for controlling fungal
pathogens afflicting bees, including but not d to Nosema species and other
pathogenic microsporidia, Chalkbrood and rood.
The first antiviral from a mushroom ever discovered was from the “Ice Man"
polypore, Fomes arius, against the Tobacco Mosaic Virus, the first virus ever to
be discovered, and related to the Tobacco Ringspot Virus. This polypore mushroom is
a saprophyte on birch, beech and other temperate deciduous hardwoods. When it
grows, the wood is softened, releasing moisture, insect-attracting fragrances and
sweetened with the rich, complex polysaccharides, as well as proteins and other
nces generated by the um of this fungus. This fungus attracts beetles
whose burrows subsequently can be occupied by native bees. In essence, this is one
example of what the inventor anticipates to be many examples of the role polypore and
other Basidiomycetes fungi play in providing bees with nutrients. Interestingly, Fomes
fomentarius is a known endophyte of birch trees — meaning that they are part of the
tree’s natural immune system. The inventor hypothesizes that many of these
endophytic fungi confer antiviral properties on plants and bees — if encountered within
a discrete, diluted , as well as other insects, as they forage or nest in wood
hosting these fungi. But, if encountered in their pure form, many of these may, in fact,
be toxic. Here is where human intervention can help evolve a bridge of ral
benefits otherwise unlikely encountered in nature. The or believes the inter-
relational dimensions wherein the biology of bees, fungi and decomposing trees and
plants all intersect will become a fertile area of scientific research for helping and
evolving tems for decades to come.
The aggressive wood rotting fungi listed in this application compete with many
other fungi to establish their dominance in ecological niches. The re mushroom
species, in particular species of Antrodia, Fomes, Fomitopsis, rma, Grifola,
Heterobasidion, Inonotus, Stereum and Trametes, produce anti-fungal properties,
present in extracts, which this inventor suggests will be effective against Nosema, a
microsporidium fungal parasite ng bees worldwide.
Of course, bears are not the only way to spread to trees Fomitopsis and other
fungi that may improve bee heath. Any activity resulting in creating wounds in trees, or
in creating dead wood, creates a potential fungal platform of bee t. The human
use of woodchips as ‘beauty bark’ or for making trails, or as a top ng around
ornamentals, would also serve to create a mycelial platform of benefit to bees.
tely, this means we can grow the mycelium of these fungi, en masse, in a pre-
sporulating or pre-conidial state, make mycelial ng pads’ for bees, or make
extracts, and in doing so creating a new generation of bee tants and nutrition
customized accordingly.
With these hypotheses in mind, the inventor sees use of a wide array of
Basidiomycetes, wood-decomposing fungi to develop a fungal bioshield, a “bee
eld” of protection from the stressors leading to colony collapse disorder.
Moreover, the antibiotic effect of these extracts on microsporidium bee
parasites, particularly Nosema apis, the cause of ‘Nosema,’ recently reclassified as a
simple fungus, will prove to be a beneficial co-occurring factor.
Another advantage of the present invention is the wide-ranging antiviral,
antibacterial and antifungal properties derived from mycelium. Many of the or’s
mycelium extract fractions demonstrate antiviral activity even when the bioguided
fractionation pathway led to antibacterials. Microbial agents are often thought of as
ial-type ic (there is some cross-over n antibacterials and anti-
parasitics and now may even be at least one class with both anti—bacterial and anti—
fungal activity), but considering how difficult it is to attain anti-viral specificity alone, and
the absence of known shared molecular targets between bacteria and viruses that also
t any degree of selectivity with respect to the host, broad anti-microbial activity is
rare. Without being bound to any theory, the inventor would hypothesize that the
extracts are acting as immuno-stimulators, immuno-potentiators and immuno-
regulators with antiviral, antibacterial and antifungal s.
It is hypothesized that the mycelial ents discussed above and/or other
known and unknown compounds are anti-bacterial and anti-fungal, helping immunity,
and hence the interaction between bees and ts of pure cultured mycelium within
discrete trations is an unanticipated advantage of the present invention.
Hyphoderme/la corrugata, Polyporus umbel/atus, and Piptoporus betulinus
are species of the polyporales known to the author from his research to t strong
antiprotozoal properties. Agaric acid is thought to be one agent responsible for
Piptoporus betulinus’s anti-protozoal activity. Agaric acid is also produced by
Fomitopsis alis, and possibly by other species in the polyporales. The production
of acanthocytes by Stropharia rugoso-annulata, known to kill nematodes, may also
provide antiprotozoal and antimiticidal benefits to bees. As such, these species and
their relatives would be preferred for testing for antiprotozoal activity and up-regulation
of antiprotozoal genes in bees.
PESTICIDES:
As bees are limited in the number and variety of enzymes needed to denature
natural and anthropogenic toxins, these toxins impair their baseline immunity, making
them more susceptible to ens from numerous vectors — from Varroa mites,
Nosema and poridia fungi, Phorid flies, and the viruses and bacteria they carry.
By increasing the bees’ ability to degrade these toxins by up—regulation of more
cytochrome P450 genes, GST genes and/or CCE genes, the bees’ immune state is
improved to better resist these ts and other stress factors. er, by
providing bees with a blend of fungal extracts that specifically limit the severity of
assaults from Phorid flies, Varroa mites, Nosema fungi and viruses, bee colony health
can be fortified for the long-term health of the brood, the s, the queen and her
. These fungal components are naturally incorporated into the honey and
propolis, thus imparting an advantage to developing generations. Ultimately, not only
are bees are protected, but honey production is expected to increase, and the quality
of the honey better supports downstream generational health and survivability.
Those mushroom species useful in bioremediation (“mycoremediation”) of
toxins, pollutants and pesticides and extracts of their mycelium are expected to n
various substances useful in turning on, up-regulating and modulating the genes
ary for the biodegradation of pesticides. Since many such genes, or the
systems such as the cytochrome system, are evolutionarily conserved or similar, it is
expected that the extracts of the mycelium of such mushrooms will similarly be useful
in up-regulating genes and systems in bees to degrade and deal with such pesticides.
Useful and preferred species include the saprophytic mushrooms tus ostreatus
and other Pleurotus species, Trametes versicolor, Trametes elegans and other
Trametes species, Fomes fomentarius, psis officinalis and F. pinicola,
Ganoderma lucidum, G. annulare, G. brown/i, G. um, G. Iingzhi, G. curtisii, G.
oregonense and G. tsugae; Heterobasidion annosum, Inonotus obliquus, I. hispidus,
lrpex Iacteus, Laetiporus sulphureus, L. coniferico/a, L. cincinnatus, Polyporus
umbellatus, Polyporus elegans, Polyporus squamosus, Antrodia s, Phaeolus
schweinitzii, Boletus mirabilis, Gymnopus peronatus, Mycena alca/ina, M.
aurantiadisca, M. haematopus, Psi/ocybe azurescens, P. a/Ienii, P. subaeruginosa, P.
ovoideocystidiata, P. cubensis, P. cyanescens, Panaeo/us cyanescens, Stropharia
ambigua, Stropharia rugoso-annulata, Stropharia lla, Hypholoma capnoides, H.
fasciulare, H. aurantiaca and other species in the Strophariodeae and Strophariaceae,
Lenzites nus, Pholiota adipose, Pholiota terrestris, Pholiota nameko, Agrocybe
aegerita, A. praecox, A. arvalis, Col/ybia tuberosa, Collybia, rel/a hydrophila, P.
epimyces, Marasmius oreades, and their associated, numerous “satellite genera” as
well as the other gilled and polypore genera and species known to the gical
science as primary and secondary decomposers of ose and Iignin.
The um of Stropharia -annulata, psis nalis,
Fomitopsis pinicola, Schizophyllum commune, Trametes s, Trametes versicolor
species and many polyporoid and gilled basidiomycetes produce bioflavonoids,
phenols and polyphenols, including coumarins and coumaric acids (both trans— and cis-
o— and p—coumaric acids) which up—regulate genes in bees which code for cytochrome
P450 enzymes as well as other enzymes critical for digestion, metabolism and toxin
destruction. The effect of these mycelial components such as coumarins, p-coumaric
acid, o-coumaric acid or their glycosides, is that they turn on more genes within bees
which allow for the bees to detoxify a wide range of toxins, particularly insecticides,
miticides, herbicides, fungicides and pesticides, and augment the bee’s innate
immunity.
P-coumaric acid, found in both grains and Iignin, is a monomer of
sporopollenin, the pal constituent of pollen cell walls and propolis, the resinous
compounds gathered and processed by bees to line wax cells. P-coumaric acid is
WO 38361
essential for increasing laccase in wood rotting fungi, a ase enzyme that breaks
down Iignin in wood, creating derivative nds palatable to insects as food, as
well as creating habitats (bees can take up residence in tunnels bored by
mycophagous beetles). As fungi rot wood, breaking down Iignin, they also weep water,
rich in these p-coumaric and nutraceutical compounds beneficial to bees. The more p-
ic acid, the more laccases expressed by the mycelium, the more the wood rots,
the more fungal polysaccharides (sugars) and ultimately the more these compounds
will be in the fungal exudates that the bees seek and from which they benefit. That
wood rotting fungi produce p-coumaric acids and coumarins that can be nverted
into p-coumaric acids is yet another age of this invention.
As was noted by Terrén et al., structurally closely-related ic
compounds have different effects on laccase activity and on lcc gene expression in the
Iigninolytic fungus Trametes sp. 1-62, Fungal Genet. Biol., Oct 2004;41(10):954-62:
“Nine phenolic compounds (p-coumaric acid, ferulic acid, guaiacol, syringol, p-
methoxyphenol, pyrocatechol, glucinol, 3,5-dihydroxybenzoic acid, and
syringaldazine) were tested for their ability to increase laccase production in the
Iigninolytic basidiomycete Trametes sp. l-62. All these compounds resulted in
increases in laccase activity, with the highest levels being detected in the presence of
p-coumaric acid (273-fold) and guaiacol (73-fold).”
Interestingly, many of the grains preferred for mycelial spawn production for
mushroom industry (see Growing Gourmet & Medicinal Mushrooms by the inventor,
Paul s, 1993, 2000, Ten Speed Press, Berkeley) are also rich sources of p-
coumaric acids and may be useful in bee attractant compositions. The y phenolic
acids in rice grain were identified as p-coumaric acid, ferulic acid, and sinapinic acid.
P-coumaric acid is not only in the grains red for mushroom spawn
production but they are also ted during the normal life cycle of mushrooms,
especially prior to dia formation. P-coumaric acid is a potent inhibitor of
tyrosinase, the enzyme essential for melaninization. The presence and abundance of
p-coumaric acid interferes with the tion of darkly d ts. Ultraviolet
light stimulates the photodecomposition of p-coumaric acids, enabling melanization
and ring primordia formation. Once primordia forms, p-coumaric acids degrade
into p—hydroxybenzoic acid. Sachan et al., Transforming p—coumaric acid into p—
hydroxybenzoic acid by the mycelial culture of a white rot fungus Schizophyllum
commune, 2010, African Journal of Microbiology 4:267-273. As an example, but not
one of limitation, the mycelium of Auricu/aria auricula (A. auricularia-judae), when
grown in culture is whitish and lacks melanin but contains p-coumaric acids. When the
mushroom mycelium is exposed to light, the mycelium bio—transforms to create dark
brown odies, which are higher in melanin as they mature, with p-coumaric acids,
an inhibitor of melanin, concurrently declining. This is one example and a strong
argument for the benefit of using lightly colored mycelium, laninization as a
source of mycelium for making extracts cial to bees due to its innate p—coumaric
acid content compounded by the native content of p-coumaric acids in the grains that
are used for spawn production for growing mycelium. Interestingly, the ideal ace
for capturing the best benefits from mycelium for its nutraceutical and p-coumaric acid
contents, is short window, often ofjust a few days in length, before and directly after
light exposure, but before dark colored fruitbody development beyond the white
primordial stage.
Given that some of the most abundant laccase producers yet tested thus far
are Ganoderma Iucidum, Trametes versicolor and Pleurotus ostreatus, these species
are specifically preferred for use in creating bee-beneficial mixtures.
2015/019543
When not immunologically depressed from man-made and natural toxins,
bees natural host defense can better protect bees from other deleterious agents,
including viruses and pathogens transmitted by Varroa mites.
As our knowledge of the many derivatives of this overarching invention
expands, the inventor anticipates that individual fungal species will offer a unique set of
benefits. Some will be more antiviral. Some will activate the fication pathways in
bees better than others against different toxins. Some emit fragrances greater in their
attractive properties. As such, blends or “fungal cocktails" of species can be
customized according to the needs of the bees, the bee keepers, based on their
desired targeted benefits, the ecosystem particulars, and conditioned upon the
availability of basic materials.
For example, critical to the bee industry is the protection and generation of
new queens. Queens are bred and reared by specialty breeders who are at risk from
mites transmitting the Black Queen Cell Virus (BQCV). Finding a selective ral to
protect queens is another major advantage of this invention. For queen breeding and
g, both Inonotus obliquus and Ganoderma resinaceum are very active ral
additives in reducing Black Queen Cell Virus (BQCV) but not as active against
Deformed Wing Virus (DWV), whereas other s are more active against DWV. A
blend of two or more mushroom s is ore red to provide a broad
bioshield of antiviral activity to protect bees.
VARROA MITES AND INSECT PARASITES:
The inventor has received several patents on compositions and s of
using the presporulating mycelium of entomopathogenic fungi as an attractant and
treatment for controlling insects, and more broad patents are pending (US. patent
application no. ,978) on arthropods, and the diseases insects and arthropods
vector (US. patent application nos. 13/317,613 and ,719). Varroa mites are
known as a vector of the Israeli Acute Paralysis Virus and the Tobacco Ringspot
viruses. Varroa mites, both plant and insect biting mites, carry more than one virus or
bacterial pathogen, meaning that mites are one, albeit significant, vector carrying and
introducing multiple pathogens in the onslaught threatening beehive health. As bees
weaken from viral exposure, for instance, they are less able to shed the attaching
Varroa mites. However, the mycelium of entomopathogenic fungi, particularly
Aspergillus flavus, Metarhizium anisopliae and Beauveria bassiana, can be used to
attract, sicken or kill the Varroa mites, reducing their activity, delivery of pathogen
ds and s, thus tilting the balance in improving the host defense of the
colony against CCD. Spores of entomopathogenic fungi, including Metarhizium,
Beauveria and the Entomophthorales can similarly be used to sicken or kill Varroa
mites, although mites may find spores repellant as ed to preconidial mycelium.
Moreover, extracts of izium anisopliae can be made ically to
attract, but not kill insects, including bees, by growing strains of Metarhizium anisopliae
that do not contain destructins, or have reduced levels of these or other toxins, or
reduced virulence and pathogenicity. Variability of toxins is true when comparing many
strains of Aspergillus flavus, a known entomopathogenic fungus, primarily toxic due to
its aflatoxin content. Aflatoxin-free s of Aspergillus flavus are available currently,
which are naturally occurring or can be made h culture selections or genetic
modifications. 80 too can destructin-free strains of Metarhizium /iae strains be
created, selected for, or d from natural genomes. s can also be produced
which are not entirely free of destructins or alfatoxins, but produce such low levels that
they can be toxic to mites but not very toxic to bees due to the fact that the bees’
cytochrome P450 levels and pathways have been enhanced from exposure to the
coumarins and other polyphenols presented by the mycelium. In e, the up-
regulation of cytochrome p450’s (CYP’s) may help bees better tolerate or fy
destructins or aflatoxins to which the bees are exposed from Metarhizium anisopliae
and i/Ius flavus and other toxins produced by entomopathogenic fungi.
The advantage of a destructin-free or a reduced destructin strain of
Metarhizium anisopliae is that the extracts of the mycelium could be ed with
high sugar and terpene content which would simultaneously attract bees and mites.
Use of an appropriately sized mesh screen or barrier or other means of selection
allows for mites to be partitioned from bees so both bees and mites could be initially
attracted to the same location of the extracts (or rly attracted to preconidial
mycelium). The proportionality of the endemic entomopathogenic toxins can be
ed to sicken mites but not bees. Using single or multiple fungal extracts as
described herein offers a latitude and flexibility of customized design, so that numerous
devices, delivery s, compositions and methods can be made available for the
first time to favor bee health and decrease CCD. Phorid flies, gnats and mites
predating on mushrooms are well known to the mushroom industry. What was not
known is that ts of entomopathogenic fungi prior to sporulation are attractive to
these s and arthropods. The present or does not believe that
hydroethanolic extracts of mushrooms or mushroom mycelium with these attractive
properties were known to the mushroom industry prior to this inventor’s disclosures in
pending and approved patents.
Combining oxalic acids with sugar enriched water loaded with spores or
preconidial mycelia of entomopathogenic fungi such as Metarhizium anisopliae and
Beauveria bassiana will improve the miticidal actions of the combination of oxalic acids
and entomopathogenic fungi and the anti-miticidal properties of other components
resident or added to sugar water, pollen patties or bee sprays, for instance. However,
oxalic acid is reactive to the ls in the fungal extracts, and this poses a hurdle for
effective formulation.
When combining oxalic acids with the extracts of filamentous Basidiomycetes
fungi, the resident minerals (calcium, phosphorus, iron) may bind with the oxalic acid
thus reducing the mineral scouring, miticidal potential of the oxalic acids. Therefore,
demineralization of the fungal extracts before combining oxalic acid to the fungal
extracts is an embodiment of this invention. Demineralization employs any of
numerous methods useful for ralizing of the fungal extracts so as to prevent
conversion of the reactive oxalic acid into water ble salts by eliminating calcium
and other minerals resident within the fungal extracts. One method of many available is
to make use of ion exchange resin technologies. The fungal extracts can be added to
distilled water at a ratio of 1:10 preferably, with ranges of 1 :1 being the most
concentrated and 1:100 being most dilute but less preferable. Upon completion,
minerals in the fungal ts, which would ise neutralize the anti-miticidal
properties of oxalic acid, will be y if not completely removed. Thereupon, oxalic
acid can be added to the reduced mineral, fungal extracts in a sufficient quantity to
have an iticidal effect, in the range of 1-10% of oxalic acid to the mass of the
solution, resulting in a low pH in the .5-3.5 pH range, with an optimal range in the .5-2.0
pH range.
“We seek to understand the botanical sources and biological ties of
resins in the field and how resin foraging behavior changes in response to
environmental factors, such as infection and other ical stresses. If we can
discover plants with preferable and more antimicrobial resins in different regions, it
should be possible to better create environments that promote bee health by
2015/019543
supporting behaviors and managerial strategies that lead to natural disease
resistance.” Wilson et al., Metabolomics reveals the origins of antimicrobial resins
collected by honey bees. PLoS One 8(10): e77512, page 11. The present inventor
suggests that pure cultured fungi and fungal um, including fungal attractants,
fungal entomopathogens, fungal immunostimulators, fungal antivirals, antibacterials
and antifungals can similarly support bee health and lead to natural resistance to
diseases and pesticides. Ecosystems and economies benefit from bees that would
otherwise suffer without these myco-remedies.
This inventor also anticipates that pollinating insects and s (bats) will
also benefit from the effects of this ion. It is also expected that birds may similarly
benefit from similar ated fungal solutions via addition to nectar feeders and bird
foods through the up—regulation of immunological and detoxification genes as well as
receiving antiviral benefits, thus extending ity.
Filamentous, basidiomycetous fungi are also sources of neuroregenerative
compounds. Species of Hericium (including but not limited to Hericium erinaceus,
Hericium corral/aides and Hericium s) produce potent nerve growth s
causing regeneration of myelin on the axons of nerves and nerve regeneration. See
Stamets, Lion’s Mane: A Mushroom That Improves Your Memory and Mood?, The
Blog, Huffington Post Healthy Living, 08/08/2012. Psilocybin and psilocybin-producing
fungi, including but not limited to species of Psilocybe, Panaeolus, Gymnopilus,
Pluteus and Conocybe such as Psilocybe azurescens, Psilocybe cyanescens,
Psilocybe allenii, Psilocybe cyanofibrillosa, Psilocybe cubensis, Psilocybe
ovoideocystidiata, Psilocybe uginosa, Copelandian Panaeoli (Copelandia
cyanescens, ndia tropicalis, Cope/andia bispora), s salicinus, Gymnopilus
luteofo/ius, Gymnopilus bilis, Conocybe cyanopus and Conocybe smithii can
trigger neurogenesis. (See Catlow et al., Effects of ybin on hippocampal
neurogenesis and extinction of trace fear conditioning, Exp Brain Res (2013) 228:481—
491 DOI 10.1007/300221—013—3579—0). Individually or in combination, mixtures of
extracts of ybin mushroom and Hericium mushroom fruitbodies, or more
preferably their mycelial extracts, could help repair s damaged by toxins,
cholinergic pesticides, oxidation, old age, or other sources of neurotoxins. The net
effect of ingesting these mixtures of nerve regenerating Hericium and psilocybin
species would improve the neurological health of bees h neurogenesis and re-
myelination, and indeed of animals, including . Another, improved form of
“mycological honey” might incorporate these elements for the benefits of bees and
people, improving cognition, preventing or repairing neuropathies presenting
lves as diseases to humans within scope of the definitions for Alzheimer’s,
Parkinson’s, Parkisonisms, MS (multiple sclerosis), or as yet uncategorized forms of
neurological impairment. Indeed such combinations could increase intelligence,
sensory ies, , es, reaction times, and problem solving abilities. As
such a ‘smart mycological honey’ is anticipated to be within the scope of this invention.
Ganoderma lucidum is one of the species of particular interest (along with
Ganoderma resinaceum, Ganoderma app/anatum, Ganoderma brown/i, Ganoderma
ii, Ganoderma oregonense, Ganoderma tsugae, rma lingzhi, rma
capense, Ganoderma annularis, and Ganoderma collosum) to the inventor as it not
only has strong antiviral properties, but has complexes of sugars that result in its
mycelium producing a viscous syrup-like ogical honey” that can be used to help
bees survive GOD. The inventor and his team at Fungi Perfecti, LLC have also noted
that the extracts of Ganoderma resinaceum will not freeze, even when freeze driers
achieve temperatures less than -50 0° under high vacuum, whereas species tested
outside the genus Ganoderma readily freeze dried into a dried state under the same
conditions. The inventor hypothesizes the mycelial extract of Ganoderma resinaceum,
and likely extracts of related Ganoderma species, maintains a liquid state even under
cryogenic conditions due to its unique assortment of complex sugars, sterols, and
glycoproteins binding to form a unique liquid matrix far different than any other species
tested. This extract may have potential as an anti-freeze with broad reaching
implications for medicine, avionics, space travel, and usefulness under extreme
temperature conditions for lubricating, preservation, and extremophile chemistry.
In all of the following examples, the inventor anticipates, as tives of his
discovery, that bioguided fractionation methods will lead to increasing the potency,
sing efficacy, and reducing the cost of production, manufacturing, and the
implementation of said ions and its many elaborations, which become obvious
subsequent to this paradigm ng discovery.
EXAMPLE 1
Fomes fomentarius, Fomitopsis officinalis, psis pinicola, Ganoderma
resinaceum, Inonotus obliquus, Piptoporus betulinus, Trametes versicolor,
Schizophyllum commune and other mushroom species are cultured and the mycelium
grown on rice, barley, flaxseeds or other , agricultural , or forest products
such as sawdust or wood chips (for a list of substrates, See s, Growing
Gourmet and Medicinal Mushrooms, 1993, Ten Speed Press, Berkeley, Ca. and
Stamets & Chilton, The Mushroom Cultivator, Agarikon Press, Olympia, WA). When
the um reaches a mass ofgrowth (preferably after 5 to 60 days growth in
fermentation or in solid state fermentation subsequent to ation, but well before
ody formation) mycelial mass can be extracted through simple aqueous,
water/ethanol (both of which are preferred) or ethanol washing of the substrate, or from
WO 38361
compression of the substrate, all of which will result in a liquid fluid or capture-able
extract ing extracellular exudates. These extracts can be utilized as they are, or
l (25—50% by volume) may be added to aqueous extracts as a preservative and
solvent (which will precipitate soluble polysaccharides). The hydroethanolic
extract can be evaporated or removed, or the alcohol and water may be evaporated
and removed separately. The crude extract can be cell free filtered using a .12-.20 pm
filter. This extract can be frozen or dried for future use. Alternatively, non-aqueous or
non-ethanolic t extracts such DMSO, ethyl acetate, ether and other ts or
combinations of solvents known to the art may be utilized, or subcritical or supercritical
fluid extracts utilizing, for example, carbon dioxide or water, and al co-solvents
such as alcohols, may be utilized, or microwave-assisted extracts may be utilized.
The extract can be added to any form of feed stocks for bee consumption.
The original extract can be used directly or diluted and added to their drinking water,
sugar water, bee candy, honey, propolis, pollen patty, grease patty and protein
supplements to give improved bee feeds and nutritional products and improved pollen
supplements, dietary supplements, feeding supplements and nutritional supplements.
The extracts may also be orated into sprays used to spray beehives, beehive
components, sticky strips, bees and plants and orated into the wax used for
making combs and supers. Ingestion and contact by bees improves the bees’ ability to
build immunity through up-regulating of toxin ing enzymes, reduces pathogen
payloads and provide a healthy source of diverse sugars, amino acids, vitamin B’s, and
nutrients. Moreover, the precipitate, although partitioned from the supernatant, contains
within it nutrient rich, and antiviral, health supporting properties, which can be used
also as feedstock for tting bees. Both the atant and the precipitate can be
combined, and enzymatically converted using amylase and other enzymes to further
transform starches and other ingredients into a more effective composition.
The medicinal mushroom mycelium is grown utilizing liquid culture techniques.
Whereas growing on rice might have 30-40% conversion of rice to mycelium, liquid vat
culture may have essentially complete conversion with >3x more mycelium per unit
mass. Hence the liquid vat culture of mycelium and its extracellular metabolites will be
easier to utilize in the development of this invention as the process of using vat culture
eliminates the need to remove non-metabolized ate ingredients.
To make the mycelial extract, use equal volumes of mycelium grown on grain
(barley, flaxseed, rice, oats, millet, wheat, rye, corn), seeds, including nuts, sawdust or
wood chips (Douglas fir, pines, oaks, birches, cottonwoods, ) and immerse into a
50:50 water-ethanol solution. Allow to sit at room temperature for two weeks, and then
press to expel the liquid t. Over several days, a precipitate will fall out of the
hydroethanolic solution. The thanolic supernatant is drawn off above the pasty
precipitate. After several more weeks, or by using a centrifuge, the precipitate further
concentrates into a semisolid state. These wet semisolids are removed and heated to
50° C for 6-8 hours while stirring. The wet volume of semisolids is d to about
40% of the original wet semisolids. The drying down of the semi-solids into the caramel
“honey—like” substance yields about 16% of the original wet solids wet. Therefore, using
1000mL of wet solids (which was 40% of the initial extract) yields about 170mL of thick
syrupy caramel like substance. Continued heating and stirring concentrates this
substance with noticeably sweeter properties. The t can be crystallized,
powdered, and used as amendment to other treatments. The liquid, lid and
crystallized forms are noticeably sweet in taste and could be ered a medicinal
candy-like substance useful to both bees and people in a wide number of applications.
EXAMPLE 4
A mycelial extract is made by extracting fruitbodies or mycelium of
basidiomycetous fungi including Ganoderma resinaceum in hot water (80-100° C) for
several hours and combined with the room ature (10-30° C) water extraction of
Fomes fomentarius, Fomitopsis alis, Fomitopsis pin/cola, Ganoderma
resinaceum, Inonotus obliquus, Piptoporus betulinus, Trametes versicolorand/or
Schizophyllum commune mycelium grown on grain or wood. To these water extracts,
ethanol is added to make the solution greater than 22% EtOH (ethanol), preferably 35-
45% EtOH. Upon addition of ethanol, polysaccharides precipitate out of solution and
settle at the bottom of the extraction vessel. Upon drawing off the atant, the
precipitated polysaccharides, rich in glycosides, glycoproteins and other ‘nectar—like’
nutrients, are collected and heated between 50-70° C over several hours, resulting in
the creation of a sweet residue tive to and beneficial to bees. Alternately, the
supernatant can be stored over several days, which further yields useful precipitating
ccharides. These precipitates contain complex sugars, rals, antibacterials,
cytochrome p450 ulating coumaric acids and coumarins, and can be combined
with other ingredients used in the feeding water, pollen patties, propolis, bees wax,
sprays, or in any delivery system y bees make contact with these precipitates,
helping bees overcome stressors associated with colony collapse er.
EXAMPLE 5
A mycelial extract made from extracting fruitbodies or mycelium of
basidiomycetous fungi including rma resinaceum is first soaked in 100%
ethanol (1 :1 ratio by mass) for 1-7 days. Upon ng off the ethanol, the mushroom-
or mycelial-mare is immersed into hot water (80-100 C) for several hours and combined
2015/019543
with the room temperature (10-30 C) water immersion and extraction of Fomes
fomentarius, Fomitopsis alis, Fomitopsis pinicola, Ganoderma resinaceum,
Inonotus us, Piptoporus betulinus, Trametes versicolor and/or Schizophyllum
commune mycelium grown on grain or wood. To these water extracts, the ethanol
extracts previously bed are added to make the total combined solution greater
than 22% EtOH, preferably 35-45% EtOH. Upon addition of ethanol fraction,
polysaccharides precipitate out of solution and settle at the bottom of the extraction
vessel. P-coumaric acid, being more soluble in ethanol than water, is richer in the
ethanolic extracted supernatant. (The ethanolic supernatant, with concentrated p-
coumaric acids, is a reservoir of neficial p450 coding compounds.) This
hydroethanolic supernatant can be stored over several days, which further yields a
mixture of polysaccharides but which is proportionately higher in p—coumaric acids than
the hot water ons alone. The precipitate also holds p-coumaric acids, and
additionally other nutrients, which can be used to feed bees. These p-coumaric
enriched itates also contain complex sugars, antivirals, antibacterials, and
families of coumarins, and can be combined with other ingredients, such as the water
soluble mushroom polysaccharides, corn syrup or sugars used in sweetening the
feeding water, or additionally orated as an ingredient in pollen patties, propolis,
bees wax, sprays, or in any delivery system whereby bees make contact with these
precipitates, helping bees overcome stressors associated with colony collapse
disorder.
EXAMPLE 6
For each type of mycelium extract (mushroom species), mixed aged honey
bees from a single hive were collected on a single day and distributed at random into
16 cages of roughly 100 bees each. Each set of 16 ted of four control cages (fed
2015/019543
sugar syrup), four low concentration cages (fed mycelium extract in sugar syrup at
0.1% v/v), four medium concentration cages (fed mycelium extract in sugar syrup at
1% v/v), and four high tration cages (fed mycelium extract in sugar syrup at
% v/v). In each group of four cages, three cages were used for longevity tests and
the ing replicate cage was used for total viral particle testing. A separate
experiment was conducted to evaluate the effect of fungal extracts on specific virus
types.
ement in Longevity
For longevity (survivorship) testing, each replicate (three cages for each
feeding concentration and control group) was monitored daily and dead bees were
counted. For every day of the experiment, the total number of bees that died as of that
date were tabulated for each replicate cage for each fungal extract and for the control
groups. These daily dead bee tabulations were then used to calculate the percent of
the original bees that were still surviving at each day of the experiment. The mean
percent survival rates were then calculated based on the data from the three replicate
cages for each fungal extract and for the control group.
Survival plots were ted with time measured in days as the independent
le s), and the mean percent of bees surviving at any point in the experiment
as the dependent variable (y-axis); the longevity graphs represent the % of the original
population that is surviving at various points in time. See 4. is a line
graph showing percent survival of bees over time in days when given extracts of the
mycelium of lnonotus obliquus (0.1%, 1% and 10% as tively shown by dotted,
dashed and double-dash lines) with sugar water as compared to a control population
fed sugar water only (shown by a solid line). is a line graph showing the percent
survival of bees over time in days when given extracts of the mycelium of Ganoderma
2015/019543
resinaceum (0.1%, 1% and 10% as respectively shown by dotted, dashed and double-
dash lines) with sugar water as compared to a control population fed sugar water only
(shown by a solid line). is a line graph showing the percent survival of bees over
time in days when given extracts of the mycelium of Fomitopsis pin/cola (0.1%, 1% and
% as respectively shown by dotted, dashed and double-dash lines) with sugar water
as compared to a control population fed sugar water only (shown by a solid line). is a line graph showing the percent survival of bees over time in days when given
extracts of the mycelium of Fomes fomentarius (1% shown by a light solid line) with
sugar water as compared to a control population fed sugar water only (shown by a dark
solid line). These and similar ches can be used in the practice of the invention to
demonstrate the effect of the invention on the health and longevity of the bees. The
figures are mean values of the experiments; the standard deviation bars were removed
for clarity.
Some, but not all, of the results in these preliminary experiments were
statistically significant; improved results are expected in continuing trials with more
replicates. Statistical significance was assessed using Kaplan—Meier (product—limit)
survival estimates prepared using JMP® statistical discovery software from SAS
Institute, Inc. See a graph of Kaplan-Meier ct-limit) al estimates
g the on of bees ing over time in days when given extracts of the
mycelium of Fomes fomentarius (0.1%, 1% and 10% as respectively shown by dotted,
dashed and double-dash lines) with sugar water as compared to a control population
fed sugar water only (shown by a solid line). This analysis compared the mean survival
time for the treatment to the mean survival time for the l (fed just sugar water)
and used a Wilcoxon test to assess whether the survival was statistically different from
chance variation in bee survival time. rates this embodiment of the
invention. In this analysis a composition of Fomes fomentarius fed at 1% v/v improved
the mean survival of bees by 9.7% (p<0.0006).
As demonstrated in 5, longevity of bees fed extracts of different fungal
s was ed, with improvement in longevity dependent on both the fungal
species and the concentration ed by the bees. In the practice of the current
invention, some of this increase in longevity is probably due to a reduction in viral
burden in most instances (as discussed below), but is also attributable to other aspects
of the invention in the instance where longevity ed but viruses were not reduced.
Improvement in longevity can be demonstrated in the practice of the invention
by the use of survival plots, such as but not limited to, those described above.
Improvement in ity can be measured numerically in the practice of the invention
by ating the difference in survival. One such method is based on the average
value of a function theorem:
1 b
favg :b_aLf(x)dx
Where values of ‘a’ and ‘b’ represent the starting and ending days over which
the effect of the invention is being measured, and ‘f(X)’ represents the survival plot
function as previously described. The difference in these figures over the specified time
interval represents average percent improvement in longevity achieved through the
practice of the invention over the specified time interval.
[014?] Other methods for measuring differences in longevity, al, or population
increases, including statistical methods such as Kaplan-Meyer analysis, Nelson Aalen
and other methods for which are known to those skilled in the art are able
alternatives in the practice of the invention.
Similarly, various quantitative s of ng virus numbers in bees may
be utilized in the practice of the present invention, including e transcription
Polymerase Chain Reaction (RT-PCR) and real-time RT-PCR based on the PCR
amplification of cDNA, ELISA (enzyme-linked immunosorbent assay), including both
normal and sandwich ELISA with the various ng agents, y/secondary
antibodies, reporter enzymes and their specific colorimetric substrate ons for
detection and quantification, lexing microarrays utilizing molecular probes for
different target RNAs or DNAs, AGID (Agarose Gel lmmuno-diffusion), serology
methods based on protein profiles or polyclonal and onal antibodies and the
large variety of other molecular biology based methods such as high throughput
sequencing technologies, pyrophosphate-based sequencing techniques, Sanger
sequencing (also referred to as the chain termination method) and integrated virus
ion systems (IVDS). See, for example, De Miranda, Diagnostic techniques for
virus detection in honey bees, in Aubert et al. (Eds), Virology and the honey bee, EEC
Publications (2008), pp. 121-232 and Evans et 8]., Standard methodologies for
molecular research in Apis mellifera, Journal of Apicultural Research 52(4) (2013).
Using this method for measuring the difference in longevity, the inventor
specifies the improvement in longevity as embodied by this ion. See Table II,
“Average Percent Improvement in Longevity of Bees.” The table represents the
ence between the average values of % of bees surviving, when assessed over
various time intervals. That ence is given as the numerical subtraction of these
percentages, with the e percent surviving over various time intervals calculated
as previously described:
longevity improvement = avg % survivingfed fungal extract — avg % survivingwntml
Improved longevity increases the number of “bee days” in which workers or
other classes of bees are available to gather pollen and in the hive or perform
other labor, whereby the improved health and sed survival of the individuals
leads to improved colony health and survival.
Reduction in Total Virus Level
For antiviral testing of each type of mycelium extract (mushroom species),
mixed aged honey bees from a single hive were collected on a single day and
buted at random into four cages of y 100 bees each. This trial was done in
parallel to the longevity testing previously described, using bees from the same hives
over the same time interval. Each fungal species set consisted of a control cage (fed
sugar syrup), a low tration cage (fed mycelium t in sugar syrup at 0.1%
v/v), a medium concentration cage (fed mycelium extract in sugar syrup at 1% v/v), and
a high concentration cage (fed mycelium extract in sugar syrup at 10% v/v).
Samples of bees were d from the cage and were frozen at day 0, day
7, and day 14. Assay of the total number of virus particles, irrespective of viral species,
was carried out by Dr. David Wick of BVS, Inc. utilizing IVDS technology; see US.
pmentnos.&524A55,&309029,8A46446,&02L884,7650908,125Q138
6,491,872, 6,485,686 and 6,051,189 (all to Charles Wick) and Charles H. Wick,
Integrated Virus Detection, CRC Press (2014). For each sample analysis, 6.0 grams of
bees were blended with 100 ml of Reverse Osmosis (RO) water and coarse filtered
through dual layer cheesecloth. A 90 ml sub-sample was then centrifuged for 60
minutes at 20,000 X g. The supernatant was recovered and iltered through a
500,000 Dalton hollow fiber filtration system followed by a rinse with a 200 ml RO wash
and reduction to approximately 2 ml. The solution was prepared for Integrated Virus
Detection System (IVDS) analysis using a 1:10 dilution with Ammonium Acetate (AA).
Each sample was filtered h a w-41 20 um paper or a .45 um PTFE .
Samples were scanned five times with the IVDS and average virus levels were
reported.
As demonstrated in 7, 8 and 9, the total viral load of bees fed ts
of different fungal species was reduced, with the level of virus reduction ent on
both the fungal species and the concentration consumed by the bees. is a bar
graph showing total virus particles in bees given extracts of the mycelium of Inonotus
obliquus (0.1%, 1% and 10% as respectively shown by dotted, dashed and double-
dash lines) with sugar water as compared to a control population fed sugar water only
(shown by a solid line) at time zero, one week and two weeks. is a bar graph
showing total virus particles in bees given extracts of the mycelium of Ganoderma
ceum (0.1%, 1% and 10% as respectively shown by dotted, dashed and double-
dash lines) with sugar water as compared to a l population fed sugar water only
(shown by a solid line) at time zero, one week and two weeks. is a bar graph
showing total virus particles in bees given extracts of the mycelium of Fomitopsis
pinicola (0.1%, 1% and 10% as respectively shown by dotted, dashed and double-dash
lines) with sugar water as compared to a control population fed sugar water only
(shown by a solid line) at time zero and one week. is a bar graph showing total
virus particles in bees given extracts of the mycelium of Schizophyl/um commune
(0.1%, 1% and 10% as respectively shown by dotted, dashed and double-dash lines)
with sugar water as compared to a control population fed sugar water only (shown by a
solid line) at time zero and two weeks. These and similar figures can be used in the
practice of the invention to trate the effect of the ion on the health of the
bees. In the practice of the current invention, most but not all, of the s that had
improved ity also had reduced virus load. This implies that viral reduction can
help longevity, but that improvements in longevity may be seen without viral reduction
because of other beneficial aspects of the invention such as general stimulation of hive
ty and antibiotic activity against non-viral pathogens like Nosema. Multiple
causes of longevity improvement are likely in the practice of the invention because
ent fungal species appear have different and specific modes of action t
different bee ens as disclosed below, by way of example and not exclusion.
Reduction in total viral load can be measured in the practice of the invention
by calculating the difference in the virus detection between bees to which the ion
has been applied and bees which have not been exposed to the invention. One such
method for quantifying this difference is based on the average value of a function
theorem:
1 b
favg :b—afaf(x)dx
Where values of ‘a’ and ‘b’ represent the starting and ending days over which
the effect of the invention is being measured, and ‘f(x)’ represents the virus detection
level as a function of temporal sampling. The “percent difference” in these values over
the specified time interval represents average “percent reduction” in virus level
achieved h the ce of the invention over the specified time interval. Other
methods for measuring differences virus level over time, including percent difference at
individual sampling time points, mean difference, and statistical methods such as
Kaplan-Meyer is are acceptable alternatives in the practice of the invention and
are incorporated by reference. Using the method described above for measuring the
difference in virus level over various time intervals, the or specifies the reduction
in virus as ed by this invention. See Table |, “Average Percent Decrease in
Total Viral Burden.”
The table represents the difference between the average values of % of bees
surviving, when assessed over various time intervals. That difference is given not as
the numerical ction of these percentages, but rather as the “percent reduction”:
avg UlTuS tlterfed fungal extract _ avg Virus tlterCOTltTUI
% decrease in viral burden = X 100
avg virus titerwmml
Fungal Species/Disease Specificity
Specific types of mycelium extract (mushroom s), when fed to mixed
aged bees can reduce the level of disease causing agents such as virus particles in a
species-specific way. This embodiment of the invention was demonstrated by feeding
fungal extracts to caged bees and ing the levels of specific types of virus in the
bees over time. For this analysis, mixed aged bees from a single hive were collected
on a single day and were evenly distributed at random into 12 cages. Four cages were
fed Ganoderma m var. resinaceum um extract at 1% v/v in sugar syrup,
four cages were fed Inonotus obliquus mycelium extract at 1% v/v in sugar syrup, and
four were used as a control and were fed only sugar syrup.
Samples of bees were removed from the cage and were frozen at day 0, day
3, day 7 and day 14. Bees were sent to Dr. Yanping (Judy) Chen of the United States
Department of Agriculture — Agricultural Research Service using real time RT-PCR as
described in Chen et 61]., Quantitative real—time reverse transcription—PCR analysis of
ed Wing Virus infection in the honeybee (Apis mellifera L.), Appl. Environ.
Microbiol., Vol. 71 (2005), p. 436-441 and Khongphinitbunjong etal., Differential viral
levels and immune gene expression in three stocks of Apis mellifera induced by
different numbers of Varroa destructor, l of Insect Physiology, Vol. 72 (2015), p.
28—34.
In this analysis, levels of virus are quantified based on the accumulation of a
scent signal as DNA of the virus is amplified in the PCR reaction. The cycle
threshold is defined as the number of cycles required for the fluorescent signal to
exceed the fluorescence ound level. Cycle threshold levels are therefore
inversely proportional to the amount of target viral nucleic acid (9.9., virus titer) in the
sample (i.e. the lower the CT level the r the amount of target nucleic acid in the
sample). As demonstrated in , the levels of Black Queen Cell Virus (as
quantified based on cycle threshold) were prevented from increasing in bees that were
fed extracts of Ganoderma lucidum var. resinaceum and Inonotus obliquus um.
See , a line graph showing cycle threshold for Black Queen Cell Virus over
time in a control population fed sugar water only (shown by solid line 111) as compared
to bees given extracts of the mycelium of Inonotus obliquus (1%) (shown by dotted
line 112) and Ganoderma resinaceum (1%) (shown by dashed line 113) with sugar
water. By contrast, the same extracts did not have a significant effect on levels of
Deformed Wing Virus. See , a line graph showing cycle threshold for Deformed
Wing Virus over time in a control population fed sugar water only (shown by solid line
121) and bees given extracts of the mycelium of Inonotus obliquus (1%) (shown by
dotted line 122) and Ganoderma ceum (1%) (shown by dashed line 123) with
sugar water.
This example of a fungal species extract having specificity against one viral
pathogen and not t r embodies the antiviral invention. It also supports
the argument that specific compositions of fungal extracts can be rly specific to
other bee pathogens (that reduce longevity) such as Nosema and bacteria and/or can,
in general, ulate metabolic, immune and detoxification systems of bees. Such
effects against non-viral pathogens or general metabolic and immunity boosts may
have been responsible for the instances where longevity was improved but viral load
remained unchanged.
Summary, ences, and Implications
To date, the inventor has data (both a longevity experiment and a total virus
reduction experiment) for 8 species of medicinal mushrooms. The inventor also has a
third experiment, reduction of a specific virus, Black Queen Cell virus, done only on
Ganoderma resinaceum and Inonotus obliquus.
The inventor herein defines a metric, the “LV , which is: LV Index = The
average percent improvement in bee longevity multiplied by the average percent
decrease in total viral burden.
This ation gives a number that assigns equal importance to both
s for measuring ement to colony health. Blank boxes in the tables below
for antiviral activity, longevity or LV indicate that either longevity or virus reduction was
negative or zero in one or both data sets.
There are many other le mathematical representations that could draw
a relationship between these data sets, such as, for example, percent longevity
improvement divided by percent virus ion. That calculation would stress the
portion of the longevity that could theoretically be related to virus reduction if there
were a 1:1 correspondence between these measures. Numerous possibilities for a
metric will be nt to those skilled in the arts and all such metrics for improved bee
health should be ered to be within the scope of the invention.
The general approach adopted herein is to compare the “area under the
curve” of longevity measurements and total virus ion measurements as
previously described. The difference between the areas under the curves, over a given
time interval, is equal to the numbers in the longevity table. The difference in the area
under the curves, over a given time interval, expressed as a “percent improvement” is
equal to the numbers in the total virus reduction tables. See Table | “Average Percent
Decrease in Total Viral Burden” and Table II ge Percent Improvement in
Longevity of Bees". These values can then be related mathematically to illustrate
features of interest in the practice of the invention such as compositions that are most
preferred for improving longevity and reducing total viral load in bees. See Table III
Average Percent Improvement in ity of Bees X Average Percent Decrease in
Total Viral Burden (LV Index).
TABLE I
Avera- 9 Percent Decrease in Total Viral Burden
Concentration
Species 0.1% 1% 10%
Timeframe
Trametes versicolor 0-7 days 9.0
0-14 days 3.6
psis pin/cola 0-7 days
0-14 days 2.1
Fomitopsis officinalis 0-7 days —
Schizophy/lum e 0-7 days — 3.8
0-14 days 19.5 20.8 26.7
Inonotus obliquus 0-7 days 47.5 41.6 42.2
0-14days —
Fomes fomentarius 0-7 days _10.0
0-14days
Ganoderma app/anatum 0—7 days 1.0
0-14 days 4.5 14.2
Ganoderma lucidum var. 0—7 days 76.7
resinaceum 044 days 85.9
Preferred 1-25% or greater decrease in virus
More Preferred 15-25% or greater decrease in virus
Most Preferred >25% se in virus
TABLE II
Averao e Percent Improvement in Lon oevit of Bees
Concentration
——-—10%
Trametes versicolor 0.2 5.0
—-7
psis officinalis
Schizophyllum commune 0.8
Inonotus obliquus 1.2
Fomes fomentarius 13.5
0-28 days 11.2
Ganoderma lucidum var. 0-7 days
resinaceum
0_1 4 days 2-2 3.7
0-28 days 3.7 9.5
1-5% or greater improvement in longevity
More Preferred 3-5% or greater improvement in longevity
Most Preferred >5% improvement in longevity
TABLE III
Average Percent Improvement in Longevity of Bees x Average
Percent Decrease in Total Viral Burden LV Index
—Concentration
Species —0.1% 1% 10%
es versicolor 44.8
27-7
psis pin/cola
Fomitopsis nalis _—
Schizophyllum commune _—3.1
Inonotus obliquus 51.2
Fomes fomentarius 135.2
0-14 days
Ganoderma applanatum 0-7 days
——_--
Ganoderma Iucidum var- —_--
resinaceum -
Preferred 1-2oo+ LV index --
More Preferred 50-200+ LV index --
Most Preferred 200+ LV index --
In the practice of the invention, fungal extract compositions may be sly
ranked with regard to preference depending on the intended application of the
composition. Examples include but are not limited to ranking with preference to
longevity improvement, ranking with preference to total virus ion, g with
regard to longevity and virus reduction. Notably, preference may also be given to
compositions which improve longevity but do not reduce viruses. Such compositions
are expected to improve ity by acting on bee stressors that are unrelated to
viruses (examples include Nosema infection, pesticide exposure, stress from cold
temperatures, etc.).
Ganoderma resinaceum extract at 14 days resulted in an almost 20%
increase in survival of worker bees over the controls. See also This differential
can be hugely significant in helping the colony survive as the ity of worker bees
during this critical time results in nurse bees not being prematurely recruited, thus
allowing them to better attend to keeping the brood, the next generation, healthy. The
addition of mycelial extracts from Ganoderma resinaceum resulted in a dramatic
reduction in overall viral pathogen ds in bees (from le viruses), while the
sugar control, without mycelial extracts, resulted in increased population of overall
viruses. As viruses are t by many bee entomologists to be the most significant
disease challenge, often facilitating the subsequent infection from other bacterial (Le.
WO 38361
foulbrood) and fungal species, reducing viruses can be a ne advantage in
protecting bees from colony collapse disorders and their many associated stressors.
In terms of sing longevity, the addition of 1% mycelial extracts of Fomes
fomentarius and Ganoderma resinaceum to sugar water (water-50 grams, sugar 49.5
grams, mycelial extract 0.5 grams), statistically, icantly extended the ans of
bees - in terms of ‘bee days of life’ by 17.6% and 8.9%, tively. Extended
e lifespan results in more workers being available for job tasks, a significant
advantage to stressed bee colonies on very thin operating margins and stressed
colonies on the edge of se. When there are more bees at any one time that is
significant for pollen acquisition and hive maintenance. By extension, many more hives
can be saved feeding them mycelial extracts in their sugar water over those just having
sugar water without mycelial extracts. Until we do field trials, we do not know yet how
many more bee days will tilt the balance to help bees overcome CCD since there are
so many complexities. However, the consensus amongst bee scientists is that
increasing longevity of worker bees, under stress, is a strong advantage. Moreover,
when the extracts are made from, in these cases, birch tree wood (Betula species), the
same tree species these polypore mushrooms habit, and ones in which bees nest, the
extracts may become more potent while less expensive to produce. That we can show
such strong, significant activity from mycelium grown on rice strengthens the argument
that the mycelium is the causal benefitting factor (the rice controls showed no activity.)
By utilizing mycelium grown on rice as spawn to inoculate x more mass in the
form of birch sawdust s the mycelium exponentially over the mycelium-on-rice
extracts reported here. The mycelium grows more densely branched and compacted
mycelial networks on birch sawdust compared to rice, meaning more surface areas is
generated for the expression of ellular constituents. Hence, this inventor
anticipates mycelial extracts from birch t will be a preferred embodiment of this
invenflon.
Many Ganoderma and other polypore species are anticipated to also offer a
similar ‘bioshield’ of protection. No doubt, there will be gilled mushrooms, due to their
close evolutionary relationship to polypores, to be of benefit similarly.
EXAMPLE 8
A liquid extract of the mycelium, or a precipitate from such extract, or a
concentrated extract from which all or part of the solvent has been removed, containing
these active principles can be added to the honey, to honey-enriched water, to sugar
water or bee candy, to pollen, to pollen substitutes, or to other substances in other
manners obvious to those d in the art of apiary e or commercial practices.
The extract can be used as an adjunct to other remedies making them more effective.
The extracts can be in liquid, frozen, freeze dried, air dried, vacuum desiccated,
tance window dehydrated, sonically dehydrated, or partially purified forms, in
amounts sufficient to have the effect of attracting bees and/or benefitting bee health,
honey production and pollinations. er, these derivative forms of extracts will be
useful for human consumption as they are palatable, high in antioxidants, and in other
properties beneficial to people, other animals, which es bees.
EXAMPLE 9
A preferred delivery system would be to orate the mycelial ts into
pollen patties or grease patties. Pollen patties are made by beekeepers and placed
above the brood chamber as a source of nutrition. They can be made from a wide
range of materials, including soy, brewer’s yeast, sugar syrup and may optionally
include organically grown pollen. These pollen patties supplement the bees
nutritionally. Because they are widely used in the fall, they help the bees survive into
the next year. These extracts also contain digestive enzymes which help the bees
better metabolize food stocks, and help break down toxins and improve baseline
immunity.
EXAMPLE 10
A mixture of compositions comprising extracts of Stropharia -annu/ata,
Fomes fomentarius, Fomitopsis officinalis, psis pin/cola, Ganoderma
resinaceum, Inonotus obliquus, Piptoporus betulinus, Trametes versicolorand/or
Schizophyllum commune, which together offer a plurality of benefits, can be added to
water. The Stropharia rugoso-annu/ata attracts bees, has a flower-like fragrance, and
provides sugar— rich (up to 75 polysaccharides) nutrient . The Fomes
fomentarius and Fomitopsis ofiicinalis ts confer antiviral benefits, plus those
additional ts already mentioned for Stropharia rugoso-annulata. All three extracts
contain polyphenols, and more particularly coumarins, which help activate p450
enzyme pathways, which help bees detoxify nous, natural, foreign and
anthropogenic toxins and their associated deleterious effects. A mixture of these
extracts can be given to the bees via their drinking water, their enriched water, honey,
propolis, pollen patties or even in the wax used for making preformed combs in the
creation of supers for honey production.
EXAMPLE 11
Add the extracts from the mycelium of psis officinalis, Fomitopsis
pinicola, Fomes fomentarius, Inonotus obliquus, Schizophyllum commune, Ganoderma
ceum, Piptoporus betulinus, Trametes versicolor and/or us obliquus to the
water typically fed to bees in the early spring before pollen levels rise, to help
reduce resident viral loads early in the season, preventing their escalation to the level
of becoming a behavior-altering disease or for causing bee-to-bee transfer of
WO 38361 2015/019543
ens. The extracts can simply be mixed into the sugar water at a rate sufficient to
have a positive effect. The range could preferably be 0.01 -20%, or more preferably 0.1 -
% of the volume of the sugar water compositions employed by beekeepers. The
ts would be mixed in the water first and then added to the sugar to make the
typical syrup. The high sugar content would act as a preservative to keep the ral
and antibacterial properties long g.
EXAMPLE 12
Extracts of medicinal mushroom um can be soaked into paper strips.
These paper strips can be combined with an adhesive. The low pH of the many
medicinal mushroom mycelium extracts, in the pH 0.5-4 range, is toxic to mites but
harmless to bees upon contact. Oxalic acid solution may optionally be added in
effective amounts.
EXAMPLE 13
Use extracts of the mycelium or fruitbodies from Ganoderma lucidum,
Ganoderma resinaceum, Fomitopsis pin/cola, Fomitopsis officinalis, lnonotus obliquus,
Piptoporus betulinus, Trametes versicolor and Schizophyllum commune whereby the
extracts are concentrated into a form tive to bees and sufficient, upon contact, to
have the effect of reducing the Tobacco Ringspot Virus, the Israeli Acute Paralysis
Virus, the Black Queen Cell Virus, the Invertebrate Iridescent Virus, or IIV6, and
Nosema microsporidia, resulting in bees being able to better overcome colony collapse
disorder.
EXAMPLE 14
Use extracts of the mycelium or fruitbodies from Ganoderma lucidum,
Ganoderma resinaceum, Fomes fomentarius, Fomitopsis pinicola, psis
officinalis, Schizophyllum commune, lnonotus obliquus and Stropharia rugoso—annu/ata
y the extracts are concentrated into a form that resembles the texture and
consistency of honey, in a form attractive to bees and sufficient, upon t, to have
the effect of reducing viruses, including but not limited to the Tobacco Ringspot Virus,
the Israeli Acute Paralysis Virus, the Black Queen Cell Virus, and Nosema
microsporidia, and causing the up-regulation of cytochrome p450 enzyme pathways,
improving overall immune function, foraging ability, overwintering, drought resistance,
ability to overcome losses of nectar providing plants, resulting in an improved health to
bees so that there is a able benefit for beehives to survive and overcome CCD
and e descendent generations. This “mycological honey” can be used
separately, or mixed into bee honey to attract and benefit bees. Moreover, this
“mycological honey” can be partially dissolved into water as a foliar spray to plants or
applied directly onto bees. Additionally, this ‘mycological honey’ can be marketed as a
nutraceutical for human ption.
EXAMPLE 15
Bees flying to or from the sugar water, upon ng the beehive, buzz and
shake their bodies to dislodge the mites. If the mites fall through a , they are in
contact with or attracted to the entomopathogenic mycoattractant, which in itself may
be lethal, or onto insecticidal mycelium, wherein the mites sicken or die, reducing the
mites’ ability to travel and infect, thus lessening its threat vector to bees. Moreover, if
bees are sprayed with an oxalic acid enriched spray, the parasitic mites become more
susceptible to the infectious or lethal properties of the entomopathogenic fungi.
EXAMPLE 16
The ts, hyphal fragments or spores of beneficial fungi, such as
Stropharia rugoso-annu/ata, and the spores of entomopathogenic fungi such as
Entomophthorales, can be orated as a mixture into the extract-enriched sugar
water, bee foods or honey, which allows for transference into the honey production
stream, tting the brood, the drones, the queen and the hive overall.
EXAMPLE 17
Extracts of the mycelium of, or spores, hyphal fragments, or tissue of,
Stropharia rugoso-annu/ata can be presented on paper strips or in water accessible to
the bees. The fragrance of Stropharia rugoso-annu/ata, to which bees can be
accustomed, helps foraging bees to return to their colonies if these fragrances are
placed near to or within the hives. Such fragrances can be emitted via any method
known to the art of delivery of fragrances, foggers, sprays or aerosol dispensers. It is
expected that the extracts of Stropharia rugoso-annu/ata mycelium and the extracts of
other mushroom mycelia will induce trail following or navigation behavior via “dance
language” and odor plumes.
EXAMPLE 18
Spores and hyphae of Metarhizium anisopliae may be mixed with the
mycelium Fomes fomentarius for producing anti-Varroa mite sprays and smokes for
helping bees resist mites, viruses, etc. for overcoming CCD. Many strains of
Metarhizium are vely nontoxic; “No harm is ed to humans from exposure to
Metarhizium anisopliae strain F52 by ingesting, inhaling, or touching products
containing this active ingredient.” Metarhizium anisopliae strain F52 6)
ticide Fact Sheet.
EXAMPLE 19
A mixture of compositions of extracts of Stropharia rugoso-annulata,
Fomitopsis officinalis, Fomitopsis pinicola, Fomes fomentarius, Ganoderma
resinaceum, Inonotus obliquus, Piptoporus nus, Trametes versicolorand/or
Schizophyllum e and Metarhizium anisopliae, which er offer a plurality of
benefits, can be added to water. The Stropharia rugoso-annu/ata attracts bees, has a
flower-like nce, and provides sugar rich (up to 75 polysaccharides) nutrient
source. The various extracts confer antiviral and antibacterial benefits and life
extension, plus the attractancy of aria rugoso-annu/ata. The Metarhizium
anisop/iae extracts can be presented in sticky strips or mats, or into any sticky, mite- or
Phorid fly- capturing substance, or in water accessible to the same to attract mites and
Phorid flies, whereupon contact, they are tated or killed, reducing their ability to
be a vector of disease; Varroa mite populations can be reduced using izium
anisop/iae extracts before the brood chambers are sealed, reducing bee deaths from
exposure to mites and the diseases they carry. All three extracts n polyphenols,
and more particularly coumarins, which help activate p450 enzyme pathways, which
help bees detoxify endogenous, foreign, natural and anthropogenic toxins and lessen
their associated deleterious effects. A solution of these mixed extracts can be given to
the bees via nectar feeders containing their ng water or their sugar or fructose
enriched water, via mixing into bee candy, honey, propolis, pollen patties or even by
mixing into the wax used for making preformed combs in the on of supers for
honey production.
EXAMPLE20
Extracts of the preconidial mycelium of Metarhizium liae pathogenic to
mites and/or flies can be mixed with spores or hyphal fragments of same, and
presented in sticky strips or mats, or into any sticky, mite- or Phorid fly- capturing
nce, or in water accessible to the mites. This combination attracts mites or flies,
which upon contact, infects them with an entomopathogenic fungus or exposes them to
a lethal doses of entomopathogenic toxins.
EXAMPLE 21
Extracts of the preconidial mycelium of Metarhizium anisopliae mixed with the
extracts, spores or hyphal fragments of Stropharia rugoso-annulata can be presented
on paper strips or in water accessible to the bees. This combination attracts mites or
flies, and bees, which upon contact harms the mites and flies but not bees.
EXAMPLE 22
Extracts of the preconidial mycelium of Aspergi/lus flavus, Aspergi/lus niger
and i/Ius fumigatus can be mixed with the spores or hyphal fragments of
Stropharia rugoso-annu/ata and presented on paper strips or in water accessible to the
bees. This combination attracts mites or flies, and bees, which upon contact harms the
mites and flies but not bees. Optionally, strains of illus flavus, Aspergillus niger
and Aspergi/Ius fumigatus can be used which have reduced xin and neurotoxin
, below the levels which would harm bees but above the levels g mites
and flies, thus conferring a net benefit to bee colony health.
EXAMPLE 23
Extracts of the preconidial mycelium of Metarhizium anisopliae can be mixed
with the spores or hyphal fragments of Stropharia rugoso—annulata can be presented
on paper strips or in water ible to the bees. This combination attracts mites or
flies, and bees, which upon contact harms the mites and flies but not bees. Optionally,
strains of Metarhizium anisopliae can be used which have reduced destructin levels,
below the levels which would harm bees but above the levels harming mites and flies,
thus conferring a net benefit to bee colony health.
EXAMPLE 24
Extracts of mushroom mycelium and/or ts of the preconidial mycelium of
Metarhizium anisopliae can be mixed with extracts or derivatives from Neem trees and
presented on paper strips, in water accessible to the bees or in topical sprays. This
2015/019543
combination attracts mites or flies, and bees, which upon contact harms the mites and
flies but not bees. Optionally, strains of Metarhizium anisopliae can be used which
have reduced destructin levels, below the levels which would harm bees but above the
levels harming mites and flies, thus conferring a net benefit to bee colony health.
Optionally, the concentration of Neem tree extracts (or the active ingredient
azadirachtin), and sugars can be balanced to optimize benefits to bees by reducing
mites and their foraging abilities, and their en payloads. Furthermore, this
combination can be further enhanced with the on of extracts of Basidiomycetes
fungi from agaricoid and polyporoid fungi, which not only provide mite-destroying oxalic
acids, and toxin ing enzymes, but also ulates bee’s innate cytochrome
p450 tic pathways to break down anthropomorphic toxins, and additionally
reduces virally, bacterially, and fungally associated pathogens afflicting bees. Such
synergistic effects from multiple constituents have the net effect of helping bees better
survive colony collapse disorder. A combination of using preconidial mycelium of
Metarhizium anisopliae, the extracts of Fomitopsis officinalis and Fomitopsis pinicola,
the extracts from Neem trees, the extracts of rma Iucidum, Ganoderma
resinaceum, Ganoderma app/anatum, Pleurotus tus, Trametes versico/or and
Stropharia rugoso-annu/ata immersed and mixed into water is anticipated to be an
effective composition and method for making a deliverable, efficacious bee spray or
ient in pollen patties or drinking water. Similar compositions may be sprayed on
plants or trees which bees pollinate, benefitting both plant and bee.
EXAMPLE 25
The methods and compositions of oxalic acid, sugar (or polysaccharide)
enriched water, and the preconidial hyphal fragments from Metarhizium anisop/iae
which upon contact with bees ively harms the mites while having a net benefit to
bees. This composition may optionally be combined with ts of medicinal
mushroom mycelium with antiviral and longevity enhancing properties and incorporated
into bee food.
EXAMPLE 26
The combination of the extracts from Fomes fomentarius, Fomitopsis la,
psis officinalis, Ganoderma lucidum, Ganoderma app/anatum, Ganoderma
resinaceum, Schizophyllum commune, Stropharia rugoso-annulata and Ganoderma
resinaceum in combination with the extracts of the preconidial mycelium of Metarhizium
anisop/iae to attract bees and mites whereby contact with this combination harms
Varroa mites, reducing viruses, pathogenic fungi and bacteria, providing a net benefit
for bees overcoming colony collapse er.
EXAMPLE 27
The combination of the preconidial mycelium of Metarhizium liae with
polysaccharides of Fomitopsis pinicola, Fomitopsis officinalis Ganoderma resinaceum,
Ganoderma lucidum, us obliquus and phyllum communes, to attract bees
and mites whereby contact with this combination harms Varroa mites, and reduces
viruses, bacteriophages, pathogenic fungi and bacteria that harm bees but has a net
benefit for bees overcoming colony collapse disorder.
EXAMPLE 28
Use ts of the mycelium or fruitbodies lacking melanin such as from so
called albino fruitbodies of Agaricus blazei, Fomitopsis officinalis, Fomitopsis pinicola,
Fomes arius, Schizophyllum commune, Trametes elegans and Stropharia
rugoso-annu/ata whereby the extracts are concentrated into a form that resembles the
texture and tency of honey, in a form attractive to bees and sufficient, upon
t, to have the effect of reducing the Tobacco Ringspot Virus, the Israeli Acute
Paralysis Virus, Invertebrate Iridescent Virus, or ||V6, and Nosema poridia, and
causing the up-regulation of cytochrome p450 enzyme pathways, ing overall
immune function, ng ability, ntering, drought resistance, ability to overcome
losses of nectar providing plants, resulting in an improved health to bees so that there
is a measurable benefit for beehives to survive and overcome colony collapse disorder
and e descendent generations. This “mycological honey” can be used
tely, or mixed into bee honey to attract and benefit bees. Moreover, this
“mycological honey” can be partially dissolved into water as a foliar spray to plants or
applied directly onto bees. Additionally, this ‘mycological honey’ can be marketed as a
nutraceutical for human consumption.
EXAMPLE 29
Culture the medicinal mushroom mycelium on plant materials which have
activity against viruses, including Ficus bengalensis (Vad), Ficus osa (Pimpal),
Jasminum latur (Jaai), Acacia catechu (Khair), Azadirachta indica (Neem),
Curcuma longa (Turmeric), Withania somnifera (Ashwagandha) and Silybum marianum
(Milk Thistle). See Deshpande et al., Antiviral activity of plant extracts against sac
brood virus in vitro — a preliminary report, International Journal of Institutional
Pharmacy and Life es 3(6): November-December 2013, p. 1-22.
Example 30
FUNGALLY TREATED STRUCTURAL ALS TO HELP PROTECT BEE
COLONIES
Beehives are typically made of wood fibers, and stackable ‘supers’ hold
frames upon which bees create honeycombs rich in honey, above the brood boxes.
These supers and the other wood based frameworks used by beekeepers eventually
degrade, often times growing molds that can be pathogenic to bees and encourage
invasion by insects and arthropods. As a result, beekeepers typically replace their
supers, brood boxes, and floors etc. every few years. The bases of bee hives tend to
last longer, but ultimately all beehive boxes degrade with opportunistic, often
pathogenic fungi, and the health of bee colonies can be negatively ed as a
result.
This invention is to add, incorporate, impregnate, coat, infuse or attach spores
or fragments of mycelium, or ts thereof, of beneficial fungi, more ically
mushroom forming fungi in the Class Basidiomycetes/Basidiomycota or Ascomycetes,
into the frameworks of beehives, which impart a benefit to bee health by providing a
host defense shield of singular or synergistic benefits. For instance, and not by
limitation, the frames of supers can be made of sheets of wood, wood fiber, and a wide
range agricultural products than be bound together with mycelium, with or without
spores. Such fungally impregnated panels not only provide a structural benefit, but the
fungi can have antiviral, anti-miticidal, antibacterial, antifungal, anti-insecticidal
properties that help bees dwelling on and within the materials used for ng bee
hives.
In addition to beehives, all ures that house animals may be
ageously d with extracts or mycelium, ing bird cages, barns and
structures to house bats.
The materials that can be used to host these beneficial fungi can be made of
wood, particle boards, biodegradable structured panels, fungally grown wood panel
substitutes, non-biodegradable materials, and may also be incorporated into the bees
wax used for the frames, or even the propolis bees use for closing gaps. Compositions
and methods of this invention can easily be incorporated into such open source bee
hive manufacturing.
In essence, as the bee hives age, they incrementally, ically or
increasingly provide a health benefit to bees from the addition of the above mentioned
fungi to offset the increased stressors that occur with bee hives boxes as they get
older. The antiviral properties of these fungi, their creation of a wide ment of
complex and simple sugars, the production of p-coumaric acid and other cytochrome
p450 activating molecules, the formation of spores of entomopathogenic fungi like
izium anisopliae that harm mites but not bees, all work synergistically to
counteract the myriad ors bees suffer from during the lifespan of es in
hives year to year.
One of numerous examples would be to grow mycelium of, for instance, the
polypores Antrodia cinnomonea, Fomes fomentarius, Inonotus obliquus, Inonotus pini,
Fomitopsis officinalis, psis pinicola, Fomitiporia robusta, Ganoderma
applanatum, Ganoderma australe, Ganoderma atrum, rma annulare,
Ganoderma annularis, Ganoderma brownii, Ganoderma lucidum, Ganoderma
resinaceum, Ganoderma tsugae, Lenzites betulina, Phellinus igniarius, Phellinus pini,
Phellinus weirii, Piptoporus betulinus, Trametes s, Trametes versicolor and the
gilled mushrooms Schizophyllum commune, Stropharia rugoso-annulata and Lentinus
ponderosus. on agricultural waste materials so that the mycelium can be formed into
the structural panels used to build bee boxes for honey bees. Additionally, the mite-
killing fungus Metarhizium anisop/iae, can be grown in a preconidial (pre—sporulating)
or post conidial (post ating) state — or a mixture thereof — and be embedded
directly into the constructed , no matter what their composition, in combination
with the fungi described herein as well as other species this inventor anticipates that
could help bees in the Basidiomycetes, Ascomycetes, or the Entomophthorales,
Hypocreales, or other fungi attacking mites or phorid flies.
Similarly, chicken coops, bird feeders, plant trellises, etc. may be constructed
of cellulosic ts impregnated with um and or spores.
Moreover, the aforementioned species and their many relatives contain and
secrete toxin degrading enzymes which can help break down insecticides (including
neonicitinoids, neonics), fungicides, pesticides, formaldehydes, tannins, dyes, c
toxins, and a wide array of anthropogenic toxins.
A preferred wood based substrate would be composed of birch panels,
boards or sawdust (Betula s) and the preferred species would be the birch
polypores such as, but not limited to Fomes arius, Inonotus obliquus,
rma resinaceum and Piptoporus betulinus. lf made of conifer woods, then
polypores such as Fomitopsis pinicola, Fomitopsis officinalis, Laetiporus sulphureus,
nus igniarius, P. pini, P. linteus and P. weirii; or gilled oms such Pleurotus
ostreatus, Lentinus ponderosus are ideal candidates. Trametes versicolor(=Coriolus
versicolor) is a re mushroom growing on deciduous and conifer woods and is
also a preferred species to deploy within the context of this invention. With each of the
species listed, they are to be considered in the broadest concept of the species, i.e.
‘sensu lato’, and close ves are also anticipated to be useful to helping bees. As
such, when bing Fomitopsis officinalis, Ganoderma app/anatum, Ganoderma
lucidum, Ganoderma resinaceum, Inonotus obliquus, Trametes versicolor, or any other
mushroom s, this means Fomitopsis officinalis sensu lato, Ganoderma
applanatum sensu lato, Ganoderma lucidum sensu lato, Ganoderma resinaceum
sensu lato, Inonotus obliquus sensu lato, Trametes versico/or sensu lato and a similar
broad description of any other species, each of which means that this is the species
concept as described within the broadest taxonomic interpretation, encompassing all
historical and modern synonyms, varieties, forms and species that have or will be split
from these species since publication. As is known in the art, names change as new
species concepts are constructed. The species anticipated to be useful is extremely
broad, many of which have been listed in the inventor’s previously approved 8 US.
patents and within the pending patent applications filed to date. Nevertheless, those
species not previously listed now become obvious, subsequent to this or’s
ery.
That the polypore mushrooms Fomes fomentarius, Inonotus obliquus and
rma resinaceum are active against viruses that harm bees and humans is
remarkable, and to the best of the knowledge of this inventor is, medically,
unprecedented. Moreover if these cross animal benefits can be obtained from the
mycelial extracts of these polypore mushrooms, and indeed many mushrooms, then
more than one animal species may benefit from the vast antiviral properties from the
mycelia of these species. Hence, bird houses, chicken , barns and animal
gs of any sort could have the addition of these cultures, their extracts or their
spores for immunological and community-protection benefit, preventing e
vectors from escalating and even curing illnesses of its residents within. Potentially
homes using mycelium and fungi could protect residents from viruses, bacteria,
insects, arthropods, toxins, environmental stressors, disease vectors, and
unexpectedly impart pleasant fragrances ic to the fungi deployed.
Extracts useful for the above ion can come as a by—product of those
using mycelium for filling forms or molds to create mycelium grown ured
materials, such as insulation, shipping materials to replace Styrofoam, building
materials, packaging materials, filtration cushions, filtration membranes, s,
scaffolding for growing mycelial based computer chips and processors, mycobacterial
based res, etc. Additionally, these useful extracts can be harvested by
expressing the liquid components from substrates used in all stages of mushroom
production as well as from the fungal fermentation methods used for making tempeh,
koji, enzymes, antibiotics, plant growth enhancers, and pharmaceuticals. In e
when growing out the mycelium, the mycelially made materials often are dried. In doing
so, the extracellular and intracellular lites and other liquids must be removed.
When growing of mycelium based structured als, this excess liquid is discarded
and not typically highly valued. This invention repurposes this ‘waste’ liquid product into
an unexpected high added suite of products that can be rich in antivirals,
antimicrobials, enzymes, acids, active ingredients, and other chemicals useful to this
invention for helping bees and for many other applications in nes, chemical
engineering, degradation ces, and bioremediation (mycoremediation). Moreover,
the now dried myceliated product can be designed so that a latent population of fungal
cells survive the drying process, only to be re-activated when the bee hives age,
causing the mycelium and its heat-tolerate sclerotia and chlamydospores to survive
and re-grow to provide an unusual benefit — as the bee hives age, the impregnated
beneficial fungi compete against fungal pathogens, provide nutrients, increase overall
bee colony longevity. Beneficial fungi can be selected specifically for heat resistant
chlamydospores and sclerotia survivability uent to the manufacturing of
mycelially grown, structured materials. The repurposed liquid from compressing the
mycelium as well as the heat—tolerant mycelium resident within the structured materials
can be combined for istic benefits to bee health.
E 31
Honey is collected from bees fed mycelium ts as above. This medicinal
honey helps both bees and people up-regulate pathways for denaturing toxins, via
cytochrome P450 pathways. Since honey is a food for more than bees and people,
such medicinal honeys are expected to have a wide range of uses. The preservative
properties of honey can help keep these nally active compounds more stable.
Example 32
α-Amylase, amyloglucosidase, betulinic acid, caffeic acid, protocatechuic
acid, trans-cinnamic acid, ferulic acid, gallic acid, ellagic acid, lanosterol, inotodiol,
enolic acids, hispolons, ergosterols, chrysin, cordycepin, trans-ο-coumaric acid,
trans-ρ-coumaric acid, ellagic acid dihydrate, ergosterol, ic acids, trans-ferulic
acid, gallic acid hydrate, hexanal, hispolon, 4- hydroxybenzoic acid, quercetin hydrate,
rutin e, syringic acid, vanillic acid, sulpherinic acid, Dehydrosulphurenic acid,
eburicoic acid, 6-chlorophenyl-2H-chromenone, ethyl 6-chlorooxophenyl-
2H-chromencarboxylate, 7-chlorophenyl-2H-chromenone, ethyl 7-chloro
oxophenyl-2H-chromencarboxylate, psilocybin, psilocin and their congeners,
isomers, structural analogs and icantly similar compounds may prove useful in
the practice of this ion. The compounds are also anticipated to be useful with
other animals, including humans.
Example 33
Since protocatechuic acid, vanillic acid, cinnamic acid, c acid and their
congeners, isomers, ural analogs and significantly similar compounds are widely
distributed and t in many edible plants and with protocatechuic acid being
naturally high in bran and grain brown rice, growing bee-benefitting fungal species
mentioned herein on a substrate already containing protocatechuic acid, its precursors
and analogs, will likely increase the net amount of these bee-benefitting compounds,
and is a further embodiment to improve this invention.
Example 34
Extracts of the spores, mycelium and hyphal fragments, or fruitbody tissue of
the polypore mushrooms Fomes fomentarius, Fomitopsis pinicola, psis
officinalis, Piptoporus betu/inus, Ganoderma resinaceum, Ganoderma Iucidum,
Schizophyllum commune, and us obliquus, can be aerosolized, or delivered via
droplet-clouds, sprayed into hives in combination with a spore-mycelium mixture of
Metarhizium anisopliae. Such a mixture will reduce viral pathogens, up-regulate
detoxification ys within bees, provide a wide assortment of complex and simple
sugars, vitamins to augment immunity and longevity of the hive. Moreover the addition
of izium anisopliae spores and mycelium can infect, l and prevent Varroa
mites and Phorid flies. The endogenous oxalic acid within all these fungi can help
l these pathogens. The individual use or combinations of the birch polypores
fungi can restrict growth of the Nosema poridium fungi, and foulbrood bacteria
(such as the bacterium Melissococcus plutonius) from inflicting harm to the bee colony.
Such aerosolized sprays can be delivered using handheld or ck sprayers.
Alternatively, absorbent strips can be deployed infused with the above beneficial
agents. Constructed materials used for building the housings of bee boxes can also be
soaked and impregnated with these beneficial agents.
Claims (19)
1. A method for reducing bee viral load and increasing bee life longevity comprising adding an effective amount of less than 10% by volume of an extract of a nal mushroom um to a feeding supplement for bees to produce a ition for ng bee viral load and increasing bee life longevity and feeding the composition for ng bee viral load and increasing bee life longevity to bees, wherein the medicinal om mycelium is selected from the group consisting of us obliquus, Ganoderma resinaceum, Fomitopsis pinicola, Fomes fomentarius, Schizophyllum commune, Trametes versicolor, Fomitopsis officinalis, Ganoderma applanatum, Ganoderma lucidum, and combinations thereof.
2. The method of claim 1, wherein the composition comprises (a) 1% by volume of the extract of the medicinal mushroom mycelium; (b) one or more bee feeding ments; and (c) a preservative selected from alcohol, sugar, or honey.
3. The method of claim 1 or 2, wherein the feeding supplement for bees comprises a product selected from the group consisting of water, sugars, sugar syrup, high fructose corn syrup water, bee candy, nectar, pollen, pollen patties, grease patties, propolis, bees wax, bee sprays, bee feed, protein supplements and ations thereof.
4. The method of any one of the proceeding claims, wherein the composition further comprises 1% by volume of one or more extract of the medicinal mushroom mycelium of one or more of Antrodia cinnomonea, Ganoderma atrum, Ganoderma brownii, Ganoderma curtisii, Ganoderma m, Ganoderma lingzhi, Ganoderma oregonense, Ganoderma tsugae, Fomitopsis officinalis (Laricifomes officinalis), Fomitiporia robusta, Heterobasidion annosum, us hispidus, us andersonii, Inonotus dryadeus, Laetiporus cincinnatus, Laetiporus sulphureus, Laetiporus conifericola, Lenzites betulina, Phellinus igniarius, Phellinus linteus, nus pini, Piptoporus betulinus, Polyporus elegans, Stereum complicatum, Stereum hirsutum, Stereum ostrea, Trametes elegans, Trametes gibbosa, Trametes hirsuta, Trametes villosa, Trametes cingulata, Trametes ea, Trametes ens, Trametes ectypa, Trametes aesculi, Wolfiporia cocos, Agaricus augustus, Agaricus blazei, Agaricus bonardii, Agaricus brasiliensis, Agaricus campestris, Agaricus lilaceps, Agaricus subrufescens, Agaricus sylvicola, be pediades, Agrocybe aegerita, be arvalis, Agrocybe praecox, Clitocybe odora, Conocybe cyanopus, Conocybe lacteus, Conocybe rickenii, Conocybe smithii, Conocybe tenera, Coprinopsis nivea, Coprinopsis lagopus, Coprinus comatus, Coprinus micaceus, Gymnopus hydrophilus, Gymnopus tus, Hypholoma aurantiaca (Leratiomyces ceres), Hypholoma capnoides, Hypholoma eritium, Hypsizygus marmoreus, Hypsizygus tessulatus, Hypsizygus ulmarius, Lentinus ponderosus, Lepiota procera (Macrolepiota procera), Lepiota es (Chlorophyllum rachodes), Lepista nuda, Mycena alcalina, Mycena pura, Mycena aurantiadisca, Panellus serotinus, Panaeolus foenisecii, Panaeolus subbalteatus, Pleurotus columbinus, Pleurotus ostreatus, Pleurotus cystidiosus, Pleurotus pulmonarius, Pleurotus sapidus, Pleurotus tuberregium, Panellus stipticus, us serotinus, Pluteus cervinus, rella aquatica, Psathyrella condolleana, rella hydrophila, Psilocybe allenii, Psilocybe azurescens, Psilocybe escens, ybe coprophila, Psilocybe cubensis, Psilocybe cyanescens, Psilocybe ocystidiata, Psilocybe stuntzii, Psilocybe uginosa, Stropharia nosa, Stropharia cyanea, Stropharia rugoso-annulata, Stropharia semiglobata, Stropharia semigloboides, Stropharia squamosa, Stropharia thrausta, Stropharia umbonotescens, Termitomyces robusta, Volvaria bombycina, Volvariella volvacea, or combinations thereof.
5. The method of any one of the preceding claims, wherein the composition further comprises one or more solvents.
6. The method of claim 5, wherein the solvent comprises water, ethanol, or a water ethanol mixture.
7. The method of any one of the ing claims, wherein the medicinal om mycelium is cultivated on a substrate selected from the group consisting of solid substrates and liquid substrates.
8. The method of any one of the preceding claims, wherein the extract of a medicinal mushroom mycelium comprises an aqueous t of medicinal mushroom mycelium, an aqueous ethanolic extract of medicinal mushroom um, itate from an aqueous extract of medicinal mushroom mycelium precipitated by addition of ethanol, atant remaining after the precipitate from an aqueous extract of medicinal mushroom mycelium precipitated by addition of ethanol is removed, precipitate from an aqueous ethanolic extract of medicinal mushroom mycelium allowed to sit, concentrate from aqueous lic extract of medicinal om mycelium which has had a n of the solvent removed, supernatant from aqueous ethanolic extract which has had a portion of solvent removed, or microwave-assisted extract of nal om mycelium.
9. The method of any one of the preceding claims, wherein the composition for reducing bee viral load and increasing bee life longevity additionally comprises a miticide selected from the group consisting of synthetic des, natural miticides and combinations thereof, and wherein the natural miticides are selected from the group consisting of Neem extracts, oxalic acid, formic acid, lactic acid and combinations thereof.
10. The method of any one of claims 1 to 8, wherein the composition further comprises one or more miticides.
11. The method of claim 10, wherein the miticide comprises Neem extracts, oxalic acid, formic acid, lactic acid, spores of entomopathogenic fungi pathogenic to mites, hyphae of entomopathogenic fungi pathogenic to mites, preconidial mycelium of entomopathogenic fungi pathogenic to mites, extracts of idial mycelium of entomopathogenic fungi pathogenic to mites, or combinations f.
12. The method of any one of the preceding claims, wherein the composition ses bee life longevity by more than 3%.
13. The method of any one of the preceding claims, wherein the composition reduces viral load by more than 15%.
14. The method of any one of the ing claims, wherein the composition increases bee life longevity and s viral load by an LV index of more than 1.
15. The method of any one of the preceding claims wherein the composition reduces viral load by an LV index of more than 45.
16. The method of any one of the preceding claims, wherein the composition increases bee life longevity and reduces viral load by an LV index of more than 50.
17. The method of any one of the preceding claims, wherein the composition increases bee life longevity and reduces viral load by an LV index of more than 200.
18. A method for reducing bee viral load and increasing bee life longevity comprising adding an t of a medicinal mushroom mycelium to a feeding supplement for bees to produce a composition for reducing bee viral load and increasing bee life longevity and feeding the composition for reducing bee viral load and increasing bee life longevity to bees, wherein the composition comprises an ive amount of 10% or less by volume of the extract of a medicinal mushroom mycelium and wherein the medicinal mushroom um is selected from the group ting of Fomes fomentarius, Trametes versicolor, and a combination thereof.
19. The method of claims 1 or 18, substantially as herein described with reference to any one of the Examples and/or
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461967117P | 2014-03-10 | 2014-03-10 | |
| US61/967,117 | 2014-03-10 | ||
| US14/247,207 | 2014-04-07 | ||
| US14/247,207 US20140220150A1 (en) | 2000-10-04 | 2014-04-07 | Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD): methods and compositions |
| US201462074023P | 2014-11-02 | 2014-11-02 | |
| US62/074,023 | 2014-11-02 | ||
| US14/641,432 US9474776B2 (en) | 2000-10-04 | 2015-03-08 | Integrative fungal solutions for protecting bees |
| US14/641,432 | 2015-03-08 | ||
| PCT/US2015/019543 WO2015138361A1 (en) | 2014-03-10 | 2015-03-09 | Integrative fungal solutions for protecting bees |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NZ723135A NZ723135A (en) | 2021-03-26 |
| NZ723135B2 true NZ723135B2 (en) | 2021-06-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017200872B2 (en) | Integrative fungal solutions for protecting bees | |
| US10821145B2 (en) | Integrative fungal solutions for protecting bees | |
| US20140220150A1 (en) | Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD): methods and compositions | |
| US11752182B2 (en) | Integrative fungal solutions for protecting bees | |
| Birkemoe et al. | Insect-fungus interactions in dead wood systems | |
| Stefanini | Yeast‐insect associations: It takes guts | |
| Ebani et al. | Entomopathogenic fungi and bacteria in a veterinary perspective | |
| Castañeda-Ramírez et al. | The possible biotechnological use of edible mushroom bioproducts for controlling plant and animal parasitic nematodes | |
| US8753656B2 (en) | Controlling zoonotic disease vectors from insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi | |
| Kwenti | Biological control of parasites | |
| US20120070414A1 (en) | Controlling disease vectors from insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi | |
| Pobożniak et al. | Biocontrol in integrated pest management in fruit and vegetable field production | |
| Izah et al. | Bioactive compounds In edible mushrooms: Sustainability and health applications | |
| Masiulionis et al. | Investigating the biology of leaf-cutting ants to support the development of alternative methods for the control and management of these agricultural pests | |
| NZ723135B2 (en) | Integrative fungal solutions for protecting bees | |
| Abdou et al. | Efficacy of two entomopathogenic fungi in combination with diatomaceous earth against Spodoptera littoralis (Boisd.)(Lepidoptera: Noctuidae) | |
| EA037750B1 (en) | Integrative solutions for protecting bees using fungi | |
| Marouf et al. | Effect of propolis extracts and Bacillus thuringiensis on leafminer fly Liriomyza sativae (Diptera: Agromyzidae). | |
| KR100474296B1 (en) | Preparation method for paecilomyces japonica with anti-diabetic activity | |
| Simone | Colony-level immunity benefits and behavioral mechanisms of resin collection by honey bees | |
| Kumar et al. | Entomopathogenic Fungi: A Biological Weapon for Pest Management | |
| Kumar et al. | Entomopathogenic Fungi: A Biological Weapon for | |
| Schuin | Understanding the role of phytopathogens in the mycobiome of blueberry-foraging Western Cape honeybees (Apis mellifera capensis). | |
| Golo et al. | Advances in the use of entomopathogenic fungi to control ixodid ticks | |
| Evans | Resin Collection and Social Immunity in Honey Bees |